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Abstract v
Abstract 
Enteroviruses, such as polio- and coxsackievirus, are positive-stranded RNA viruses, 
and belong to the family of Picornaviruses. Positive-stranded RNA viruses follow a 
common mechanism to replicate their RNA genomes. First, the viral genome is 
transcribed into a minus-strand intermediate, which then acts as a template for the 
synthesis of new plus-strands. The same viral RNA-dependent RNA polymerase 
synthesizes both RNA strands using viral and host factors to initiate synthesis. 
Enteroviruses make very efficient use of their small genomes. Several cis-acting 
replication elements can be found throughout their genome, including one within the 
coding region. Most of these elements consist of RNA regions, which fold into 
secondary structures that can form complexes with viral and cellular proteins. Such 
complex formations are often required to initiate a new step in replication, and thus, 
function as key players in regulation of the viral life cycle. Some of the cis-acting 
replication elements have overlapping functions and play a role in several steps in RNA 
synthesis.  
In this thesis, two cis-acting replication elements in enteroviruses were analyzed for 
their roles in RNA synthesis: the cloverleaf structure in poliovirus and the cre(2C) 
hairpin RNA in coxsackievirus B3 (CVB3). 
 A cloverleaf-like RNA structure formed at the 5’-end of the poliovirus plus-strand is 
required for negative-strand RNA synthesis but has also been implicated in positive-
strand RNA synthesis. Analyzing the precise role of the cloverleaf RNA element in 
positive-strand RNA synthesis has been hindered by its role in negative-strand 
synthesis, as mutations disrupting the structure and/or functions on the cloverleaf 
disrupt minus-strand RNA synthesis.  To overcome this limitation, we have developed 
a novel approach to analyze cis-acting elements with multiple roles in virus replication. 
Poliovirus replicons were engineered to contain two tandem cloverleaf structures to 
separate multiple functions. Thus, a downstream cloverleaf, which only supports 
minus-strand RNA synthesis, allowed the genetic analysis of a 5’-terminal cloverleaf 
dedicated to promote plus-strand RNA synthesis. Our results reveal that the cloverleaf 
structure in the plus-strand functions as a promoter for both positive- and negative-
strand RNA synthesis. We could show that stem a sequences within the cloverleaf 
structure are essential for plus-strand RNA synthesis. Also required to initiate plus-
strand RNA synthesis are the binding sites for the viral polymerase precursor 3CD and 
the host factor PCBP2 located within the cloverleaf structure. Furthermore, in a 
functional assay we could demonstrate that the viral 2C protein is directly involved in 
plus-strand RNA synthesis. Based on our results, we propose a new model for the 
initiation of positive-strand RNA synthesis in poliovirus. 
In the second part of this thesis, the cre(2C) RNA of coxsackievirus B3 and its role in 
RNA replication was analyzed. A stem-loop element located within the 2C coding 
region of CVB3 has been proposed to function as a cis-acting replication element. The 
MFOLD program was used to predict the structure and the precise location of the 
cre(2C) hairpin. Characterization of the cre(2C) loop showed that a proposed entero- 
and rhinoviral consensus sequence is also applicable to the CVB3 cre(2C) loop 
sequence, and that the cre(2C) element functions as a template for VPg-uridylylation in 
vitro. Even though previous studies of the cre(2C) in poliovirus have shown that the cre 
RNA is not required for initiation of negative-strand RNA synthesis, we were able to 
demonstrate that the CVB3 cre(2C) is required for the imitation of both, negative- and 
positive-strand RNA synthesis.  
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Enteroviren, wie zum Beispiel Polio- und Coxsackieviren, sind positivsträngige RNA-Viren und 
gehören zur Familie der Picornaviren. Positivsträngige RNA-Viren replizieren ihre Genome auf 
sehr ähnliche Art und Weise, indem das Virusgenom zunächst in einen Minusstrang 
umgeschrieben wird, welcher im nächsten Schritt als Vorlage zur Synthese von neuen 
Plussträngen dient. Dieselbe virale RNA-abhängige RNA Polymerase synthetisiert, unter 
Mithilfe von viralen und Wirtsproteinen bei der Initiierung der Synthese, beide RNA-Stränge. Im 
Genom von Enteroviren finden sich mehrere cis-aktive Replikationselemente, von denen sogar 
eines innerhalb des kodierenden Bereichs liegt. Die meisten solcher Elemente bestehen aus 
RNA-Bereichen, die sich in Sekundärstrukturen falten und  dann Komplexe mit viralen und 
zellulären Proteinen eingehen können. Solche Komplexformationen sind häufig Vorraussetzung 
zur Initiierung eines neuen Replikationsschrittes und stellen daher Schlüsselereignisse in der 
Regulation des Lebenszyklus der Viren dar. Einige der cis-aktiven Replikationselemente haben 
mehrere überlappende Funktionen und spielen eine Rolle in mehreren Schritten der RNA-
Synthese. In der vorliegenden Dissertation wurden zwei cis-aktive Replikationselemente von 
Enteroviren auf ihre Rolle in der RNA-Synthese analysiert: die Kleeblatt-Struktur in Poliovirus 
und die cre(2C) Haarnadelstruktur in Coxsackievirus B3 (CVB3). 
Eine Kleeblatt-ähnliche Sekundärstruktur am 5’-Ende des Positivstrangs von Poliovirus ist 
essentiell für die Negativstrangsynthese, wurde aber auch mit der Positivstrangsynthese in 
Verbindung gebracht. Die Analyse der präzisen Rolle der Kleeblatt RNA-Struktur in der 
Positivstrangsynthese wurde bisher durch ihre Rolle in der Negativstrangsynthese behindert, da 
Mutationen, die die Struktur und/oder die Funktion der Kleeblatt-Struktur zerstören, die 
Negativstrangsynthese behindern. Um diese Einschränkung zu umgehen, haben wir ein neues 
System entwickelt, das die Analyse cis-aktiver Elemente mit mehreren Rollen in der 
Virusreplikation erlaubt. Poliovirus-Replikons mit zwei direkt aufeinander folgenden Kleeblatt-
Strukturen ermöglichten die genetische Analyse der 5’-terminalen Kleeblatt-Struktur, die die 
Positivstrangsynthese unterstützt, während die nachgeschaltete Kleeblatt-Struktur nur für die 
Negativstrangsynthese zur Verfügung stand. Unsere Ergebnisse zeigen, dass die Kleeblatt-
Struktur im Positivstrang als Promoter sowohl für die Negativ- als auch die 
Positivstrangsynthese dient. Die Sequenzen des Stem a der Kleeblatt-Struktur waren für die 
Positivstrangsynthese unentbehrlich. Zwei weitere Bindungsstellen innerhalb der Kleeblatt-
Struktur, für 3CD, die Proteinvorstufe der viralen Polymerase, und das Wirtsprotein, PCBP, sind 
ebenfalls für die Positivstrangsynthese erforderlich. Auβerdem konnten wir nachweisen, dass 
das virale Protein 2C direkt an der Positivstrangsynthese beteiligt ist. Basierend auf unseren 
Ergebnissen stellen wir ein neues Modell für die Initiierung der Positivstrangsynthese in 
Poliovirus vor. 
Im zweiten Teil dieser Dissertation wurde die Rolle der cre(2C) RNA in der RNA-Replikation von 
Coxsackievirus B3 untersucht. Eine Haarnadelstruktur innerhalb des 2C  Kodierungsbereichs 
von CVB3 wurde als cis-aktives Replikationselement vorhergesagt. Mit Hilfe von MFOLD 
wurden die Struktur und die präzise Lage der cre(2C) Haarnadelstruktur berechnet. Die 
Charakterisierung der Schleifensequenzen von cre(2C) zeigte, dass eine vorhergesagte Entero- 
und Rhinovirus Konsensussequenz auch auf das CVB3 cre(2C) zutrifft, und dass das cre(2C) 
als Kopiervorlage zur VPg-Uridylylierung in vitro dient. Im Gegensatz zu früheren 
Untersuchungen, die gezeigt haben, dass das Poliovirus cre(2C) nicht an der 
Negativstrangsynthese beteiligt ist, konnten wir nachweisen, dass das CVB3 cre(2C) sowohl für 
die Initiierung der Negativ- als auch der Positivstrangsynthese notwendig ist.   
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aa 
ATP 
CTP 
cDNA 
cpm 
DNA 
dNTP 
DTT 
EDTA 
EGTA 
ER 
FPLC 
GTP 
HEPES 
hnRNP 
Ig 
IPTG 
kb 
kDa 
min 
mRNA 
nt 
NTP 
PAGE 
PCR 
RNA 
RNP 
rRNA 
SDS 
tRNA 
UMP 
UTP 
 
 
 
amino acid 
adenosine triphosphate 
cytidine triphosphate 
complementary desoxyribonucleic acid 
counts per minute 
desoxyribonucleic acid 
deoxyribonucleotides 
dithiothreitol 
ethylene diamine tetraacetic acid 
ethylene glycol tetraacetic acid 
endoplasmic reticulum 
fast protein liquid chromatography 
guanosine triphosphate 
N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
heterogeneous nuclear ribonucleoprotein 
immunoglobulin 
Isopropyl β-D-1-thiogalactopyranoside 
kilobase 
kilo Dalton 
minute 
messenger RNA 
nucleotide 
ribonucleotides 
polyacrylamide gel electrophorese 
polymerase chain reaction 
ribonucleic acid 
ribonucleoprotein 
ribosomal ribonucleic acid 
sodium dodecyl sulphate 
transfer ribonucleic acid 
uridine monophosphate 
uridine triphosphate 
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1. Introduction 
 
Since the first discovery of poliovirus as the causative agent of paralytic poliomyelitis in 
1909 by Landsteiner & Popper (Landsteiner, 1909), the studies to understand the life 
cycle and pathogenesis of this virus have ultimately led to a new field of science called 
“Molecular Virology”. The revolutionary development of new genetic techniques paved 
the way for numerous viral research milestones achieved by polio- and 
picornavirologists during the last 50 years. The Picornaviridae family includes many 
animal and human pathogens such as rhinovirus, the most important cause of the 
common cold; foot-and-mouth disease virus, an important agricultural pathogen; 
hepatitis A virus, which causes acute liver infections; and enteroviruses such as 
poliovirus or coxsackie A and B virus, which have been associated with a variety of 
clinical manifestations. Research on picornaviruses has had an impact on virology and 
even biology in general. Such research highlights include growth of these viruses in 
cell culture (Colter et al., 1957; Alexander et al., 1958), the development of inactivated 
and attenuated vaccines (Salk, 1953c, a, b; Sabin et al., 1954; Sabin, 1955a, b), the 
discovery of receptor families (Holland & McLaren, 1959), the demonstration of the first 
RNA-dependent RNA polymerase activity of an animal virus (Franklin & Baltimore, 
1962; Baltimore et al., 1963), polyproteins as precursors for viral polypeptides and their 
proteolytic cleavage (Jacobson & Baltimore, 1968; Summers & Maizel, 1968), the first 
full sequence analysis of a virus (Kitamura et al., 1981; Racaniello & Baltimore, 1981b), 
demonstration that a cDNA copy produced virus progeny after transfection into cells 
(Racaniello & Baltimore, 1981a), the first resolution of the three-dimensional structures 
of animal viruses at the atomic level (Hogle et al., 1985), the discovery of internal 
ribosomal entry sites (IRES) to initiate translation in a cap-independent mechanism 
(Jang et al., 1988; Pelletier & Sonenberg, 1988), and the production of infectious virus 
in cell-free extracts programmed with purified  viral RNA (Molla et al., 1991). However, 
the precise details of molecular events of picornavirus replication, such as virion 
uncoating, translation initiation, viral RNA replication, virus assembly, and virus-host 
interactions remain to be elucidated.  
Poliovirus in particular has proven a good model system that has helped to shed light 
on mechanisms of the viral life cycle common not only to picornaviruses, but to many 
positive-strand RNA viruses. The eradication of poliovirus as an agent of human 
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disease is just around the corner. Nevertheless, with human picornaviruses alone 
causing an estimated 6 billion infections per year, continued detailed research remains 
critical to learn as much as possible about the life cycles of these viruses.  
 
1.1 Vaccines 
Fifty years ago, polio was endemic throughout the world (Paul, 1971). In 2001, the total 
number of polio cases worldwide was estimated to be <1000 (World Health 
Organization, 2002). The widespread immunization with both the inactivated (IPV) and 
the oral attenuated live (OPV) poliovirus vaccine has made this near eradication 
success possible (Plotkin, 1999; Sutter, 1999). There are three serotypes of poliovirus 
(type 1, 2, and 3) that are defined by their gross serological properties and the cross 
protection induced, such that infection with one type does not give solid protection 
against the other two (Rueckert, 1997). The main site of replication of poliovirus is in 
the intestine, and transmission of infection is normally by the fecal-oral route. Disease 
occurs when the virus escapes its normal intestinal replication site and infects the 
central nervous system (Bodian, 1955, 1958). Both the IPV and OPV vaccines induce 
protection through a strong serotype specific humoral neutralizing antibody response 
and immunity is thought to persist for life. Several studies suggest that immunization 
protects from disease rather than reinfection by the virus (Modlin, 1995). Using the 
OPV for immunization provides advantages in ease of administration by oral route, 
lower costs in production and administration, and the ability to induce intestinal 
immunity that is capable of effectively blocking person-to-person transmission of wild-
type poliovirus in an immune population. The OPV also results in shedding of the 
attenuated vaccine strains by vaccinees, with the potential advantage of conferring 
herd immunity. However, this shedding carries the risk of propagating acquired 
mutations (revertants, for example) in the transmitted vaccine strains, which can result 
in increased pathogenesis and a neurovirulent phenotype. The calculated risk for 
contracting paralytic poliomyelitis from an OPV infection is 1 in 2.5 million individuals, 
with the risk increasing in immunocompromised persons (Modlin, 1995). Unlike the live 
OPV strains, the IPV consists of a formalin-killed preparation of wild-type viruses 
(Plotkin, 1999). This provides the advantage of being non-replicative, and thus unable 
to revert to a neurovirulent phenotype. The efficacy rate of IPV is similar to that of OPV. 
The disadvantages of IPV are that it does not induce intestinal immunity, and since 
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there is no shedding of live viruses it does not lead to herd immunity. However, with the 
eradication efforts closing in on their goal, IPV will be the vaccine of choice for the 
future to avoid circulation of new potentially neurovirulent polioviruses. 
 
Table 1: Current classification of Picornaviridae (Stanway, 2002) 
Genus                           Species 
 
Enterovirus                        Poliovirus 
                                          Human enterovirus A (HEV-A) 
                                          Human enterovirus B (HEV-B) 
                                          Human enterovirus C (HEV-C) 
                                          Human enterovirus D (HEV-D) 
                                          Bovine enterovirus (BEV) 
                                          Porcine enterovirus A (PEV-A) 
                                          Porcine enterovirus B (PEV-B) 
Rhinovirus                         Human rhinovirus A (HRV-A) 
                                          Human rhinovirus B (HRV-B) 
Cardiovirus                        Encephalomyocarditis virus (EMCV) 
                                          Theilovirus (ThV) 
Aphtovirus                         Foot-and-mouth disease virus (FMDV) 
                                          Equine rhinitis A virus 
Hepatovirus                       Hepatitis A virus 
                                          Avian encephalomyelitis-like virus (AEV) 
Parechovirus                     Human parechovirus (HPeV) 
Erbovirus                           Equine rhinitis B virus (ERBV) 
Kobuvirus                          Aichi virus (AiV) 
Teschovirus                       Porcine teschovirus (PTV) 
 
1.2 Genetics of poliovirus 
1.21 Classification 
The viral family Picornaviridae was originally divided into four genera. This 
classification was based on shared pathogenic properties in humans and animals, and 
biophysical properties such as density, sedimentation coefficient, virion weight, 
absence of lipid envelope, ether resistance and stability over a certain pH-range 
(Melnick et al., 1974). The fast accumulation of new information such as a large 
amount of sequence data, structural analysis and receptor identification called for a 
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new classification of this virus family. Classification is now based on phylogenetic 
properties that more accurately reflect evolutionary history and the details of the virus 
replication mechanisms (Stanway, 2002). Traditionally, picornaviruses have been 
defined in terms of serotypes, grouped into genera. Recently, a radical change has 
been introduced: the concept of picornavirus species, generally consisting of several 
serotypes (King, 2000). To date, the Picornaviridae family is divided into nine genera 
with most of them consisting of several species (see table 1). 
The conditions for a picornavirus to be classified as a species of the genus Enterovirus 
are the following (King, 2000): 
 a 5’untranslated region (UTR) of a particular general form and function 
 a 2A protein that is related to the chymotrypsin group of proteases 
 no leader protein 
 a 3’UTR containing at least two stem-loops that interact to form a tertiary 
structure                                                                                                   
 
1.22 Genetic organization of poliovirus 
Picornaviruses are positive-stranded RNA viruses, whose genome and mRNA are of 
the same polarity. Poliovirus genomic RNA and mRNA are identical molecules except 
that the viral protein, VPg, is absent from mRNA. Following infection and uncoating of 
the virus, VPg is removed by a cellular enzyme that cleaves the phosphodiester bond 
(Ambros et al., 1978; Ambros & Baltimore, 1980; Wimmer, 1982) 
The poliovirus RNA genome is 7433 nucleotides long and includes a 5’UTR followed 
by a single open reading frame (ORF) of 6528 nt and a polyadenylated 3’UTR. The 5’-
end of the genome is covalently linked to a viral peptide of 22 amino acids, VPg (Yogo 
& Wimmer, 1972; Flanegan et al., 1977; Lee et al., 1977; Racaniello & Baltimore, 
1981b). The 5’ UTR is 743 nt long and contains a high degree of secondary structure 
as predicted both by computer modeling and biochemical analysis. The ORF is 
translated into one polyprotein that is co-translationally processed by the virally 
encoded proteases 2A, 3CD and 3C into several precursors and 12 final peptides 
(Kräusslich & Wimmer, 1988). An overview of the genomic organization and protein 
processing is shown in Figure 1.1. The N-terminal portion of the polyprotein (P1 region) 
encodes the structural proteins, none of which are required for genomic replication. 
The P2 and P3 regions encode the non-structural proteins required for replication. The 
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first cleavage event is mediated by the 2A protease and leads to the release of the P1 
region from the rest of the polyprotein (Toyoda et al., 1986). The remaining cleavage 
events are mediated by the 3C or 3CD proteases (Hanecak et al., 1982; Hanecak et 
al., 1984). Picornaviruses make very efficient use of their small genomes in that protein 
precursors, in addition to fully processed, peptides have very distinct and often multiple 
functions within the virus life cycle. 
. 
 
 
 
 
 
 
 
Figure 1.1: Structure of poliovirus genomic RNA and processing of the polyprotein. The single-
stranded RNA of poliovirus is shown with the terminal protein VPg at its 5’-end and the 3’-UTR with the 
poly(A) tail at its 3’-end. The 5’UTR consists of the cloverleaf and the large IRES element. The location of 
the cre(2C) hairpin in the coding region of 2C is indicated. The polyprotein contains structural (P1) and 
non-structural (P2, P3) domains. The single ORF as well as the gene products are represented by open 
boxes. The final proteins that result after proteolytic cleavage by viral proteases are indicated; the 
cleavage sites are represented by red triangles. 
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1.3 Effects of poliovirus infection in the host cell 
1.31 Host cell translation shutoff 
Picornaviruses have developed subtle strategies to interfere with the host cell 
metabolism and to simultaneously promote the expression of their own genome. 
Infected cells lose the capability of synthesizing cellular proteins within 2 to 3 hours 
after infection, a phenomenon called “host cell shutoff”, while translation of viral 
proteins increases progressively (Sonenberg, 1990, 1996; Ehrenfeld, 1997). Poliovirus 
translation is initiated from an IRES located within the long 5’UTR region, whereas 
cellular mRNA translation occurs by a cap-dependent mechanism (Kitamura et al., 
1981; Racaniello & Baltimore, 1981b).  There is overwhelming evidence that the viral 
protein 2Apro mediates cleavage of the translation initiation factor eIF4GI (formerly 
known as p220, then called eIF4G before being renamed eIF4GI) (Kräusslich et al., 
1987; Lloyd et al., 1988; Sun & Baltimore, 1989; Davies et al., 1991; Aldabe et al., 
1995). eIF4GI constitutes an ideal target, as it acts as a central scaffold in the 
assembly of a complex between the capped mRNA and the ribosome during initiation 
of cap-dependent protein synthesis. The interaction of these various players results in 
the circularization of the functional mRNA in the state of translation and reinitiation 
(Michel et al., 2000). Thus, cleavage of eIF4GI leads to the inactivation of cap-
dependent translation and consequently to the shutoff of cellular protein synthesis.  
The cleavage of eIF4GI is the main, but not the only, strategy of the virus for the 
shutoff of host cell translation. During an infection in the presence of 2 mM guanidine 
hydrochloride (GuHCl), which inhibits replication, complete cleavage of eIF4GI is 
observed yet cap-dependent translation is blocked by only 40-50% (Leibowitz & 
Penman, 1971; Nielsen & McConkey, 1980). What is responsible for the inhibition of 
the other 50%? Several other cleavage events of cellular proteins are observed in such 
virus infections that are blocked by treatment with GuHCl. eIF4GII, a functional 
homologue of eIF4GI, is also cleaved during poliovirus infection, albeit at a slower rate 
than 4GI (Gradi et al., 1998). Another viral protease, 3Cpro, is responsible for the 
cleavage of the TATA-binding protein (TBP) (Das & Dasgupta, 1993), the transcription 
factors CREP (cyclic AMP-responsive element-binding protein required for activation of 
cAMP-regulated genes) and Oct-I (octamer-binding protein that activates SnRNA 
transcription) (Yalamanchili et al., 1997b; Yalamanchili et al., 1997c), the 
poly(A)binding protein (PABP) (Joachims et al., 1999; Kuyumcu-Martinez et al., 2002), 
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and the microtubule-associated protein 4 (MAP-4) (Joachims et al., 1995). Similar 
events are promoted by the other viral protease 2Apro, which also cleaves TBP 
(Yalamanchili et al., 1997a) and PABP, (Joachims et al., 1999), in addition to both 
forms of eIF4G (Kräusslich et al., 1987; Gradi et al., 1998). With the exception of 
eIF4GI these cleavages all occur later in infection when the expression levels of 2Apro 
and 3Cpro are higher. One study indicates that 3Cpro preferentially cleaves ribosome-
associated PABP (Kuyumcu-Martinez et al., 2002). This would specifically target 
PABP, which is involved in the circularization of mRNAs, and therefore supporting 
translation and reinitiation of cellular protein synthesis. This cleavage event results in 
the cleavage of only 70% of cellular PABP. Recently, PABP was identified to play a 
role in poliovirus replication. Here, it is part of an RNA-protein-protein-RNA bridge that 
results in the circularization of the viral genome and leads to initiation of negative-
strand RNA synthesis (Herold & Andino, 2001). This could explain why the virus might 
target only specific PABP, which is involved in cellular translation, and why cleavage is 
not 100% efficient. The rest of the PABP in the cell remains available to poliovirus to 
recruit into its replication complex. To which extent the individual cleavage events 
contribute to the host shutoff needs to be elucidated but in sum they could account for 
the complete shutoff of cellular protein synthesis during poliovirus infection. 
 
1.32 Host cell transcription shutoff 
Many viruses are known to shut off transcription and/or translation of host cell genes to 
increase expression of their own genes (Kaariainen & Ranki, 1984). Poliovirus first 
shuts off RNA Pol I-mediated transcription in the host cell at the early stage of 
infection, followed by Pol II- and Pol III-mediated transcription at the mid-stage of 
infection. This strategy is believed to increase the pool of free ribonucleotides that the 
poliovirus-encoded RNA-dependent-RNA polymerase (RdRP) uses to transcribe and 
replicate the viral genomic RNA.  
RNA Pol I is responsible for transcription of a single class of genes, the rRNA genes. In 
humans, Pol I transcription requires the cooperative binding of UBF (upstream binding 
factor) and SL1 (species-specific factor) to the rRNA promoter (Learned et al., 1985; 
Learned et al., 1986). SL1 consists of TBP and three TBP-associated factors (TAFs). 
The viral protease 3Cpro targets SL1 by cleavage of one of the TAFs, which appears to 
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be the cause for inactivation of Pol I transcription (Rubinstein & Dasgupta, 1989; 
Rubinstein et al., 1992).  
A crucial basal factor for Pol II transcription is TBP,  which interacts with the TATA-box 
(Zawel & Reinberg, 1992). 3Cpro is responsible for cleavage of TBP, which in return is 
unable to form the TBP-TATA-box complex, and hence prevents further recruitment of 
transcription factors and Pol II (Clark et al., 1993). This inactivation of TBP seems to be 
the major cause of Pol II transcription shutoff (Yalamanchili et al., 1996). In addition, 
3Cpro also cleaves three activator proteins that are involved in activator-dependent 
transcription mediated by Pol II: cleavage of CREP and Oct-1, resulting in altered 
binding of these factors to their target sequence, and cleavage of the tumor suppressor 
p53, seemingly affecting interaction of this factor to some cellular protein (Yalamanchili 
et al., 1997b; Yalamanchili et al., 1997c; Weidman et al., 2001). As a result, poliovirus 
infection inhibits both basal and activator-dependent transcription by Pol II promoters.  
RNA Pol III transcribes a set of genes giving rise to small RNAs, including 5SRNA and 
tRNA (Segall et al., 1980). Pol III transcription requires binding of TFIIIC to the B-box 
internal promoter, and recruitment of TFIIIB and Pol III. During poliovirus infection, a 
subunit of TFIIIC is cleaved by 3Cpro, affecting DNA-binding properties, and 
consequently leads to shutoff of Pol III transcription (Clark & Dasgupta, 1990; Clark et 
al., 1991; Shen et al., 1996). 
 
1.33 Effects on cellular membrane metabolism and function 
As is typical of cytolytic animal viruses, poliovirus infection leads to profound alterations 
in cellular membranes (Carrasco et al., 1989; Carrasco, 1995). Both morphology and 
functioning of cell membranes are modified upon infection. The events taking place can 
be divided into effects at early and at late stages of infection. During viral entry, early 
membrane permeabilization is directed to locate the virus genome in the cytoplasm 
(Carrasco, 1981; Belnap et al., 2000a). Later in infection, three types of changes are 
observed in cellular membranes: (i) proliferation of intracellular membranous vesicles, 
(ii) inhibition of vesicular trafficking with the consequent blockage of protein 
glycosylation, and (iii) enhanced membrane permeability that requires viral gene 
expression and involves the diffusion of ions and small molecules through the plasma 
membrane.  
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Electron microscopic study revealed the existence of a large number of membrane 
vesicles in the perinuclear region of poliovirus infected cells (Dales et al., 1965). These 
structures are apparent 3 h post infection and proliferate extensively, occupying almost 
all of the cytoplasm by 7 h post infection. Recent studies have shown that these 
vesicles have a double lipid bilayer, suggesting a double-budding mechanism or a 
wrapping of the cytosol by membranous compartments (Schlegel et al., 1996). Their 
origins are not completely clear. Markers from the ER, golgi apparatus and lysosomes 
were found (Bienz et al., 1994; Schlegel et al., 1996). High-resolution autoradiography 
indicated that viral RNA replication is associated with these vesicles (Bienz et al., 1983; 
Bienz et al., 1992; Troxler et al., 1992; Egger et al., 1996). Studies suggest that the 
viral proteins 2B, 2C and 3AB could mediate the association between the membranous 
vesicles and the replication complexes that consist of viral RNA, and viral and host 
proteins required for replication (Bienz et al., 1987; Johnson & Sarnow, 1991; Heinz & 
Vance, 1995).  
In addition to these vesicles, a complete change in the morphology of poliovirus 
infected cells can be observed.  This includes rearrangement of the intracellular 
membranous organelles of the secretory pathway, the disappearance of the Golgi 
complex, and a swelling of the ER together with the reorganization of the cytoskeletal 
framework (Lenk & Penman, 1979; Joachims & Etchison, 1992). This change is 
associated with the viral proteins 2B, 2BC and 3A, since they are able to block 
glycoprotein transport when they are expressed individually in mammalian cells 
(Doedens & Kirkegaard, 1995; Doedens et al., 1997; Sandoval & Carrasco, 1997). 3A 
blocks transport from the ER to the Golgi apparatus, whereas 2B and 2BC act on a 
later step in the secretory pathway. Several recent studies have elucidated the 
mechanism how 3A interferes with the secretory pathway (Belov et al., 2005; Wessels 
et al., 2006; Belov et al., 2007). 3A inhibits the activation of the GTPase ADP-
ribosylation factor (ArfI), which regulates the recruitment of the COP-I coat complex to 
membranes. 3A specifically inhibits the function of GBFI (a guanidine nucleotide 
exchange factor (GEF)) for ArfI, by interacting with its N-terminus (Wessels et al., 
2006).  A study by Belov et al. has shown that the viral proteins 3A and 3CD 
independently recruit different Arf GEFs (GBFI and BIG1/2) to the new virus-induced 
membrane structures. The recruitment of these GEFs explain the sensitivity of virus 
growth to brefeldin A, which can be rescued by the overexpression of GBFI (Belov et 
al., 2005; Wessels et al., 2006; Belov et al., 2007). Inhibition of protein secretion might 
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help the virus evade the host immune response by interfering with secretion of 
interferon and other cytokines, and by blocking antigen presentation in the context of 
major histocompatibility complex class I molecules (Doedens & Kirkegaard, 1995).  
Late membrane permeability alters the internal milieu and has important consequences 
for both cellular and viral macromolecular synthesis. This membrane damage is 
reflected in parameters such as intracellular change in monovalent cations, membrane 
potential, pH, divalent cations, and leak of metabolites and enzymes out of the cells 
and diffusion of low-molecular weight inhibitors into the cells (Carrasco, 2002). The 
viral proteins 2BC and 2B have been identified as major factors responsible for these 
changes at late time of infection (Doedens & Kirkegaard, 1995; Aldabe et al., 1996). All 
the cellular changes occurring at late stage of infection ultimately lead to cytopathic 
effect (CPE), and thus, cell lysis and release of new progeny (Carrasco, 2002). 
 
1.4 Viral life cycle of poliovirus 
For an overview of the life cycle of poliovirus see Figure 1.2. 
1.41 Entry & uncoating 
Picornaviruses use a variety of cell receptors for their entry into the host cell. Poliovirus 
recognizes CD155 (also called Pvr) on the cell surface. CD155 is a transmembrane 
glycoprotein with three extracellular Ig-like domains (Mendelsohn et al., 1989). Its 
cellular function is not well understood.  With respects to poliovirus, several studies 
suggest that the first (N-terminal) Ig-like domain of Pvr is responsible for virus-binding 
and infection (Koike et al., 1991a; Selinka et al., 1991; Morrison & Racaniello, 1992; 
Selinka et al., 1992). Binding of the virion to the receptor triggers a conformational 
change in the virus which results in formation of the altered or A particle (Joklik & 
Darnell, 1961; Fenwick & Cooper, 1962). The A particle differs from the native particle 
in sedimentation (135S versus 160S for native) and antigenicity (De Sena & Mandel, 
1977). The A particle is sensitive to proteases and highly hydrophobic, whereas the 
virion is soluble and stable to proteases (Fricks & Hogle, 1990). The next step is not 
well understood. It has been proposed that the N-terminus of VP1 and possibly the 
myristoyl group of VP4, which are external in the A particle but internal in the virion, 
may facilitate cell entry by disrupting the cell membrane or by forming a pore through 
which the RNA is extruded (Fricks & Hogle, 1990; Moscufo & Chow, 1992). Indeed, the 
change in VP1 leads to an increase in its hydrophobicity, and results in the ability of the 
1. Introduction 12 
A particle to bind to liposomes which might direct the entry of the viral RNA (Fricks & 
Hogle, 1990).  Following this interaction, a second altered form of the virus can be 
observed that has lost its RNA (80S), which is the empty A particle after the RNA is 
released into the cell (Ketterlinus & Wiegers, 1994). It has been shown that infection is 
not dependent on either low pH or clathrin-mediated endocytosis, and thus, supports 
the proposed models of RNA entry into the cell (Perez & Carrasco, 1993; DeTulleo & 
Kirchhausen, 1998).  
Cell receptors are one of the most important determinants of tissue tropisms for 
viruses. Humans are the only natural hosts for poliovirus. The presence of the receptor 
is enough to confer susceptibility to infection in mice, effectively changing the host 
range of poliovirus (Selinka et al., 1992). However, studies of the expression of Pvr 
show that tissue tropism does not necessarily correlate with the receptor expression 
(Mendelsohn et al., 1989; Ren & Racaniello, 1992). This indicates that the cell receptor 
is not the only determinant of tissue tropism, and that other factors contribute to it. 
 
1.42 Translation 
After release of the viral VPg-linked RNA into the cell, VPg is removed by a cellular 
enzyme that cleaves the phosphodiester bond (Ambros et al., 1978; Ambros & 
Baltimore, 1980; Wimmer, 1982). Next, the viral RNA immediately functions as mRNA 
and is translated into the polyprotein. Early studies of poliovirus showed that cellular 
translation was shut-off during infection (see section 1.31). However, viral translation 
still occurred, suggesting that poliovirus mRNAs initiate translation by a unique and 
novel mechanism different from the known cap-dependent translation mechanism of 
cellular mRNAs. In 1981, with the complete sequence of poliovirus available, it was 
shown that the 5’-end of the viral genome was not capped and the 5’UTR was 
extremely long and highly structured (Kitamura et al., 1981; Pelletier & Sonenberg, 
1988). The 5’UTR precedes the initiating AUG codon, and numerous AUG triplets in 
context apparently favorable for initiation were present, yet not utilized. The initiation of 
translation at a specific AUG in a cap-independent fashion uncovered the function of 
an IRES element, demonstrated for the first time for poliovirus and EMCV (Jang et al., 
1988; Pelletier & Sonenberg, 1988). Since then, several other positive-strand RNA 
viruses, as well as a subset of cellular mRNAs, have also been shown to contain an 
IRES element (Martinez-Salas et al., 2001).  
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Three types of picornavirus IRES elements have now been defined, with enteroviruses 
containing type I (Wimmer et al., 1993). The three types of IRES elements differ by 
sequence and secondary structure, and their definition was based on sequence 
comparison and biochemical or enzymatic probing. Between members of the same 
IRES type, sequence identity is moderate; but predicted secondary structures are 
highly conserved. In poliovirus, the IRES element spans over a region of five stem-loop 
structures (II-VI) within the 5’UTR (Pilipenko et al., 1989; Skinner et al., 1989). The 3’ 
boundary of the IRES is an AUG triplet which is not used for initiation. Rather, 
translation initiation occurs 150 nt downstream at the next AUG (Agol, 1991). Despite 
great differences in sequence and structure between the different IRES types, some 
sequence motifs that are key elements in translation initiation are conserved among all 
picornavirus IRES elements:  
(i) the Yn-Xm-AUG motif, in which Yn is a pyrimidine-rich region (also called A box), 
Xm is a spacer of 15-25nt, and the AUG box (box B) marks the 3’-boundary of the 
IRES (Pilipenko et al., 1992a)  
(ii) the GNRA tetraloop (N is any nt, and R is a purine) is present within the stem-loop 
IV of the type I IRES and has been shown to be important for IRES function (Kaminski 
et al., 1994; Lopez de Quinto & Martinez-Salas, 1997; Robertson et al., 1999). RNA 
tetraloops with GNRA consensus are often found within large RNAs with stable tertiary 
structures and are believed to mediate interactions between RNA that contain the motif 
and other RNA or protein targets 
(iii) an A/C-rich sequence, which is present in stem-loop IV and V in type I IRES 
structures. The functional importance of this motif has been confirmed by mutational 
analysis (Nicholson et al., 1991; Lopez de Quinto & Martinez-Salas, 1997) and it has 
been suggested that the A/C-rich loop in domain V of the poliovirus IRES participates 
in the formation of a pseudoknot formation (Le et al., 1992).  
Despite a vast amount of structural and mutational studies of IRES elements, the 
precise mechanism by which ribosomes are recruited to the RNA, and thus how 
translation is initiated in a cap-independent way, is still unknown. Cap-dependent 
translation is initiated by binding of eIF4E to the m7G cap group at the 5’-end of the 
mRNA. This binding event triggers further recruitment of translation initiation factors, 
the initiator tRNA and the ribosomal unit to form a multicomponent complex, which 
subsequently initiates protein synthesis (Jackson, 2002). eIF4G functions as the key 
component in organizing all necessary components and as a scaffold for this complex. 
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The IRES element on the other hand, initiates translation internally and not through the 
cap group. It has been shown that a complete set of canonical initiation factors, except 
the cap binding-protein, is also required for poliovirus IRES-dependent translation 
(Scheper et al., 1992; Pause et al., 1994; Ohlmann et al., 1996; Pestova et al., 1996). 
Here, eIF4G is an essential player in anchoring the initiation complex to the RNA (De 
Gregorio et al., 1999). The ultimate goal of translation initiation is to direct the 
ribosomes to the mRNA. The most likely location for ribosome binding is at the 3’-end 
of the IRES element, but other parts of the IRES element structure could be also 
involved.  
In addition to canonical translation factors, cellular proteins have been shown to play a 
role in IRES-mediated translation. The protein synthesis of poliovirus in rabbit 
reticulocyte lysate (RRL) is inefficient unless HeLa cell fractions are added (Dorner et 
al., 1984; Phillips & Emmert, 1986). The same was shown for translation in Xenopus 
oocytes where coinjection of HeLa cell cytoplasmic extract rescued translation 
efficiency, indicating the requirement of mammalian cellular factors for translation 
(Gamarnik & Andino, 1996). Proteins identified in participating in viral translation 
initiation include the pyrimidine tract binding protein (PTB, a nuclear protein 
presumably involved in RNA splicing) (Hunt & Jackson, 1999) and the La autoantigen 
(Meerovitch et al., 1993; Svitkin et al., 1994). These factors seem to stimulate viral 
protein synthesis in RRL. Binding of these proteins to the IRES might help in stabilizing 
the three-dimensional structure of the IRES; however, their precise role is not known.  
Another cellular protein with a role in IRES-mediated translation in poliovirus is poly(rC) 
binding protein 2 (PCBP2; also known as hnRNP E or –αCP). PCBP2 is a cytoplasmic 
RNA-binding protein with three KH domains. Originally, it was found to bind to stem-
loop IV of the IRES (Blyn et al., 1996). When HeLa cell extracts were depleted of 
PCBP2 by an affinity column procedure, the extract lost its capacity to support 
poliovirus translation, an effect which could be rescued by addition of recombinant 
PCBP2 (Gamarnik & Andino, 1997). However, the role of PCBP2 is more complex than 
just supporting translation. A molecular mechanism has been proposed that involves 
the cloverleaf structure (stem-loop I) of the poliovirus 5’UTR and describes the switch 
from translation to replication (Parsley et al., 1997; Gamarnik & Andino, 1998, 2000). 
PCBP2 binds two specific sites in poliovirus, the above mentioned stem-loop IV of the 
IRES structure and the cloverleaf structure. Translation generates the viral protein 
3CD, which binds to the cloverleaf structure forming a complex that binds PCBP2 more 
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tightly, which down regulates translation and is required for initiation of viral RNA 
synthesis. Several mutations within the cloverleaf or deletion of the entire cloverleaf 
structure resulted in reduced translation levels, indicating a role of the cloverleaf 
structure in viral translation (Simoes & Sarnow, 1991; Gamarnik & Andino, 1998).  
Finally, the IRES element is not only important for translation but also seems to be a 
major determinant for virulence. This is supported by several studies. Mutations within 
the IRES are a defining factor for the attenuated phenotype of all three Sabin vaccine 
strains (Minor, 1992), and disruptions of a region in stem-loop II generated viruses that 
were highly attenuated in poliovirus-sensitive mice, transgenic for the poliovirus 
receptor (Shiroki et al., 1997). Further evidence comes from studies using chimeric 
viruses where part of the IRES of one enterovirus was substituted by the equivalent 
region of another (Gromeier et al., 1999; Chapman et al., 2000). Those substitutions 
led to attenuation of the chimeric virus in cell culture or even in mice.   
 
1.43 RNA replication 
1.431 The switch from translation to replication 
Positive-stranded RNA viruses face several obstacles when it comes to replication of 
their own genome. In a unique reaction they need to synthesize new RNA genomes 
using RNA as a template. This process is carried out by the viral RNA-dependent RNA 
polymerase (RdRP, 3Dpol in poliovirus) which is generated during translation. For the 
specificity of this reaction, the RdRP needs to distinguish between the viral RNA and 
cellular mRNAs, which also contain a poly(A) tail at the 3’-end . This requires cis-acting 
replication elements within the viral RNA that can guide the polymerase either directly 
or through cofactors, to the right location in the genome to initiate RNA synthesis. 
Another problem is the switch from translation to replication, since the ribosomes move 
from 5’ to 3’ along the viral genome for translation. However, the viral polymerase 
starts synthesizing RNA at the 3’-end of the RNA molecule and moves towards the 5’-
end. Without any regulation of these processes, this could lead to collision of the 
ribosomes and the RdRP.  
Several studies suggest that the switch from translation to replication is regulated. 
Using in vitro translation reactions of poliovirus replicons and purified 3Dpol, Gamarnik 
& Andino (1998) showed that the polymerase is unable to replicate the input RNA 
templates while it is undergoing translation. They proposed that the switch from 
translation to RNA synthesis is achieved when a critical concentration of 3CDpro 
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accumulates in the infected cell. Without the presence of 3CDpro, PCBP2 binds with 
high affinity to the IRES structure and promotes translation. With the generation of 
3CDpro during protein synthesis, the viral protein binds to the cloverleaf and increases 
the binding affinity of PCBP2 to this structure, which in return represses translation. 
Another study demonstrated that, using poliovirus in a cell-free translation replication 
system, translating ribosomes inhibit negative-strand RNA synthesis (Barton et al., 
1999).  
 
1.432 A common replication mechanism 
It is generally accepted that all picornavirus replication follows a common mechanism. 
The positive-strand is used as a template to synthesize a complementary negative-
strand, which results in a double-stranded intermediate, called replicative form (RF) 
(see Figure 1.2). The negative-strand is then used to generate several new positive-
strands, which produces an intermediate that is partially single- and partially double-
stranded, called replicative intermediate (RI) (Wimmer et al., 1993; Agol et al., 1999). 
RNA synthesis results in asymmetry in the production of positive- and negative-
strands, such that the ratio of plus- to minus-strands is approximately 50:1 in poliovirus 
infected cells (Novak & Kirkegaard, 1991). Consistent with these data, negative-
strands can only be found in association with RF or RI and free minus strands are not 
detectable in cells. It is believed that RF is a true replication intermediate rather than an 
artifact (Wimmer et al., 1993; Agol et al., 1999). Both newly synthesized positive- and 
negative-strands are VPg-linked at their 5’-end (Lee et al., 1977; Ambros & Baltimore, 
1978). The new positive-strands are then used either as mRNA, and after translation 
subsequently start a new round of RNA synthesis, or as genomic RNA for 
encapsidation into new virions later in infection (see Figure 1.2).  
 
1.433 Viral proteins involved in replication 
Picornaviruses utilize their small genomes very efficiently. All non-structural proteins 
are involved in RNA synthesis, and a number of their precursors in addition to the 
mature polypeptides carry out several different functions (Wimmer et al., 1993). 
Proteins of the P2 region are the least understood, but they are strongly associated 
with the biochemical and structural changes that are induced in the host cell following 
infection. The P3 proteins are most directly involved in the process of RNA synthesis, 
with 3B, also called VPg, functioning as the primer for the viral polymerase; 3CDpro, the 
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uncleaved precursor of the polymerase, acting as a co-factor in several steps of RNA 
replication; as well as 3Dpol, the polymerase and thus the key player in RNA synthesis. 
 
 
 
Figure 1.2: Poliovirus life cycle. Shown are the steps leading to infection and replication of poliovirus. 
The viral RNA is delivered into the host cell after interaction with the cognate receptor. The genomic RNA 
is then translated to yield the structural proteins (that go on to participate in assembly of new virions) and 
the non-structural proteins (which participate in the synthesis of negative and positive polarity RNA). Newly 
synthesized VPg linked genomic sense RNA is either recycled and used for the translation of more viral 
polypeptides, or packaged into new infectious particles. Virus particles are released upon lysis of the 
infected cell. 
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1.434 Cis-acting replication elements 
The cloverleaf-structure 
Negative-strand RNA synthesis starts at the poly(A) tail at the 3’-end of the viral 
genome. However, as mentioned above, cellular mRNAs also contain poly(A) tails, and 
hence, other more specific cis-acting replication elements must be involved in initiation 
of RNA synthesis. One essential replication element is the cloverleaf structure at the 5’-
end of poliovirus, an element which is present in all enteroviruses. This 5’-end RNA 
structure of 94 nt was originally predicted by computer-modeling and verified by site-
directed mutagenesis and by chemical and RNAse probing (Andino et al., 1990). The 
cloverleaf RNA was identified to form a ternary complex with the viral protein 3CDpro 
and a cellular protein (Andino et al., 1990; Andino et al., 1993), later identified as 
PCBP2 (Parsley et al., 1997). Mutational analysis demonstrated that 3CDpro interacts 
with the stem-loop d and PCBP2 interacts with stem-loop b of the cloverleaf structure 
(Andino et al., 1993; Parsley et al., 1997; Gamarnik & Andino, 2000). Mutations 
disrupting the formation of the ternary complex affected the accumulation of positive-
strands in cells, suggesting a role for the cloverleaf in positive-strand RNA synthesis 
(Andino et al., 1990).  
More recent data identified the cloverleaf structure as a key cis-acting element for 
initiation of negative-strand RNA synthesis. The ternary complex formed around the 
cloverleaf structure can interact with the cellular factor, poly(A) binding protein (PABP), 
which binds to the poly(A) tail at the 3’-end of the genome (see Figure 1.3). This leads 
to circularization of the viral genome and initiation of negative-strand RNA synthesis 
(Barton et al., 2001; Herold & Andino, 2001). The interaction between the 5’- and the 
3’-end of the viral genome might be a common mechanism for positive-strand RNA 
viruses to initiate negative-strand RNA synthesis. Indeed, flaviviruses have 
complementary sequences within their 5’ and 3’UTR that can promote direct RNA-RNA 
interaction without using any proteins to form a bridge (Khromykh et al., 2001; Corver 
et al., 2003; Lo et al., 2003; Alvarez et al., 2005). Data is also accumulating for 
coronaviruses and brome mosaic viruses, that support the RNA-protein-protein-RNA 
bridge as a way for both ends to communicate (Diez et al., 2000; Spagnolo & Hogue, 
2000). In all these viruses, circularization of the genome brings a replication initiation 
complex, formed at the 5’-end of the genome, in close proximity to the 3’-end where 
the polymerase initiates negative-strand synthesis. It has also been shown that 3AB 
and 3CDpro can form a ribonucleoprotein complex with the cloverleaf structure that 
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plays a role in replication (Harris et al., 1994; Xiang et al., 1995). Its significance, 
however, remains unclear. 
 
 
 
 
Figure 1.3: A model for initiation of negative-strand RNA synthesis during poliovirus replication. 
After translation of the poliovirus polyprotein, the viral polymerase containing polypeptide 3CD binds, 
together with the cellular PCBP, to the 5’ cloverleaf, thus down regulating translation. Interactions between 
3CD, PCBP, and PAPB hold the 5’- and the 3’-end of the poliovirus RNA in a noncovalent juxtaposition 
that leads to the circularization of the genomic RNA. These interactions bring the viral polymerase in close 
proximity of the 3’ poly(A) tail and allow for the initiation of negative-strand RNA synthesis (Herold & 
Andino, 2001) 
 
The 3’UTR and the poly(A) tail 
Poliovirus has a highly structured 3’UTR, consisting of two stem-loop structures. A 
model has been proposed in which both stem-loops interact with each other, resulting 
in a “kissing” interaction (Pilipenko et al., 1996; Melchers et al., 1997). This model has 
been supported by mutational analysis of this structure in poliovirus and coxsackievirus 
B. Mutations disrupting this interaction negatively affect replication, indicating its 
importance as a cis-acting replication element (Pilipenko et al., 1996; Melchers et al., 
1997). Surprisingly, viral RNAs completely lacking the 3’UTR showed impaired 
replication, but produced viable viruses (Todd et al., 1997).  
The poly(A) tail at the 3’-end of the viral genome is a common cis-acting replication 
element for positive-strand RNA viruses. Although not unique to viral RNAs, as cellular 
mRNAs also bear poly(A) tails, it is the location where the polymerase binds to start 
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negative-strand RNA synthesis. In teamwork with other cis- and trans-acting factors, 
the polymerase can specifically be directed to it. The poly(A) tail of poliovirus consists 
of approximately 90 nt (Yogo & Wimmer, 1972). It has been shown that viruses with  
poly(A) tails of less than 20 A’s retain only 5% of wild-type infectivity (Spector & 
Baltimore, 1974) . Other studies have shown that at least 8-12 A’s are required in 
poliovirus for efficient replication, a length that enables PABP to bind (Sarnow, 1989; 
Herold & Andino, 2001). New data have shown that negative-strand RNA synthesis in 
poliovirus is initiated at A8 which results in negative-strands with 8 U’s at its 5’-end 
(Polacek, C. & Andino, R, unpublished date). These negative-strands are then used as 
a template to generate new positive-strands with only 8 A’s. However, new plus-
strands isolated from infected cells have again acquired a long poly(A) tail. A cellular 
poly(A) polymerase might be responsible for extending the short poly(A) tail to its final 
length (Polacek, C. & Andino, R, unpublished date). 
 
The cre RNA 
In 1986, the first cis-acting replication element within the coding region of a 
picornavirus was discovered by McKnight & Lemon (1986, 1988). The small hairpin 
within the VP1 coding region of human rhinovirus 14 was named cre (cis-acting-
replication element). Similar cre hairpins were also found in other picornaviruses 
(Lobert et al., 1999; Gerber et al., 2001a), including in the 2C-coding region of 
poliovirus (cre(2C)) (Goodfellow et al., 2000). The hairpin structures in the different 
viruses differ in sequence and structure but seem to have similar function in vivo, since 
disruption of the hairpin structure results in inhibition of replication. Studies of the cre 
RNAs of poliovirus and HRV2 indicated at least two possible roles for the hairpin (Paul 
et al., 2000; Rieder et al., 2000; Gerber et al., 2001a): (i) that it functions as a site of 
recognition and binding of 3CDpro prior to the in vitro uridylylation of VPg by 3CDpol, (ii) 
that it serves as specific template in vitro for the protein priming reaction. 
The viral polymerase is strictly primer-dependent (Flanegan & Baltimore, 1977), and 
both positive- and negative-strands of poliovirus are VPg-linked (Nomoto et al., 1977a). 
Subsequently, uridylylated VPg was discovered in poliovirus infected cells (Crawford & 
Baltimore, 1983). Eventually a model evolved that VPg serves as a primer for the 
polymerase (Paul et al., 1998). VPg-uridylylation can be accomplished in different ways 
in an in vitro reaction using purified proteins. In a reaction containing poliovirus RNA, 
3Dpol, and oligo(U), full-length minus-strand is synthesized (Baron & Baltimore, 1982). 
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This elongation reaction also proceeds efficiently on a poly(A) template (Flanegan & 
Baltimore, 1977). In vitro, it has been shown that poly(A) can serve as a template for 
uridylylation of VPg, which generates VPg-poly(U) as a final product (Paul et al., 1998; 
Paul et al., 2000; Gerber et al., 2001b), and which also resembles the 5’-end of 
negative-strands (Nomoto et al., 1977a). In vitro studies demonstrated that in reactions 
where full-length poliovirus or HRV2 RNAs were used as templates, cre(2C) in case of 
poliovirus or cre(2A) in HRV2 was used as the primary template for the synthesis of 
VPgpUpU (Paul et al., 1998; Goodfellow et al., 2000; Paul et al., 2000; Gerber et al., 
2001a). This reaction was stimulated by addition of 3CDpro.  
It was initially observed that all picornavirus cre RNAs contain a common conserved 
sequence of AAACA that is located either in the loop or bulge of the hairpin and is 
required for replication (McKnight & Lemon, 1998; Goodfellow et al., 2000; Rieder et 
al., 2000). More recently, Yang et al. (2002) postulated a common 
R1NNNAAR2NNNNNNR3 motif (R, A/G; N, any nucleotide) for the loop of rhinovirus 
and enterovirus cre’s, an observation that was confirmed for poliovirus (Yin et al., 
2003). Biochemical studies of the cre demonstrated the importance of the A’s within 
this motif (Paul et al., 2003). The data are consistent with a slide-back mechanism in 
which the first A is used as a template for the linkage of UMP to VPg. This is followed 
by the slide-back of VPgpU to hydrogen bond with A2. The second UMP is then added 
again by 3Dpol on the A1 template nucleotide, resulting in VPgpUpU (Paul et al., 2003). 
This has been proposed to be the primer for both negative- and positive-strand RNA 
synthesis (Paul et al., 2000; Rieder et al., 2000; Gerber et al., 2001a). Recent reports, 
however, showed that a structurally disrupted cre mutant retained the capacity to 
induce negative-strand RNA synthesis in a cell-free translation replication system, 
suggesting that the cre-generated VPgpUpU is only required for positive-strand RNA 
synthesis (Goodfellow et al., 2003b; Morasco et al., 2003; Murray & Barton, 2003). It 
has been proposed that the poly(A) tail functions as a template for VPg-poly(U), which 
is then used as a primer for negative-strand RNA synthesis, and the cre-mediated 
VPgpUpU as a primer for positive-strand RNA synthesis. 
 
1.435 Positive-strand RNA synthesis 
As mentioned before, replication is a highly asymmetric process, as many more 
positive- than negative-strands are produced, suggesting different regulation 
mechanisms for each synthesis. However, most replication mechanisms remain poorly 
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understood and the least is known about how positive-strand RNA synthesis occurs. 
Two recent studies demonstrated the importance of precise 5’-end sequences of the 
viral genome for efficient positive-strand RNA synthesis. Herold & Andino have shown 
that additional non-viral sequences at the 5’-end of poliovirus RNA lead to defects in 
positive-strand RNA synthesis in a cell-free system and to a two hour delay in 
replication in cells, where the non-viral sequences get eventually deleted (Herold & 
Andino, 2000). A study by Sharma et al. (2005) highlighted the importance of the 5’-
terminal 9 nucleotides for efficient plus-strand synthesis. Since the 5’-end of the 
positive-strand is the template for the 3’-end of the negative-strand, which is the 
location where the primer and the polymerase bind for plus-strand RNA synthesis; it 
has been proposed in both reports (Herold & Andino, 2000; Sharma et al., 2005) that 
these precise end-sequences are required on the level of the negative-strand. The 5’-
end sequence of the positive-strand is highly conserved among enteroviruses and 
rhinoviruses and starts with UU (Klump et al., 1990; Zell & Stelzner, 1997; Zell et al., 
2002). This results in AA at the 3’-end of the negative-strand. This sequence is 
consistent with a cre-generated primer VPgpUpU that binds to the two A’s and initiates 
positive-strand RNA synthesis.  
The remaining question is: What other cis-acting replication elements and trans-acting 
factors are involved in plus-strand RNA synthesis? The cloverleaf structure was found 
to be involved in positive-strand RNA synthesis (Andino et al., 1990). However, the 
precise mechanism of how the cloverleaf promotes positive-strand RNA synthesis was 
not identified in the initial study. Proteins that are involved in positive-strand RNA 
synthesis might have specific binding-affinities to the 3’-end of the minus-strand, since 
positive-strand RNA synthesis starts at this location. Two proteins have been identified 
with such binding properties. These proteins are the viral protein 2CATPase (Banerjee et 
al., 2001) and a cellular protein that was recently identified as hnRNP C1 (Roehl & 
Semler, 1995; Roehl et al., 1997; Brunner et al., 2005). However, evidence for their 
role in positive-strand RNA synthesis has yet to be demonstrated.  
 
1.436 The role of membranous vesicles in replication 
All RNA synthesis events take place in the cytoplasm as part of replication complexes 
that are associated with membranous vesicles (see section 1.33). 3AB interacts with 
the membrane through the hydrophobic domain of its 3A moiety (Giachetti et al., 1992; 
Towner et al., 1996). It is generally assumed that 3AB, through its binding to 3Dpol and 
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3CDpro, recruits these proteins to the replication complex, which by themselves are 
unable to associate with membranes (Hope et al., 1997; Xiang et al., 1998). 
Membranous vesicles isolated from infected cells were shown to contain not only 
single-stranded RNA but also double-stranded intermediates, RF and RI, indicating 
that both negative- and positive-strand RNA synthesis occurs in the same replication 
complexes attached to membranes (Bienz et al., 1992). The role of membranes in 
replication is still not clear. It was suggested that membranes act either as scaffold for 
the assembly of the replication complex and/or to protect the viral RNA from 
degradation by cellular enzymes. Alternatively, they serve to concentrate the viral 
proteins at the site of RNA synthesis or to physically separate viral RNA template from 
other cellular mRNAs. A recent study suggests that the formation of poliovirus 
replication complexes requires coupled translation, vesicle production and viral RNA 
synthesis (Egger et al., 2000). However, the main question regarding the role of the 
membranes in viral RNA synthesis is still open.  
 
1.44 Assembly & encapsidation 
The poliovirus virion is composed of 60 copies each of VP1, VP2, VP3, and VP4, 
forming an icosahedral surface around a single copy of the VPg linked genomic RNA. 
The particles are approximately 30 nm in diameter, and have a sedimentation 
coefficient of 155S. The crystal structure of poliovirus has been solved in different 
conditions: poliovirus alone, bound to the receptor, or the empty virion intermediate 
during assembly (Hogle et al., 1985; Basavappa et al., 1994; Belnap et al., 2000b; 
Bubeck et al., 2005). Despite differences in primary sequence, the major capsid 
proteins VP1, VP2, and VP3 share a high degree of structural similarity, forming a β-
barrel structure domain found in a variety of icosahedral viruses. These proteins 
display structural differences within the loop that connects the elements that form the 
β-barrel core. The outer surface of the virus is dominated by star-shaped mesas at the 
five-fold axes and three-fold propeller-like structures (see Figure 1.4). These prominent 
surface features are punctuated by depressions surrounding the five-fold axes and 
crossing the two-fold axes. The depressions surrounding the five-fold axes are joined 
to form a canyon, which is the site of receptor attachment. At the five-fold axes of 
symmetry cluster five copies of VP1, while VP2 and VP3 are found alternating around 
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the 20 three-fold axes of symmetry. VP4 appears as an N-terminal extension of VP2 
(Hogle & Racaniello, 2002).  
 
 
Figure 1.4: The structure of the poliovirus virion. a) A simple geometric figure showing the symmetry 
and approximate shape of the poliovirus particle. The positions of VP1, VP2 and VP3 that forms a single 
protomer are indicated in relation to the two-fold, three-fold and five-fold axes of symmetry of the particle. 
Vertices of the geometric figure correspond to the prominent protusions which occur at the five-fold and 
three-fold axes of the virion. b) Space-filling representation of the outer surface of the poliovirion. VP1 is 
blue, VP2 is yellow, and VP3 is red. Antigenic sites are highlighted in white (Page et al., 1988). 
 
Early co-translational cleavage of the polyprotein by 2Apro releases a precursor protein 
P1 from the N-terminus of the polyprotein. Further processing of the P1 protein by the 
viral protease 3CDpro generates the capsid proteins VP0 (uncleaved VP4 and VP2), 
VP3 and VP1, and is dependent on a cellular factor (Harris et al., 1992; Blair et al., 
1993). This cleavage event is associated with the formation of VP0, VP3, and VP1, 
which assemble into a 5S protomer. Next, five protomers assemble to form the 14S 
pentamer. Twelve 14S pentamers then either assemble around an RNA molecule or 
form the 80S procapsid structure into which an RNA molecule is threaded. In either 
case, this assembly process results in the formation of a short-lived 150S provirion 
(Compton et al., 1990). Processing of the immature protein VP0 to yield VP4 and VP2 
is associated with encapsidation of the RNA (Arnold et al., 1987; Basavappa et al., 
1994; Ansardi et al., 1996). There is no known protease requirement for this cleavage 
and it is thought to be autocatalytic, depending only on the capsid proteins themselves 
and perhaps the viral RNA. Cleavage of VP0 to form the mature virion is associated 
with a significant increase in the stability of the particle. Proper capsid assembly and 
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RNA encapsidation are essential for virus infectivity, and cellular chaperones associate 
with newly synthesized virus particles and possibly contribute to virus particle assembly 
(Macejak & Sarnow, 1992). 
The amino-terminus of the poliovirus polyprotein is myristylated. This fatty-acid 
modification is thought to occur co-translationally after the removal of the initiator 
methionine to yield an exposed glycine. Thus, N-terminal cleavage of the P1 protein 
precursor yields myristoyl-VP0, which further cleavage then releases as myristoyl-VP4. 
Mutant viruses defective in myristylation are not viable in cell culture. This modification 
could not be associated with targeting of the structural proteins or the assembly 
intermediates to the membranous replication complexes (Lee & Chow, 1992). 
However, myristylation of P1 seems to be required for proteolytic cleavage by 3Cpro 
(Marc et al., 1989; Kräusslich et al., 1990). Several studies have shown that the 
modification is required for the proper assembly of viral particles (Ansardi et al., 1996). 
The myristate moiety makes several contacts with amino acids from VP3 and VP4 
located at the five-fold axis of symmetry in the β-tube, which is thought to be important 
for the nucleation of pentamer assembly intermediates. This proposal is supported by 
findings that viruses mutant in myristylation have defects in accumulation of assembly 
intermediates and mature viral particles. It has been shown that mutants defective in 
myristylation also display a decrease in infectivity as measured by the particle to PFU 
(plaque-forming units) ratio, which led to the proposal that the fatty acid molecule plays 
a role earlier in infection, possibly in the cell entry of the virus (Marc et al., 1990; 
Moscufo et al., 1991).  
One of the least understood processes in the life cycle of poliovirus and other 
picornaviruses is the mechanism of RNA encapsidation. Studies to define 
encapsidation signals within the viral RNA could only narrow down the RNA regions 
containing them. Defective interfering (DI) genomes lacking the capsid-coding region 
are efficiently packaged, indicating that major encapsidation signals of poliovirus lie 
somewhere outside this region (Kuge et al., 1986). There is evidence that unidentified 
signals in the 5’UTR stimulate poliovirus RNA packaging (Johansen & Morrow, 2000). 
It has also been proposed that packaging signals are most likely located within the 2B 
or 3D coding regions (Barclay et al., 1998) In addition, mutations in the 2C-coding 
region of poliovirus may affect the assembly pathway (Li & Baltimore, 1990; Vance et 
al., 1997).  
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However, there might not be any clear encapsidation signals within the viral RNA at all, 
but packaging could be linked to certain events occurring during the infectious cycle. 
Encapsidation is associated with viral RNA synthesis, since VPg-lacking genomes, 
which function as mRNA for translation, are not efficiently packaged (Nomoto et al., 
1977b; Nugent et al., 1999). Virion assembly seems to be another determinant for RNA 
packaging. There is evidence that each protein component of the pentamer (VP0, VP3, 
and VP1) contacts the viral RNA in the poliovirus replication complex (Nugent & 
Kirkegaard, 1995; Pfister et al., 1995). Therefore, encapsidation may start at the 
pentamer level rather than at the empty particle step.  
 
1.5 Model systems of poliovirus replication 
The methods of reverse genetics facilitated the successful reconstruction of a positive-
stranded RNA virus genome as an infectious cDNA clone (Racaniello & Baltimore, 
1981b). Viral RNA can be synthesized in vitro by DNA-dependent RNA polymerases 
using cDNA clones as templates (Ahlquist et al., 1984; van der Werf et al., 1986). Both, 
the cDNA (Racaniello & Baltimore, 1981a) as well as in vitro synthesized RNA (van der 
Werf et al., 1986), are infectious when introduced into cells, providing a powerful tool 
for the genetic manipulation and analysis of the viral replication cycle.  
In 1991, Molla and colleagues developed the synthesis of infectious poliovirus from 
cell-free systems, containing uninfected human HeLa cell extracts. Barton and 
colleagues (1995) demonstrated the formation of RNA replication complexes, which 
contained membranous vesicles, viral RNA and cellular proteins, and catalyzed the 
replication of poliovirus RNA. During the course of the infection cycle, a significant 
overlap develops between the translation and replication steps because of their mutual 
interdependence. Therefore, the amplification of viral RNA in infected cells occurs in a 
circular pathway involving iterative steps of translation and RNA replication. The 
inhibition of either step significantly affects the other and complicates the analysis of 
the regulatory mechanisms controlling virus replication. By using a reversible inhibitor 
of poliovirus RNA replication, it is possible to synchronize viral RNA replication in the 
cell-free system. Pre-initiation complexes are formed when replication is inhibited by 
guanidine hydrochloride (GuHCl). These complexes, when sedimented by 
centrifugation, initiate RNA replication upon their resuspension in reaction mixes 
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lacking GuHCl (Barton et al., 1995). This enables the direct measurement of the 
sequential synthesis of negative- and positive-strand RNA (Barton & Flanegan, 1997).  
Poliovirus RNA in vitro transcripts with extra nucleotides at the 5’-end are able to 
initiate RNA replication but lack efficient positive-strand RNA synthesis in a cell-free 
translation replication system (Herold & Andino, 2000). Transcription of DNA clones 
containing a hammerhead ribozyme 5’ of the poliovirus genome permitted the 
generation of RNA transcripts with authentic 5’-ends in vitro, which not only replicated 
in a cell-free replication system comparably to virion RNA, but showed improved 
kinetics in tissue culture cells (Herold & Andino, 2000). Using these improved 
transcripts in the in vitro system is of significant practical importance since conditional 
and lethal mutations of the virus can be tested for their specific effect on individual 
steps in the RNA replication cycle. 
An alternative and complementary system using Xenopus Laevis oocytes has been 
developed in our laboratory for the study of viral replication (Gamarnik & Andino, 
1996). Microinjection of poliovirus RNA into Xenopus oocytes leads to the production of 
viral particles, provided that a HeLa cell extract is coinjected. The fact that the oocyte is 
an intact cell is advantageous since it more faithfully recreates the environment that the 
virus encounters in an infected cell.  
The only natural hosts of poliovirus are humans. Until recently only monkeys and 
chimpanzees provided an experimental animal model for the study of immunology and 
pathogenesis, since they express a homologue to the human poliovirus receptor, which 
makes them susceptible to the virus (Koike et al., 1990). The identification of the 
receptor for poliovirus (Pvr) allowed for the generation of transgenic mouse lines 
susceptible to poliovirus infection (Ren et al., 1990; Koike et al., 1991b). Mice infected 
with poliovirus develop a polio-like paralytic disease, opening up the possibility to study 
the mechanism of pathogenesis of poliovirus in a reproducible manner. In addition, 
these mice have proven to be useful in the study of the immune responses generated 
by poliovirus recombinant vectors (Andino et al., 1994; Morrow et al., 1994; Mandl et 
al., 1998).   
 
1.6 Coxsackievirus B3 
With the eradication campaign of poliovirus moving into an advanced stage, poliovirus 
will soon be banned from research labs. Virologists who use poliovirus as a model to 
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study the life cycle of picornaviruses will have to rely on other model systems. Because 
of its research restriction in Europe, poliovirus has already been replaced by other 
enteroviruses such as coxsackie- and rhinovirus as the focus of research. Since these 
pathogens are still a major threat to our society, it makes sense to study them in more 
detail, both as models and as pathogens. 
Coxsackievirus B3 is classified as a serotype of the species Human enterovirus B 
(HEV-B) and belongs, like poliovirus, to the genus Enterovirus. Enteroviruses were 
originally classified as poliovirus (PV), coxsackievirus A (CVA), coxsackievirus B 
(CVB), and echovirus on the basis of their pathogenicity in experimental animals 
(Melnick, 1996). Coxsackieviruses are mouse pathogens, and they were discriminated 
into A and B subgroups on the basis of the disease observed in newborn mice: CVAs 
cause flaccid paralysis while CVBs cause spastic paralysis (Hyypiä et al., 1993). This 
is due to the involvement of the central nervous system by the CVB infection whereas 
CVAs replicate in the muscle tissue. In humans, the members of the large HEV-B 
group cause a great variety of diseases varying from exanthemas to carditis and 
infections of the central nervous system, but the most frequent consequence of 
infection is mild respiratory infection (Grist et al., 1978). Coxsackievirus B3 uses CAR 
(the coxsackievirus B and adenovirus 2 receptor) for cell entry (Bergelson et al., 1997). 
Unlike CD155, the receptor used by poliovirus, CAR has been reported to have cell 
adhesion function (Honda et al., 2000). The precise physiological function of CAR that 
is highly conserved between primates and rodents remains obscure.  However, DAF 
(decay accelerating factor) can also function as a receptor for a large number of B-, C-, 
and D-cluster enteroviruses (Shafren et al., 1995).  
The current classification of enteroviruses based on phylogenetic properties and 
genome organization (see section 1.21) underscores the similarities between CVB3 
and poliovirus in genomic structure, although some notable differences exist. In CVB3, 
the 5’UTR also contains a cloverleaf structure at the very 5’-end and a large higher 
order structure that functions as a type I IRES. The 3’UTR contains three stem-loop 
structures (X, Y, Z) rather than two as in poliovirus (X, Y) (Pilipenko et al., 1992b), but 
mutational analysis of the 3’UTR in CVB3 and poliovirus supports a “kissing” 
interaction between X and Y for both of them (Pilipenko et al., 1996; Melchers et al., 
1997). Based on homology with poliovirus, it has been suggested that a cre RNA is 
also located in the 2C coding region of coxsackievirus B3 (Goodfellow et al., 2000; 
Paul et al., 2000; Rieder et al., 2000; Witwer et al., 2001)  
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2. Aims of this thesis 
Enteroviruses make very efficient use of their small RNA genomes. Several cis-acting 
replication elements can be found throughout the genome. Most of these elements 
consist of RNA regions which fold into secondary structures that can form complexes 
with viral and cellular proteins. Such complex formations are often required to initiate a 
new step in replication, and thus function as key players in regulation of the viral life 
cycle. Some of the cis-acting replication elements have overlapping functions and play 
a role in several steps in RNA synthesis. It is not clear how the same RNA element 
regulates different events.  
One of the key players in RNA replication is the small cloverleaf structure at the 5’-end 
of the enterovirus genome. When originally described, this RNA element was found to 
be involved in positive-strand RNA synthesis, which is initiated at the 3’-end of the 
opposite strand. However, more recent studies identified the cloverleaf as a key 
element in initiation of negative-strand RNA synthesis, which starts at the 3’-end of the 
genome. The question about the role of the cloverleaf in positive-strand RNA synthesis 
remains. Does it form the same complex to initiate both, positive- and negative-strand 
RNA synthesis? Is the cloverleaf structure that can form on the negative-strand 
important? What proteins are involved in positive-strand RNA synthesis? 
Another cis-acting replication element is the recently identified cre-element which lies 
within the coding region of most enteroviruses. It has been shown that this RNA hairpin 
functions as a template for VPgpUpU formation, which was thought to be the primer for 
both negative- and positive-strand RNA synthesis. Recently, it has been demonstrated 
that it is required for positive- but not negative-strand RNA synthesis. It has been 
proposed that the poly(A) tail functions as a template for the synthesis of VPg-poly(U), 
which then serves as a primer for minus-strand synthesis. This opens the question: is 
poly(A) tail mediated VPg-uridylylation the common mechanism by which the virus 
generates the primer for negative-strand RNA synthesis, or is there an alternative 
mechanism the virus can use in case the cre-mediated VPg-uridylylation is inhibited?  
In the first part of this thesis, poliovirus was used to analyze the role of the cloverleaf 
structure in positive-strand RNA synthesis. Analyzing the precise role of the RNA 
cloverleaf element in positive-strand RNA synthesis has been hindered by its role in 
negative-strand RNA synthesis, as mutations disrupting the structure and/or functions 
of the cloverleaf disrupt minus-strand synthesis. The first aim of this thesis was to 
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overcome this limitation by developing a system that enabled us to separate the 
cloverleaf function in negative- and positive-strand RNA synthesis. Once this system 
was in place, the structural and sequence requirements of the RNA element to support 
positive-strand RNA synthesis were identified by mutational analysis. Replication 
phenotypes of cloverleaf mutants were characterized in a cell-free translation 
replication system and after transfection into HeLa cells. Additional analysis focused on 
possible roles of proteins involved in positive-strand RNA synthesis either through 
binding to the RNA structure itself or through a different mechanism.  
The second part of this thesis focused on cre(2C) in coxsackievirus B3 (CVB3). A 
stem-loop element located within the 2C coding region of CVB3 has been proposed to 
function as a cis-acting replication element. The MFOLD program was used to predict 
the structure and the precise location of the cre(2C), and its structure and sequence 
was then compared to a recently published enteroviral cre consensus loop sequence. 
The aim of this study was to examine the structural and functional requirements of the 
CVB3 cre(2C) in RNA replication. Cre(2C) loop mutants were analyzed for their 
capacity to serve as a template for VPg-uridylylation and to induce negative- and 
positive-strand RNA synthesis using HeLa S10 extract.  
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3. Materials & Methods 
3.1 Equipment  
PTC-200, Peltier Thermal Cycler, MJ Research          GMI, Ramsey, MI 
Luminometer: Optocomp                                              MGM Instruments, Hamden, CT 
Spectrometer: BioSpec-1601                                       Shimadzu, Columbia, MD 
Electro cell manipulator 600                                         BTX, Holliston, MA 
Centrifuge 5415C                                                         Eppendorf, Westbury, NY 
Tabletop centrifuge: MTX-150                                      TOMY, Fremont, CA 
Sorvall RC 3B plus                                                        Sorvall, New Castle, DE 
Gel dryer: Model 583                                                    Bio-Rad, Hercules, CA 
Gel-imaging system: FluorChemTM8900                      Alpha Innotech, San Leandro, CA 
Sonicator 3000                                                             Misonix, Farmingdale, NY 
Scintillation counter S6500                                           Beckman Coulter, Fullerton, CA 
Typhoon 9400, Amersham Biosciences                       GE Healthcare, Piscataway, NJ 
Äkta FPLC system, Amersham Biosciences                GE Healthcare, Piscataway, NJ 
 
3.2 Molecular Biology 
3.21 Plasmids and cloning  
3.211 Primers used for cloning of the poliovirus plasmids: 
         (purchased from Elim Biopharmaceuticals, Hayward, CA) 
1. 5’-GCAGAGGCCGAGGCCGCCTCGGCCTCTGAGCTATT-3’  
2. 5’-TTAAAGAGCTCGTTACGGGAAGGGAGTA-3’ 
3. 5’- GGTATCCCGGGTTCTTAAAACAGGAGCTCTTAAAACAGCTCTGGGGTTG-3’ 
4. 5’-GAGTGCTGAGCGCAACGCATCG-3’ 
5. 5’-GGGTTCTTAAAACACACGTTGTTTTAGAGCT-3’ 
6. 5’-CTAAAACAACGTGTGTTTTAAGAACCC-3’ 
7. 5’-GGGTTCTTAAAACAGCCCACGTGGCTGTTTTAGAGCT-3’ 
8. 5’-CTAAAACAGCCACGTGGGCTGTTTTAAGAACCC-3’ 
9. 5’-GAGGCCCACGTGGCGGCTAGTACTCCGGTATTGCGGTACCCTTGTACGCCACAAAAATACTCCCTTCC 
                    CGTAAC-3’ 
10. 5’-TATATCCCGGGTTCTTCCGGCAGCTCTGGGGTTGTACC-3’ 
11. 5’-GGGAGTATGGCCCAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
12. 5’-GTACGCCTGCCGGATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
13. 5’-TTTTGGAGGCCTAATACGACTCACTATAGGGTGCCGGAACTGATGAGGCGCTT-3’ 
14. 5’-AATTAAGAGCTCTTCCGGCAGCTCTGGGGTTGTACC-3’ 
15. 5’-GGGTTCTTAAAACAGCTCTAAAGTTGTACCCACCCCAGAGGCCCAC-3’ 
16. 5’-GTGGGCCTCTGGGGTGGGTACAACTTTAGAGCTGTTTTAAGAACCC-3’ 
17. 5’-GGGTTCTTAAAACAGCTCTGGGGTTGTACCCACTTTAGAGGCCCAC-3’ 
18. 5’-GTGGGCCTCTAAAGTGGGTACAACCCCAGAGCTGTTTTAAGAACCC-3’ 
19. 5’-CCGGGTTCTTAAAACAGGAGACCCCATGTACCCTGGGGTCTCGCCCAC-3’ 
20. 5’-GTGGGCGAGACCCCAGGGTACATGGGGTCTCCTGTTTTAAGAAC-3’ 
21. 5’-CCGGGTTCTTAAAACAGGCTGTCTGCTGTACCCGCAGACAGCGCCCAC-3’ 
22. 5’-GTGGGCGCTGTCTGCGGGTACAGCAGACAGCCTGTTTTAAGAAC-3’ 
23. 5’-TTAATTCACGTGGGCCTCTGGGGTAAGCTTAACCCCAGAGCTGTTTTAAG-3’ 
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24. 5’- GAGGCCCACGTGGCGGCTAGTACTCCGGcATTGCGGcACCCTTGTACG-3’ 
25. 5’-GAGGCCCACGTGGCGGCTAGTACTCCGGTgTTGCGGTgCCCTTGTACG-3’ 
26. 5’-GAGGCCCACGTGGCGGCTAGTACTCCGGTATTGCGgtacGTACCCTTGTACG-3’ 
27. 5’-TTAATTAAGAGCTCGTATAAAACAGGCGTACAAGCCATCCGCAAATGGGGAGTACTAGC-3’ 
28. 5’-TTAATTAAGAGCTCGTATAAAACAGGCGTACAAGCCATCCGCAATACCGGAG-3’ 
29. 5’-TTAATTAAGAGCTCGTATAAAACAGGCGTACAAGGCGCAATACCGGAGTAC-3’ 
30. 5’-TTAATTAAGAGCTCGTATAAAACAGGCGTACAAGGGTACGAACCTACCGGAGTACTAGC-3’ 
31. 5’-TATATCCCGGGTTCTTTTTTCAGCTCTGGGGTTGTACC-3’ 
32. 5’-GGGAGTATTTTTCAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
33. 5’-GTACGCCTGAAAAATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
34. 5’- TTTTGGAGGCCTAATACGACTCACTATAGGGTGAAAAAACTGATGAGGCGCTT-3’ 
35. 5’- AATTAAGAGCTCTTTTTTCAGCTCTGGGGTTGTACC-3’ 
36. 5’-CCTAATACGACTCACTATAGGGTGTTAAAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
37. 5’-CCGGGATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTTTAACACCCTATAGTGAGTCGTATTAGG-3’ 
38. 5’-TATATCCCGGTATCCCGGGTTCTTTTAACAGCTCTGGGGTTGTACC-3’ 
39. 5’-GGGAGTATTTAACAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
40. 5’-GTACGCCTGTTAAATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
41. 5’-CCTAATACGACTCACTATAGGGTGAATTAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
42. 5’-CCGGGATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTAATTCACCCTATAGTGAGTCGTATTAGG-3’ 
43. 5’-TATATCCCGGTATCCCGGGTTCTTAATTCAGCTCTGGGGTTGTACC-3’ 
44. 5’- GGGAGTATAATTCAGGCGTACAAGGGTACCGCAGCGATACCGGA-3’ 
45. 5’-GTACGCCTGAATTATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
46. 5’-CCTAATACGACTCACTATAGGGTGTTTCAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
47. 5’-CCGGGATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTGAAACACCCTATAGTGAGTCGTATTAGG-3’ 
48. 5’-TATATCCCGGTATCCCGGGTTCTTGAAACAGCTCTGGGGTTGTACC-3’ 
49. 5’-GGGAGTATGAAACAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
50. 5’-GTACGCCTGTTTCATACTCCC-3’ 
51. 5’-CCTAATACGACTCACTATAGGGTGTTCTAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
52. 5’-CCGGGATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTAGAACACCCTATAGTGAGTCGTATTAGG-3’ 
53. 5’-TATATCCCGGTATCCCGGGTTCTTAGAACAGCTCTGGGGTTGTACC-3’ 
54. 5’-GGGAGTATAGAACAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
55. 5’-GTACGCCTGTTCTATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
56. 5’-CCTAATACGACTCACTATAGGGTGTCTTAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
57. 5’-CCGGCATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTAAGACACCCTATAGTGAGTCGTATTAGG-3’ 
58. 5’-TATATCCCGGTATCCCGGGTTCTTAAGACAGCTCTGGGGTTGTACC-3’ 
59. 5’-GGGAGTATAAGACAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
60. 5’-GTACGCCTGTCTTATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
61. 5’-CCTAATACGACTCACTATAGGGTGCTTTAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
62. 5’-CCGGGATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTAAAGCACCCTATAGTGAGTCGTATTAGG-3’ 
63. 5’-TATATCCCGGTATCCCGGGTTCTTAAAGCAGCTCTGGGGTTGTACC-3’ 
64. 5’-GGGAGTATAAAGCAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
65. 5’-GTACGCCTGCTTTATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
66. 5’-CCTAATACGACTCACTATAGGGTGTTCCAACTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
67. 5’-CCGGGATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTGGAACACCCTATAGTGAGTCGTATTAGG-3’ 
68. 5’-TATATCCCGGTATCCCGGGTTCTTGGAACAGCTCTGGGGTTGTACC-3’ 
69. 5’-GGGAGTATGGAACAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
70. 5’-GTACGCCTGTTCCATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
71. 5’-CCTAATACGACTCACTATAGGGTGTTCCTTCTGATGAGGCCGAAAGGCCGAAAACCCGGTATC-3’ 
72. 5’-CCGGGATACCGGGTTTTCGGCCTTTCGGCCTCATCAGTTAAGGCACCCTATAGTGAGTCGTATTAGG-3’ 
73. 5’-TATATCCCGGTATCCCGGGTTCTTAAGGCAGCTCTGGGGTTGTACC-3’ 
74. 5’-GGGAGTATAAGGCAGGCGTACAAGGGTACCGCAATACCGGA-3’ 
75. 5’-GTACGCCTGCCTTATACTCCCTTCCCGTAACTTAGACGCAC-3’ 
76. 5’-GCCAACGCAGCCTGGACCA-3’ 
77. 5’-GGGTTCTTAAAACAGCTCTAAAGTTGTACCCACTTTAGAGGCCCAC-3’ 
78. 5’-GTGGGCCTCTAAAGTGGGTACAACTTTAGAGCTGTTTTAAGAACCC-3’ 
79. 5’-GGGTTCTTAAAACAGCTCTAAAGTTGTACCCACTTTATAGGCCCAC-3’ 
80. 5’-GTGGGCCTATAAAGTGGGTACAACTTTAGAGCTGTTTTAAGAACCC-3’ 
81. 5’-GGGTTCTTAAAACAGCTTTAAAGTTGTACCCACTTTAGAGGCCCAC-3’ 
82. 5’-GTGGGCCTCTAAAGTGGGTACAACTTTAAAGCTGTTTTAAGAACCC-3’ 
83. 5’-GGTATCCCGGGTTGTTAAAACAGC-3’ 
 
3.212 Poliovirus plasmid design 
prib(+)Luc-Wt: The luciferase-expressing poliovirus-derived replicon plasmid, 
containing a 5’-end hammerhead ribozyme to generate precise 5’-ends of the viral 
RNA transcripts, has been described before (Herold & Andino, 2000). 
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prib(-)Luc-Wt: The same as prib(+)Luc-Wt but contains a point mutation that inactives 
the hammerhead ribozyme, thus, the viral transcripts contain about 50 additional non-
viral nt at their 5’-end (Herold & Andino, 2000) 
 
prib(+)Xpa: containing the cDNA of the Mahoney strain of poliovirus as well as the 
hammerhead ribozyme, as described before (Herold & Andino, 2000). 
 
prib(+)Luc-SacI:  5’-TTAAAACAG in addition to a SacI site was introduced 5’ of the 
poliovirus sequence using prib(+)Luc-Wt as the parental plasmid for easier cloning of 
tandem cloverleaf constructs containing the wild-type cloverleaf at the downstream 
position. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #3+4. The 
PCR product was cut with SmaI and BlpI and ligated to the vector prib(+)Luc-Wt, cut 
with the same enzymes. 
 
pG-Cpair-cloverleaf: The four A-U pairs in stem a of the cloverleaf were replaced by 
four G-C pairs using prib(+)Luc-Wt as the parental plasmid. The complementary 
sequence of the hammerhead ribozyme was also altered to ensure sufficient cleavage. 
Two PCRs were performed using prib(+)Luc-Wt as the template and the two primer 
sets: #10+11; #4+12. The two resulting fragments were used as a template in an 
overlapping PCR with the primers #4+10. The final PCR product was cut with XmaI 
and BlpI and ligated with the vector prib(+)Luc-Wt, cut with the same enzymes; 
resulting in pG-Cpair-cloverleaf A. 
pG-Cpair-cloverleaf A was used as a template in a fourth PCR using primers #4+13. 
The resulting PCR product was cut with StuI and BlpI and ligated with vector pG-Cpair-
cloverleaf A, cut with the same enzymes.  
 
Single cloverleaf mutations: 
pStemB-mut(+): Poliovirus replicon containing stem b mutation in cloverleaf, that 
disrupts the stem b structure in the plus-strand. 
Anneal primers #15+16, then ligate with vector prib(+)Luc-Wt, cut with SmaI and PmlI. 
 
pStemB-mut(-): Poliovirus replicon containing stem b mutation in cloverleaf, that 
disrupts the stem b structure in the minus-strand. 
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Anneal primers #17+18, then ligate with vector prib(+)Luc-Wt, cut with SmaI and PmlI. 
 
pStemB-DNC1: Poliovirus replicon containing stem b mutation in cloverleaf, that 
maintains the structure on both strands. 
Anneal primers #77+78, then ligate with vector prib(+)Luc-Wt, cut with SmaI and PmlI. 
 
pStemB-DNC8: Poliovirus replicon containing stem b mutation in cloverleaf, that 
disrupts the structure on the plus-strand. 
Anneal primers #79+80, then ligate with vector prib(+)Luc-Wt, cut with SmaI and PmlI. 
 
pStemB-DNC81: Poliovirus replicon containing stem b mutation in cloverleaf, that 
disrupts the structure on the minus-strand. 
Anneal primers #81+82, then ligate with vector prib(+)Luc-Wt, cut with SmaI and PmlI. 
 
pStemD-mut(+): Poliovirus replicon containing stem d mutation in cloverleaf, that 
disrupts the structure on the plus-strand. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #24+4. The 
PCR product was cut with PmlI and BlpI, and then ligated with vector prib(+)Luc-Wt, 
cut with the same enzymes. 
 
pStemD-mut(-): Poliovirus replicon containing stem d mutation in cloverleaf, that 
disrupts the structure on the minus-strand. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #25+4. The 
PCR product was cut with PmlI and BlpI, and then ligated with vector prib(+)Luc-Wt, 
cut with the same enzymes. 
 
pStemD-insert: Poliovirus replicon containing an insertion in stem-loop d that 
increases the loop. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #26+4. The 
PCR product was cut with PmlI and BlpI, and then ligated with vector prib(+)Luc-Wt, 
cut with the same enzymes. 
 
ribozyme(-)constructs: To generate poliovirus replicons with the single cloverleaf 
mutation in the ribozyme(-) context, a PCR was performed using the respective 
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ribozyme(+) single cloverleaf mutant plasmid as the template and primers #83+4. The 
resulting PCR product was cut with PmlI and BlpI, and then ligated with vector prib(-) 
Luc-Wt, cut with the same enzymes.  
 
Tandem cloverleaf constructs with wild-type cloverleaf downstream 
pWt-Wt: Tandem cloverleaf construct with two wild-type cloverleaves next to each 
other. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers # 1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector prib(+)Luc-SacI, cut 
with the same enzymes.  
 
pStemD-mut(+)-Wt: Tandem cloverleaf construct with a wild-type cloverleaf 
downstream and a StemD-mut(+) cloverleaf at the 5’-end. 
A PCR was performed using pStemD-mut(+) as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector prib(+)Luc-SacI, cut 
with the same enzymes.  
 
pStemD-mut(-)-Wt: Tandem cloverleaf construct with a wild-type cloverleaf 
downstream and a StemD-mut(-) cloverleaf at the 5’-end. 
A PCR was performed using pStemD-mut(-) as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector prib(+)Luc-SacI, cut 
with the same enzymes.  
 
pStemD-insert-Wt: Tandem cloverleaf construct with a wild-type cloverleaf 
downstream and a StemD-insert cloverleaf at the 5’-end 
A PCR was performed using pStemD-insert as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector prib(+)Luc-SacI, cut 
with the same enzymes.  
 
Tandem cloverleaf constructs with G-C pair cloverleaf downstream 
pPlus 9: The G-C pair cloverleaf sequence was introduced into the cloverleaf of 
prib(+)Luc-SacI, resulting in a G-C pair cloverleaf with wild-type 5’-end sequence in 
addition to a SacI site between the 5’-end sequence and the G-C pair cloverleaf. This 
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plasmid was used as the parental plasmid for all tandem cloverleaf constructs 
containing a G-C pair cloverleaf downstream. The SacI-site was used for easier cloning 
to the tandem construct. 
Two PCRs were performed using prib(+)Luc-SacI as the template and the two primer 
sets: #11+14; #4+12. The two resulting fragments were annealed and used as the 
template in an overlapping PCR with the primers #4+14. The final PCR product was cut 
with SacI and BlpI and ligated with the vector prib(+)Luc-SacI, cut with the same 
enzymes. 
 
pdouble-Luc-Wt: Tandem cloverleaf construct with G-C-pair cloverleaf downstream 
and wild-type cloverleaf at the 5’-end. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector pPlus9, cut with the 
same enzymes.  
 
pPlus 20: G-C pair cloverleaf with wild-type stem a at the 5’-end. 
Anneal primer #5+6, and anneal with vector pPlus9, cut with SmaI and SacI. 
 
pPlus 27: GC-pair cloverleaf with wild-type stem a and stem c at the 5’-end. 
Anneal primer #7+8, and anneal with vector pPlus9, cut with SmaI and SacI. 
 
pdble-StemA-disr: G-C pair cloverleaf downstream and a disrupted stem a at the 5’-
end.  
A PCR was performed using prib(+)Luc-Wt as a template and the primers #9+4. The 
PCR product was cut with PmlI and BlpI, and annealed with vector prib(+)Luc-Wt, cut 
with the same enzymes, resulting in prib(+)Luc-StemA-disr. 
A second PCR was performed using prib(+)Luc-StemA-disr as a template and the 
primers #1+2. The PCR product was cut with SfiI and SacI, and annealed with the 
vector pPlus9, cut with the same enzymes.  
 
pdble-StemB-mut(+): G-C pair cloverleaf downstream and a StemB-mut(+) cloverleaf 
at the 5’-end. 
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A PCR was performed using pStemB-mut(+) as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with vector pPlus9, cut with the 
same enzymes.  
 
pdbl-StemB-mut(-): G-C pair cloverleaf downstream and a StemB-mut(-) cloverleaf at 
the 5’-end. 
A PCR was performed using pStemB-mut(-) as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector pPlus9, cut with the 
same enzymes. 
 
pdbl-StemB-swap: G-C pair cloverleaf downstream and StemB-swap cloverleaf 
(sequences of stem b are swapped) at the 5’-end. 
Primers #19+20 were annealed, and then ligated with the vector prib(+)Luc-Wt, cut 
with XmaI and PmlI, resulting in pStemB-swap. 
A PCR was performed using pStemB-swap as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and then ligated with the vector pPlus9, cut 
with the same enzymes. 
 
pdbl-StemB-shuffle: G-C pair cloverleaf downstream and StemB-shuffle cloverleaf 
(sequences of stem b are randomly shuffled) at the 5’-end. 
Primers #21+22 were annealed, and then ligated with the vector prib(+)Luc-Wt, cut 
with XmaI and PmlI, resulting in pStemB-shuffle. 
A PCR was performed using pStemB-shuffle as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and then ligated with the vector pPlus9, cut 
with the same enzymes. 
 
pdbl-StemB-ΔPCBP: G-C pair cloverleaf downstream and a cloverleaf with mutation 
in PCBP-binding site at the 5’-end. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #1+23. The 
PCR product was cut with PmlI and SfiI, and then ligated with the vector prib(+)Luc-Wt, 
cut with the same enzymes, resulting in pStemBΔPCBP. 
A second PCR was performed using pStemB-ΔPCBP as a template and the primers 
#1+2. The PCR product was cut with SfiI and SacI, and then ligated with the vector 
pPlus9, cut with the same enzymes. 
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pdbl-StemD-mut(+):  G-C pair cloverleaf downstream and a StemD-mut(+) cloverleaf 
at the 5’-end. 
A PCR was performed using pStemD-mut(+) as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector pPlus9, cut with the 
same enzymes.  
 
pdbl-StemD-mut(-):  G-C pair cloverleaf downstream and a StemD-mut(-) cloverleaf at 
the 5’-end. 
A PCR was performed using pStemD-mut(-) as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector pPlus9, cut with the 
same enzymes.  
 
pdbl-StemD-insert:  G-C pair cloverleaf downstream and a StemD-insert cloverleaf at 
the 5’-end. 
A PCR was performed using pStemD-insert as a template and the primers #1+2. The 
PCR product was cut with SfiI and SacI, and ligated with the vector pPlus9, cut with the 
same enzymes.  
 
pdbl-StemD-swap:  G-C pair cloverleaf downstream and a StemD-swap cloverleaf 
(sequences of stem d are swapped) the 5’-end. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #27+1. The 
PCR product was cut with SfiI and SacI, and then ligated with the vector pPlus9, cut 
with the same enzymes. 
 
pdbl-StemD-disr:  G-C pair cloverleaf downstream and a StemD-disr cloverleaf 
(mutation that disrupts the structure on both strands) at the 5’-end. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #28+1. The 
PCR product was cut with SfiI and SacI, and then ligated with the vector pPlus9, cut 
with the same enzymes. 
 
pdbl-StemD-Δ3CD: G-C pair cloverleaf downstream and a cloverleaf with mutation in 
3CD-binding site at the 5’-end. 
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A PCR was performed using prib(+)Luc-Wt as a template and the primers #29+1. The 
PCR product was cut with SfiI and SacI, and then ligated with the vector pPlus9, cut 
with the same enzymes. 
 
pdbl-StemD-loop: G-C pair cloverleaf downstream and a StemD-loop cloverleaf 
(mutations in loop sequences) at the 5’-end. 
A PCR was performed using prib(+)Luc-Wt as a template and the primers #30+1. The 
PCR product was cut with SfiI and SacI, and then ligated with the vector pPlus9, cut 
with the same enzymes. 
 
Tandem cloverleaf constructs with stem a mutations: 
To introduce mutations in stem a of the cloverleaf, three areas needed to be mutated; 
the two parts of the stem, as well as the complementary sequence of the hammerhead 
ribozyme had to be altered to ensure sufficient cleavage.  
The common cloning strategy if not mentioned otherwise was the following:  
1. Perform two PCRs with the primer pair C+D and the primer pair E+#4 with 
prib(+)Luc-Wt as the template. 
2. Overlapping PCR with PCR products from (1) as the template, using the 
primers C+#4, resulting product was cut with XmaI and BlpI, then anneal with 
annealed primers A+B. The resulting long product is ligated with the vector 
prib(+)Luc-Wt, cut with StuI and BlpI. The resulting plasmid is called: 
prib(+)Luc-stemA-mut. 
3. Perform PCR on prib(+)Luc-StemA-mut as the template and the primers #1+2. 
The PCR product is cut with SfiI and SacI, and then ligated with the vector 
pPlus9, cut with the same enzymes.  
 
pdbl-StemA-mut1: Primer A: #36; B: #37; C: #38; D: #39; E: #40 
pdbl-StemA-mut2: Primer A: #41; B: #42; C: #43; D: #44; E: #45 
 
pdbl-StemA-mut3:  
1. Perform two PCRs with the primers #31+32 and the primers #33+4 with 
prib(+)Luc-Wt as the template. 
2. Overlapping PCR with PCR products from (1) as the template, using primers 
#31+4, cut resulting product with XmaI and BlpI, then ligate with the vector 
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prib(+)Luc-Wt, cut with the same enzymes. The resulting plasmid is called: 
prib(+)Luc-StemA-mut3A. 
3. Perform PCR on prib(+)Luc-StemA-mut3A as the template and the primers 
#34+4. The PCR product is cut with StuI and BlpI, and then ligated with the 
vector prib(+)Luc-StemA-mut3A, cut with the enzymes. The resulting plasmid is 
called: prib(+)Luc-StemA-mut3.  
4. Perform PCR on prib(+)Luc-StemA-mut3 as the template and the primers #1+2. 
The PCR product is cut with SfiI and SacI, and then ligated with the vector 
pPlus9, cut with the same enzymes.  
 
pdbl-StemA-mut4: Primer A: #46; B: #47; C: #48; D: #49; E: #50 
pdbl-StemA-mut5: Primer A: #51; B: #52; C: #53; D: #54; E: #55 
pdbl-StemA-mut6: Primer A: #56; B: #57; C: #58; D: #59; E: #60 
pdbl-StemA-mut7: Primer A: #61; B: #62; C: #63; D: #64; E: #65 
pdbl-StemA-mut8: Primer A: #66; B: #67; C: #68; D: #69; E: #70 
pdbl-StemA-mut9: Primer A: #71; B: #72; C: #73; D: #74; E: #75 
 
pdbl-StemA-mut10: Perform PCR on pG-Cpair-cloverleaf as the template and the 
primers #1+2. The PCR product is cut with SfiI and SacI, and then ligated with the 
vector pPlus9, cut with the same enzymes.  
 
pdbl-StemA-disr-virus: Perform PCR on pdbl-StemA-disr as the template and the 
primers #1+76. The PCR product is cut with AgeI and SfiI, and ligated with vector 
rib(+)Xpa, cut with the same enzymes. 
 
pdbl-StemA-mut3-virus: Perform PCR on pdbl-StemA-mut3 as the template and the 
primers #1+76. The PCR product is cut with AgeI and SfiI, and ligated with vector 
rib(+)Xpa, cut with the same enzymes. 
 
pdbl-StemA-mut8-virus: Perform PCR on pdbl-StemA-mut8 as the template and 
primers #1+76. The PCR product is cut with AgeI and SfiI, and ligated with vector 
rib(+)Xpa, cut with the same enzymes. 
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pdbl-StemA-mut10-virus: Perform PCR on pdbl-StemA-mut10 as the template and 
the primers #1+76. The PCR product is cut with AgeI and SfiI, and ligated with vector 
rib(+)Xpa, cut with the same enzymes. 
 
3.213 Expression vector for MBP-2C 
An expression vector for the expression of the fusion protein MBP-2C was cloned, 
using the pMAL-c2E vector from New England Biolabs (NEB, Ipswich, MA) as the 
parental plasmid. A PCR was performed using prib(+)Luc-Wt as a template and the 
following primers (to amplify the 2C sequence):  
1) 5’-AATTAAGAATTCGGTGACAGTTGGTTGAAGAAG-3’ (bold: EcoRI-site; italics: N-
terminal of 2C) 
2) 5’-TTAATTAAGCTTACTATTGAAACAAAGCCTCCATAC-3’ (bold: stop codon; 
italics: C-terminal of 2C)  
The PCR product was cut with EcoRI and HindIII, and ligated with vector: pMAL-c2E, 
cut with the same enzymes. The resulting plasmid was called: pMBP-2C. The 
expression of this plasmid results in a fusion protein of MBP-2C, with MBP at the N-
terminal of 2C.  
 
3.214 Coxsackievirus B3 plasmid design 
Construction of cre mutants. All cre mutations were introduced into the CVB3 
infectious clone (Klump et al., 1990) by using the Altered Sites in vitro mutagenesis 
system (Promega, Madison. MA). Selected clones were verified for the correct 
mutation by using sequence analysis and a BssHII/XbaI digestion was used to ligate 
the mutated cres into pRibCB3/T7.  
 
pHR-CRE(Art) 
Silent mutations disrupting the CRE structure [distortion mutant (DM)] were introduced 
into p53CB3/T7-Luc, making use of unique BssHII and BstEII restriction sites. The 
insert was ligated into the luciferase gene-containing vector, creating p53CB3/T7-Luc-
DMCRE. A PCR-derived cloning cassette, containing unique restriction sites, was 
introduced between the luciferase gene and 2A junction by using forward primer 5′-
GCCCGGAGCGGCCGCGAAGACGCCAAAAACATA-3′, containing a NotI site 
(underlined), and reverse primer 5′-GGGGGGGGGTTTAAACCGCGG CCCGGG 
GGCGATCGCAGATCTCAATTTGGACTTTCCGCCCTTCTTGGA-3′, containing five 
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additional unique sites (DraI, underlined; BglII, dotted line; SgfI, double underlined; 
XmaI, bold type; SacII, italic type). The PCR product, digested with NotI and DraI, was 
ligated into p53CB3/T7-Luc-DMCRE digested with NotI and HpaI, generating 
p53CB3/T7-Luc-linker DMCRE. By using infectious clones containing wild-type or CRE 
loop point mutants as a template, CRE-containing PCR products were generated with 
forward primer 5′GGGGGGGGGAGATCTGCGATCGCCGCACTTTTCCAAGGA 
GAGAAGAAGATGAGCAATTACATACAGTTCAA-3′ and reverse primer 5′-
GGGGGGGGGCCGCGGCCCGGGGCTCCCGTGCAGGAGCAAACATACAGGTTCAA
-3′, and inserted into p53CB3/T7-Luc-linker-DMCRE by using BglII and SacII 
(underlined)-digested fragments, creating pGG-CRE(Art). The PCR product contained 
an additional 3CDpro cleavage sequence (italic type) to cleave off appending protein 
sequences at the carboxy-terminal end of the luciferase enzyme, due to translation of 
translocated CRE sequences that might affect luciferase activity. Subsequently, by 
using a SalI and ApaI digestion of constructs p53CB3/T7-Luc-linker-DMCRE and 
pRibCB3/T7, the hammerhead ribozyme sequence was ligated into the p53CB3/T7-
Luclinker vector rendering pHR-CRE(Art). 
 
Oligonucleotide site-directed mutagenesis. Oligonucleotide-directed mutagenesis 
was performed by using phagemid pALTER-1 as described previously (Melchers et al., 
1997). Synthetic oligonucleotides (Biolegio, see 3.215) were used to introduce site-
specific mutations. The mutated fragments were cloned into the infectious cDNA clone 
(pRibCB3/T7) and sequence analysis was used to verify the mutated nucleotide 
sequence.  
 
3.215 Primers used for mutagenesis of cre-mutants 
          Underlined nucleotides indicate mutations from the wild-type sequence. 
 
DM                5’-AGGGCTCCCGTGCAGGAGCAAGCAAACCGGTTCTATCCTACACTTACTTTTAAATTGAA 
                          TATAATTGCTCATCTTCTTCTC-3’ 
DM+A5G       5’-AGGGCTCCCGTGCAGGAGCAAGCAAACCGGTTCTATCCTACACTCACTTTTAAATTG 
                          AATATAATTGCTCATCTTCTTCTC-3’ 
CRE PM1      5’-AATACGGCATTTGGAGTTGAACTGTATGTAATTGC-3’ 
CRE PM2      5’-AATACGGCATTTGGATTTGAACTGTATGTAATTGC-3’ 
CRE PM3      5’-ACAGGTTCAATACGGCATTGGGACTTGAACTGTATG-3’ 
CRE PM4      5’-ACAGGTTCAATACGGCATTCGGACTTGAACTGTATG-3’ 
CRE PM5      5’-ACAGGTTCAATACGGCATTAGGACTTGAACTGTATG-3’ 
CRE PM6      5’-ACAGGTTCAATACGGCATCTGGACTTGAACTGTATG-3’ 
CRE PM7      5’-ACAGGTTCAATACGGCATGTGGACTTGAACTGTATG-3’ 
CRE PM8      5’-ACAGGTTCAATACGGCATATGGACTTGAACTGTATG-3’ 
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CRE PM9      5’-ACAGGTTCAATACGGCACTTGGACTTGAACTGTATG-3’ 
CRE PM10    5’-ACAGGTTCAATACGGCAGTTGGACTTGAACTGTATG-3’ 
CRE PM11    5’-ACAGGTTCAATACGGCAATTGGACTTGAACTGTATG-3’ 
CRE PM12    5’-ACAGGTTCAATACGGCGTTTGGACTTGAACTGTATG-3’ 
CRE PM13    5’-ACAGGTTCAATACGGCTTTTGGACTTGAACTGTATG-3’ 
CRE PM14    5’-CAAACATACAGGTTCAACACGGCATTTGGACTTG-3’ 
CRE PM15    5’-CAAACATACAGGTTCAAGACGGCATTTGGACTTG-3’ 
CRE PM16    5’-CAAACATACAGGTTCAAAACGGCATTTGGACTTG-3’ 
CM                5’-ACAGGTTCAATACGGTGTTTGGACTTGAACTGTATG-3’ 
 
3.22 PCR protocols 
Standard PCR protocol: Using the primers described for the cloning of the different 
plasmids, the desired region was amplified in a standard PCR reaction using 10-50 ng 
of template DNA, 1 x PCR reaction buffer (Stratagene, Cedar Creek, TX), 0.4 µM 
forward and reverse primer, 200 µM dNTP, 2.5 U Pfu Turbo DNA polymerase 
(Stratagene) and H2O to 50 µl. The DNA was amplified with the following program:  
 Denaturing for 2 min at 94° 
 30-33 cycles of : 30 seconds at 94°, annealing for 30 seconds at 50-60°C 
(depending on the annealing temperature of the used primers), elongation for 1 
min per 1000 bp at 72°C 
 Elongation for 8 min at 72°C 
Overlapping PCR:  
For an overlapping PCR, two PCR reactions were performed using two different sets of 
primers. The resulting PCR products had overlapping regions and were used in equal 
molar ratios as the template in a third PCR. Here, 3 cycles were performed without 
primers. The overlapping regions of the two DNA fragments should anneal and the 
annealed regions function as the primers to fill up the single-stranded regions, resulting 
in one long double-stranded template. After 3 cycles, the PCR is paused, and two 
primers binding to the two ends of the long template are added, and then 30 more 
cycles following the standard PCR protocol is performed.  
The amplified DNA fragments were then analyzed on a 0.8 -1% agarose 0.5 x TBE gel 
containing ethidium bromide (50 ng/ml), using 0.5 x TBE as running buffer. The DNA 
was mixed with DNA loading buffer (NEB). The bands were visualized under UV light. 
 
10 x TBE buffer:  
108 g Tris base 
  55 g Boric acid 
  40 ml 0.5 M EDTA (pH 8.0) 
 add H2O to 1 l 
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3.23 Restriction digest 
Restriction enzymes used for restriction digests were usually purchased from NEB, and 
the reactions were set up in the manufacturer’s recommended buffer and incubated at 
the recommended temperature. When possible, double digests were set up. The 
resulting DNA fragments were either gel purified using the QIAquick gel extraction kit 
(Qiagen, Valencia, CA) or purified using the QIAquick PCR purification kit (Qiagen).  
 
3.24 Ligation and transformations 
Ligation reactions were done in a 10 µl reaction containing about 3-5 molar excess of 
insert to vector (using about 50 ng vector DNA), 400 U T4 DNA Ligase (NEB) and  1x 
Ligase buffer (NEB). The reaction was incubated over night at 16°C. The reaction was 
dialyzed against H2O by incubating 5 µl of the reaction on top of a nitrocellulose 
membrane that was floating on the surface of a beaker filled with H2O for 10 min. The 
ligation reaction was then transformed into 10 µl ElectroMAX™ DH5α-E™ Cells 
(Invitrogen, Carlsbad, CA) in 0.1 cm cuvettes in a total volume of 40 µl using an Electro 
Cell Manipulator 600 (BTX, Holliston, MA) with the following settings: 1.4 kV, 129 Ω. 
460 µl of LB medium was added and 100 µl of the bacteria was plated on an LB plus 
ampicillin (100 µg/ml) plate and incubated at 37°C over night to allow for single colony 
formation. Individual colonies were picked and transferred into 5 ml of LB medium 
containing 100 µg/ml ampicillin, and incubated shaking over night at 37°C. The DNA 
was purified using the QIAprep spin mini prep kit (Qiagen). All plasmids were 
sequenced on an ABI 3730xl sequencer (by Elim Biopharmaceuticals, Hayward, CA), 
using plasmid specific primers.  
 
3.25 DNA preparations 
To achieve higher yields of plasmid DNA, single bacterial colonies (transfected with a 
plasmid) were grown in 100-200 ml of LB medium supplemented with ampicillin over 
night at 37°C. Plasmid DNA was then purified using either the PureYield Midiprep 
System (Promega) or the QIAfilter plasmid midi kit (Qiagen). 
 
3.26 Transcription of viral RNA 
Poliovirus-specific plasmid DNA was linearized with ApaI. Coxsackievirus B3-specific 
plasmid DNA was linerarized with MluI. RNAs were transcribed in vitro in reactions 
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containing bacteriophage T7 RNA polymerase, 1 x transcription buffer (80 mM HEPES-
KOH (pH 7.5), 24 mM MgCl2, 2 mM spermidine, 40 mM DTT) and 7.5 mM NTP-mix. 
After incubation at 37°C for 3 h, 2 U DNaseI (Roche, Indianapolis, IL) was added and 
reactions incubated at 37°C for 15 min. RNA was precipitated by adding 50% (in 
volume) of LiCl2-solution (7.5mM LiCl2; 50 mM EDTA, pH 8.0) and incubation over 
night at -20°C. After centrifugation at 12,000 g for 20 min, the pellet was washed once 
with 70% ethanol. The RNA was then resuspended in RNA storage solution (Ambion), 
and stored in aliquots at -80°C. The RNA was analyzed on a 0.8% agarose gel, 0.5 x 
TBE, and quantified measuring A260 and A280. 
 
3.27 In vitro translation replication system 
3.271 HeLa S10 extract  
3 liters of HeLa S3 spinner culture was harvested by centrifugation at 300 g for 12 min 
at 4°C. The supernatant was removed and the cells washed three times in 40 ml of 
isotonic buffer (35 mM HEPES, pH 7.4; 146 mM NaCl; 11 mM glucose). After the last 
wash, the cells were resuspended in 1 volume of ice-cold hypotonic buffer (20 mM 
HEPES, pH 7.4; 10 mM KCl; 1.5 mM magnesium acetate; 1 mM DTT) and incubated 
for 10 min on ice. The cells were disrupted by 25 strokes in a pre-chilled dounce 
homogenizer (Bellco, Vineland, NJ), using pestle B. 0.1 volume of ice-cold 10 x 
resuspension buffer (200 mM HEPES, pH 7.4; 1200 mM potassium acetate; 40 mM 
magnesium acetate; 50 mM DTT) was added and immediately placed on ice. The 
lysate was centrifuged at 2000 rpm for 10 min at 4°C (TOMY MTX-150). The 
supernatant was transferred into a new tube and both tubes were then again 
centrifuged at 9000 rpm for 10 min at 4°C. The supernatant of both tubes were 
combined and dialyzed for 2 x 1 h (with a buffer change after 1 h) against 500 volumes 
of dialysis buffer (40 mM HEPES, pH 8.0; 120 mM potassium acetate; 5.5 mM 
magnesium acete; 10 mM potassium chloride; 6 mM DTT), using the Slide-A-Lyzer 
cassettes (10,000; Pierce, Rockford, IL). After dialysis, 1/1000 volume 1 M CaCl2, and 
75 U/ml S7 Micrococcal Nuclease (resuspended in 1 mM Tris, pH 7.5; Roche) were 
added, and the extract was incubated for 15 min at room temperature. To quench the 
reaction, 1/100 volume 200 mM EGTA was added. After centrifugation at 9000 rpm for 
10 min at 4°C (TOMY MTX-150), the supernatant was frozen in aliquots at -80°C.  
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3.272 Initiation factor 
Uninfected HeLa cells were harvested and homogenized as described above for the 
preparation of the S10 extract. After homogenization, the nuclei were removed by 
centrifugation without the addition of any buffer or salt. The postnuclear supernatant 
was centrifuged for 15 min at 10,000 rpm at 4°C in a JA-20 rotor. The S10 supernatant 
was centrifuged at 60,000 rpm for 1 h at 4°C in a Beckman 70 Ti rotor to pellet the 
ribosomes. The supernatant was discarded, and the ribosomal pellet was resuspended 
in hypotonic buffer at 240 A260 U/ml. The ribosomes were adjusted to a concentration of 
0.5 M KCl by the addition of 4 M KCl and stirred for 15 min on ice. The salt-washed 
ribosomes were centrifuged at 60,000 rpm for 1 h in a 70 Ti rotor at 4°C, and the 
supernatant was removed and dialyzed for 2 h at 4°C against solution containing 5 mM 
Tris-HCl (pH 7.5), 100 mM KCl, 0.05 mM EDTA, 1 mM DTT, and 5% glycerol. This 
ribosomal salt wash IF preparation was frozen in aliquots at -80°C. 
 
3.273 Translation replication assay 
1 µg RNA transcripts were mixed with 25 µl HeLa S10 cell extract, 2 µl initiation 
factors, 5 µl 10 x NTP/energy mix (10 mM ATP, 2.5 mM CTP, 2.5 mM GTP, 600 mM 
potassium acetate, 300 mM creatine phosphate, 155 mM HEPES (pH 7.0), 0.4 mg 
Creatine Kinase / 100µl), and 1 µl 100 mM guanidine hydrochloride in a total volume of 
50 µl. After incubation at 30°C for 4 h, 1 µl was removed and added to 50 µl cell culture 
lysis reagent (Promega, Madison, WI) of which 10 µl was then used to measure 
luciferase activity to monitor translation. The rest of the original translation reaction was 
centrifuged at 12,000 g for 15 min, the supernatant was carefully removed, and the 
preinitiation complexes were resuspended in 25 µl labelling mix, containing 15 µl HeLa 
S10 cell extract, 2.5 µl 10 x NTP/energy mix, 2.5 µl of puromycin (1mg/ml) and 30 µCi 
[α-32P]-UTP (3000Ci/mmol) (Perkin Elmer, Waltham, MA). After incubation at 30°C for 
2 h (if not indicated otherwise), the samples were mixed with 175 µl TENSK buffer (50 
mM Tris/HCl (pH7.5), 5 mM EDTA, 100 mM NaCl, 1% (v/v) SDS, 200 µg/ml  proteinase 
K) to stop the reaction. After incubation at 37°C for 2 h, RNA was extracted by using 1 
volume phenol/chloroform (1:1, v/v), and RNA was precipitated by using ethanol. The 
pellet was resuspended in RNA-storage solution (Ambion) and gel-loading buffer (New 
England Biolabs, Ipswich, MA) was added prior to loading on a 0.8% agarose gel (0.5 x 
TBE). The gel was run at 20 V constant current over night. After drying the gel, 
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products were visualized by using autoradiography. Bands were quantified using a 
phosphorimager (Typhoon 9400; GE Healthcare, Piscataway, NJ) 
 
Coxsackie virus B3 in vitro assay:  
For replication of coxsackievirus B3 RNA transcripts in vitro, 2 µg rather than 1 µg of 
RNA transcripts were used to program the HeLa S10 extract. 
In order to quantify the accumulated replicative form (RF) bands, irrespective of loading 
and RNA-extraction efficiency, the amount of [32P]UMP incorporated in both the RF and 
the 28S rRNA was determined by using a phosphorimager (Storm 860; Molecular 
Dynamics). The amount of 28S rRNA in each lane represents the amount of RNA 
loaded on the gel and was normalized to wild-type. Subsequently, the accumulated RF 
was corrected for the amount loaded on the gel. 
 
3.274 VPg-uridylylation assay with poliovirus replicons 
HeLa S10 cell extract was programmed with replicon RNA as described in 3.282. Pre-
initiation complexes were resuspended as decribed above with incubation for 1 h rather 
than 2 at 30°C. The synthesis of VPgpUpU was then detected by the two methods 
described below: 
(i) Method 1: After centrifugation of the reactions at 12,000 g for 15 min, the 
supernatant was removed and the replication-complexes were resuspended in 40 µl 
Tricine-sample buffer (Bio-Rad, Hercules, CA).  The samples were heated at 94°C for 
5 min, and then analyzed on a 20% Tris-Tricine gel (see below) at 75 mA for 1 h and 
then for 72 h at 11 mA at 4°C. After drying the gel, products were visualized by using 
autoradiography using a phosphorimager (Typhoon 9400; GE Healthcare, Piscataway, 
NJ). 
(ii) Method 2: 500 µl Dynabeads®ProteinA (Invitrogen, Carlsbad, CA) were washed 
twice with 0.1 M NaPhosphate buffer (pH8.0) and then resuspended in 500 µl of the 
same buffer. 125 µl of anti-VPg polyclonal antibodies was added to the 
Dynabeads®ProteinA and incubated rotating for 1 h at room temperature. The 
Dynabeads® were washed twice again and resuspended in 500 µl 0.1 M NaPhosphate 
buffer (pH8.0). After the 1 h incubation of the replication reaction as described above, 
2.5 µl of 0.5 M NaPhosphate buffer and 25 µl of the Dynabeads®ProteinA coupled with 
anti-VPg antibodies were added. After incubation rotating at 4°C for 1 h, the 
Dynabeads® were washed four times with phosphate-buffered saline (PBS). The 
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Dynabeads® were resuspended in 15 µl of Tricine-sample buffer (Bio-Rad, Hercules, 
CA). The samples were heated at 94°C for 5 min and the supernatant was analyzed on 
a 20% Tris-Tricine gel at 75 mA for 1 h and then for 72 h at 11 mA at 4°C. After drying 
the gel, products were visualized by autoradiography using a phosphorimager 
(Typhoon 9400; GE Healthcare, Piscataway, NJ). 
 
Tricine gel buffer: 3 M Tris, 0.3 % SDS, pH 8.45 
Tricine running buffer: 0.1 M Tris, 0.1 M Tricine, 0.1 % SDS  
20 % Tricine-gel: 20 ml gel buffer, 30 ml 40 % acrylamide/bis (29:1), 8 g glycerol 
                              adjust volume to 60 ml 
                              add 600 µl 10 % APS, and 60 µl TEMED 
Stacking gel: 2 ml gel buffer, 833 µl 40 % acrylamide/bis (29:1), 5.5 ml H20 
                       add 250 µl 10 % APS and 25 µl TEMED 
 
3.3 Cell culture and viruses 
3.31 Cultured cells 
3.311 HeLa S3 cells 
HeLa S3 cells (ATCC CCL 2.2) were grown either (i) in tissue culture flasks in 
Dulbecco’s modified Eagle medium-nutrient mixture F-12 (Ham) (DMEM/F12) (1:1), 
supplemented with 2mM L-glutamine, 100 U of penicillin and streptomycin per ml, and 
10% newborn calf serum or (NCS) (ii) in suspension, in suspension minimal essential 
medium (Joklik modified, Cambrex) supplemented with 2 mM L-glutamine, 100 U of 
penicillin and streptomycin per ml, and 10% newborn calf serum. All medium and 
supplements (if not mentioned otherwise) were purchased from Cell Culture Facility 
(UCSF, San Francisco, CA). Cells were incubated at 37°C and 5% CO2. 
 
3.312 Buffalo green monkey (BGM) cells 
BGM cells were grown in minimal essential medium (Invitrogen) supplemented with 
10% fetal bovine serum (Invitrogen).  
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3.32 Transfections  
3.321 Poliovirus RNA transfection and luciferase assay 
HeLa S3 cells were trypsinized, washed three times with PBS, and adjusted to 5 x 106 
cells/ml. Then 800 µl aliquots were electroporated in 0.4 cm cuvettes with 20 µg of 
replicon RNA, using an Electro Cell Manipulator 600 (BTX Inc.) with the following 
settings: 300 V, 1000 μF, 24 Ω. Subsequently, 16 volumes of medium was added, the 
cells were divided by half and guanidine hydrochloride (Sigma Chemical Co., St. Louis, 
MO) was added to one half  to a final concentration of 2 mM. 2 x 105 cells were plated 
per well in 12-well plates and incubated at 37°C in a 5% CO2 incubator until harvested 
for luciferase assay at indicated time-point. Replicon-transfected cells were scraped 
off, washed once with PBS, and then lysed in 100 µl cell culture lysis reagent 
(Promega, Madison, WI). Luciferase activity in 10 µl of lysate was determined in a 
luminometer using the luciferase assay system (Promega).  
 
3.322 CVB3 RNA transfection and luciferase assay 
BGB cells, grown in six-well plates to a confluency of 80%, were transfected as 
described previously with 4 µg T7 RNA polymerase-generated RNA derived from MluI-
linearized replicon plasmid, containing the firefly luciferase gene. Ten hours post-
transfection, cells were washed twice with PBS, prior to lysis using 200 µl lysis buffer 
(Promega). Luciferase activity was measured on a BioOrbit 1251 luminometer using 
the Luciferase Assay system according to the recommendations of the manufacturer 
(Promega).  
 
3.33 Virus production of rib(+)Xpa and double-Wt 
In vitro RNA transcripts of rib(+)Xpa and double-Wt were electroporated into HeLa S3 
cells under the same conditions as described in 3.221, using 20 µg of viral RNA 
transcripts and 4 x 106 cells. After electroporation 5 volumes of medium supplemented 
with 3% newborn calf serum was added. Cells were then incubated at 37°C and 5% 
CO2 over night. After three freeze/thaw cycles viruses were further clarified through 
centrifugation at 3000 g for 5 min and the virus supernatant was stored at -80°C (P0) 
virus. The titers of the virus were determined according to standard plaque-assay (see 
3.33).  
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3.34 Plaque-assay  
6-well plates were seeded with 106 HeLa cells/well and incubated over night at 37°C 
and 5% CO2. The next day, the cells were washed once with PBS. Virus supernatant 
was diluted in a 1:10 dilution series in serum-free DMEM/F12 medium. 250 µl of virus 
dilution was added / well. The cells were incubated with the virus for 30 min at 37°C 
and 5% CO2 to allow virus adsorption. The medium was removed and the cells were 
washed once with PBS. Each well was overlayed with 3 ml of 1% agarose in 1 x 
DMEM/F12 medium supplemented with 3% newborn calf serum. Once the agarose 
had solidified, the plates were incubated for 2 days (if not indicated otherwise) at 37°C 
and 5% CO2. Agarose overlays were then removed, and plates were stained with a vital 
dye (0.1% crystal violet, 20% ethanol) to reveal the viral plaques, which were counted. 
 
3.35 Growth curve with rib(+)Xpa and double-Wt 
6-well plates were seeded with 106 HeLa S3 cells/well and incubated over night. Cells 
were washed with PBS and infected with a multiplicity of infection (MOI) of 10 of either 
rib(+)Xpa or double-Wt viruses (P0 virus) in serum-free medium. After incubation at 
37°C for 30 min, cells were washed twice with PBS and fresh medium supplemented 
with 3% newborn calf serum was added to each well. The plates were incubated at 
37°C and 5% CO2. At indicated time-points viruses were harvested by three 
freeze/thaw cycles followed by centrifugation. The supernatant contained the virus and 
was stored at -80°C. The titers of the virus were determined by standard plaque assay 
(see 3.34). 
 
3.36 Virus production of mutant poliovirus and plaque-purification  
In vitro RNA transcripts of mutant polioviruses were transfected into HeLa S3 cells in 
the same conditions as described in 3.231 using 20 µg of viral RNA transcripts and 4 x 
106 cells. After electroporation 5 volumes of medium was added. Cells were then 
incubated at 37°C and 5% CO2 for 72 hours or until total cytopathic effect was reached. 
After three freeze/thaw cycles viruses were further clarified through centrifugation at 
3000 g for 5 min and the virus supernatant was stored at -80°C (P0) virus. The plaque-
phenotype was determined by plaque-assay (see 3.34).  
For plaque-purification of viruses, individual plaques were transferred with a pipette tip 
to 6-well-plates (seeded with 106 cells/well the night before) to which 500 µl of fresh 
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medium/well was added. The 6-well plates were incubated for 72 hours. After three 
freeze/thaw cycles viruses were further clarified through centrifugation at 3000 g for 5 
min. Total RNA from the supernatant was purified by trizol® extraction (Invitrogen) and 
isopropanol precipitation by the following protocol: to 500 µl of viral suspension 500 µl 
of trizol reagent was added and incubated for 5 min at room temperature (RT). 100 µl 
of chloroform was added, and the tube was shaken by hand and incubated for 3 min at 
RT. After centrifugation for 4 min at 12,000 g at 4°C, the supernatant was transferred to 
a new tube. The RNA was precipitated by adding 250 µl of isopropanol, and the tube 
was mixed by inverting several times, and then incubated for 10 min at RT. The RNA 
was pelleted by centrifugation at 12,000 g for 10 min at 4°C. The isopropanol was 
removed. The pellet was washed once with 500 µl 75% ethanol. After centrifugation at 
12,000 g for 5 min at 4°C, the supernatant was carefully removed. The pellet was air 
dried for 5 min and resuspended in 15 µl RNase-free water and stored at -80°C.  
 
3.361 RT-PCR of plaque-purified viruses and sequencing 
cDNA was synthesized using the ThermoscriptTM RT-PCR system for First-Strand 
cDNA Synthesis (Invitrogen, Carlsbad, CA): in a PCR tube, 10 µl of the resuspended 
RNA was mixed with dNTPs (final concentration 0.5 mM) and 1 µl dT primer. The tube 
was incubated for 5 min at 65°C, then placed on ice. 4 µl 5 x RT reaction buffer, 1 µl 
RNase OUT, 5 mM DTT, and 1 µl of Thermoscript was added to the tube in a total 
volume of 20 µl, incubated at 50°C for 1 hour and then stored at 4°C.  
Using specific primers for the poliovirus genome, the viral genome was amplified in a 
PCR reaction: 1 x  PCR reaction buffer (Invitrogen), 1.5 mM MgCl2, 2 µl RT reaction 
(from previous step), 0.4 µM forward and reverse primer, 200 µM dNTP, 2.5 U Taq 
DNA polymerase (Invitrogen) and H2O to 50 µl. The DNA was amplified with the 
following program:  
 Denaturing for 2 min at 94° 
 33 cycles of : 30 seconds at 94°, annealing for 30 seconds at 55°C, elongation 
for 1 min per 1000 bp at 72°C 
 Elongation for 8 min at 72°C 
The amplified DNA fragments were then sequenced (by Elim Biopharmaceuticals) 
using poliovirus specific primers.  
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3.362 5’-RACE  
The 5’-RACE system for rapid amplification of cDNA ends (Invitrogen) was used to 
amplify the very 5’-end of the plaque-purified virus RNA. With this system, cDNA is 
synthesized from the purified viral RNA using a virus-specific reverse primer located 
within the capsid region. After first strand cDNA synthesis, the original RNA template is 
removed by RNase treatment with the RNase mix. Unincorporated dNTPs, primer, and 
proteins are separated from cDNA using a S.N.A.P. column. A homopolimeric tail is 
then added to the 3’-end of the cDNA using terminal transferase (TdT) and dCTP. PCR 
amplification is then accomplished using Taq DNA polymerase, a nested, 5’UTR 
specific viral primer that anneals to a site located within the cDNA molecule, and a 
novel deoxyinosine-containing anchor primer provided with the system.  
cDNA-production: After the trizol extraction and isopropanol precipitation 14.5 µl of 
RNA and 0.5 µM reverse primer (specific for the capsid region of poliovirus) were 
mixed and incubated for 10 min at 70°C, and then put on ice. A reaction containing the 
RNA, the reverse primer, 1 x PCR-buffer, 1 mM MgCl2, 0.4 mM dNTPs  and 4 mM DTT 
in a total volume of 25 µl was incubated for 1 min at 42°C. 1 µl of Superscript II was 
added, and the reaction was subsequently incubated for 50 min at 42°C, then for 15 
min at 70°C, and then for 1 min at 37°. 1 µl of RNase mix was added and the reaction 
incubated for 30 min at 37°C and then put on ice.  
Purification of cDNA: The cDNA was purified using the provided S.N.A.P. columns 
according to the manufacturer’s protocol.  
dC-tailing of cDNA: 10 x tailing buffer (to a final concentration of 1 x) and 0.2 mM 
dCTPs in a volume of 7.5 µl was added to 16.5 µl of purified cDNA. The reaction was 
incubated for 2 min at 94°C, then transferred on ice. 1 µl of TdT was added and 
incubated for 37°C, followed by incubation for 10 min at 65°C and then transferred on 
ice.  
PCR of dC-tailed cDNA: Using one specific reverse primer for the poliovirus 5’UTR 
and one forward primer that binds to the poly(C) tail of the cDNA, the viral genome was 
amplified in a PCR reaction containing: 1 x PCR reaction buffer (Invitrogen), 1.5  mM 
MgCl2, 5 µl dC-tailed cDNA (from previous step), 0.2 µM forward and reverse primer, 
200 µM dNTP (Invitrogen), 2.5 U Taq DNA polymerase (Invitrogen) and H2O to 50 µl. 
The DNA was amplified with the following program:  
 Denaturing for 2 min at 94° 
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 35 cycles of : 30 seconds at 94°, annealing for 30 seconds at 55°C, elongation 
for 1 min at 72°C 
 Elongation for 8 min at 72°C 
If the yield of this PCR was too low, another nested PCR was performed using the 
previous PCR product as a template. The amplified DNA fragments were gel purified 
using the QIAquick gel extraction kit (Qiagen), then sequenced on an ABI 3730xl 
sequencer (by Elim Biopharmaceuticals) using poliovirus specific primers.  
 
3.4 Biochemistry 
3.41 Purification of anti-2C and pre-immune serum 
Anti-2C polyclonal antibodies were obtained commercially by the inoculation of the 2C 
C-terminal peptide (CNIGNCMEALFQ) conjugated to KLH into rabbits (HTI 
Bioproducts, Ramona, CA). 2 ml of anti-2C polyclonal antibodies and 2 ml of pre-
immune serum taken before inoculation, were purified on an Äkta FPLC (GE 
Healthcare, Piscataway, NJ) using a 1 ml HiTrap Protein A column (GE Healthcare). 
The serum was mixed 1:5 with 20 mM NaPhosphate buffer (pH 7.0) before loading 
onto the column. The column was washed twice with 20 ml of 20 mM NaPhosphate 
buffer (pH 7.0).  The antibodies were eluted with 0.1 M citric acid (pH 4.0) in 500 µl 
fractions into collection tubes which each contained 125 µl of 1 M Tris-HCl (pH 9.0). 
Fractions were tested for their specific recognition of 2C protein in Western Blots (see 
3.43)  
 
3.42 Expression and purification of MBP-2C 
Expression: 20 ng of pMBP-2C was transformed into 5 µl ElectroMAX™ DH5α-E™ 
Cells (Invitrogen) in 0.1 cm cuvettes in a total volume of 40 µl using an Electro Cell 
Manipulator 600 (BTX) with the following settings: 1.4 kV, 129 Ω. 100 μl of a 1:10 
dilution of the bacteria was plated on an LB plus ampicillin plate and incubated at 37°C 
over night to allow for single colony formation. An individual colony was picked and 
transferred into 40 ml of LB medium containing 100 µg/ml ampicillin and 0.2 % glucose, 
and incubated shaking at 37°C over night. The next day, the 40 ml culture was 
transferred into 2 l of LB medium also supplemented with ampicillin and glucose and 
incubated shaking at 37°C until A600 = 0.6 was reached (approximately 3.5 h). The 
culture was then induced by adding 600 µl of 1 M IPTG (final = 0.3 mM IPTG) and 
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incubated shaking for 2 h at 37°C. The cells were harvested by centrifugation at 6000 g 
for 15 min at 4°C. The supernatant was removed and the cells washed once with 20 ml 
of PBS. The pellet was stored at -80°C.  
Purification: 4 ml of Amylose resin (NEB) was washed three times with 4 ml column 
buffer (10 mM Na-phosphate-buffer, pH 7.2; 0.5 M NaCl; 1 mM DTT; 1 mM EGTA), 
then resuspended in 45 ml of column buffer. The pellet of 2 l cells was thawed quickly 
at 37°C and resuspended in 5 ml lysis buffer (10 mM Naphosphate-buffer, pH 7.2; 0.5 
M NaCl; 0.25% Tween 20; 1 mM DTT; 10 mM EDTA; 10 mM EGTA). The cells were 
broken by 5 cycles of 40 seconds each of sonication using a microtip (pulse on/off = 1 
second/1 second) at setting 4 on ice. The cell lysate was added to the 45 ml of 
amylose resin from the previous step, and incubated rotating for 2 h at 4°C. The 
lysate/resin mix was poured onto an empty column and the flow-through was collected. 
The column was washed once with 10 ml of column buffer containing 0.25 % tween, 
and then washed once with 40 ml column buffer. The protein was eluted with 13 ml of 
column buffer containing 10 mM maltose and 1 ml fractions were collected. 10 µl of 
each fraction was mixed in equal amounts with Laemmli-loading buffer (Bio-Rad) and 
analyzed on an SDS-polyacrylamide gel (ReadyGel, Precast SDS-PAGE Gels, 12% 
Tris-HCL, 10 Well; Bio-Rad). The gel was stained with Commassie blue (100 ml acetic 
acid, 900 ml ddH20:Methanol (1:1), 2.5 g Commassie blue G-250), then destained (100 
ml acetic acid, 900 ml ddH2O:Methanol (1:1)), and then photographed using a gel-
imaging system (FluorChemTM8900, Alpha Innotech,  San Leandro, CA). The fractions 
with the biggest yield were combined and dialyzed in Slide-A-Lyzer Dialysis cassette 
(Pierce) against column buffer containing 10% glycerol. After dialysis the protein was 
concentrated using Amicon ultra centrifugal filter device (10,000 MW, Millipore, 
Billerica, MA) by spinning at 4000 g for 30 min at 4°C. The protein concentration was 
determined by measuring the A280 in the presence of 6 M guanidine hydrochloride and 
using the following absorbance coefficients: 111 270 M-1cm-1.  
 
3.43 Western Blot with anti-2C 
Testing purified anti-2C and pre-immune serum: 10 µl of cell extract from MPB-2C 
induced and non-induced cells after sonication in lysis buffer (see 3.42) was mixed with 
10 µl of Laemmli-loading buffer, incubated for 5 min at 94°C (Bio-Rad, Hercules, CA), 
and separated on an SDS-PAGE (ReadyGel, Precast SDS-PAGE Gels, 10% Tris-HCL, 
10 Well; Bio-Rad; Running-buffer: 25 mM Tris, 0.192 M glycine, and 0.1% SDS (pH 
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8.3)).  The gel was transferred in a wet transfer onto nitrocellulose membrane (Bio-
Rad) using the Bio-Rad Mini-PROTEAN system (Bio-Rad) for 1 h at 450 mA in transfer 
buffer. After transfer, the membrane was blocked for 1 h shaking with 5 % non-fat milk 
in TBST (Tris-Buffered Saline Tween 20, see below). The membrane was blotted with 
either the purified anti-2C antibodies or pre-immune serum (see 3.41) diluted 1:500 in 
5% non-fat milk in TBST by shaking for 1 h. The membrane was washed 5 times for 5 
min each with TBST shaking. Then, the membrane was blotted with the secondary 
antibodies ECLTM anti-rabbit IgG, horseradish peroxidase linked (from donkey, GE 
Healthcare, Piscataway, NJ) diluted 1:10,000 in 5% non-fat milk in TBST by shaking for 
1 h. The membrane was washed 5 times for 5 min each with TBST. After the final wash 
the bands were visualized using the SuperSignal West Pico Chemiluminescent 
Substrate (Pierce) and the exposed films were scanned.  
 
Testing fractions after MBP-2C purification: The fractions of purified MBP-2C 
protein as analyzed on SDS-PAGE and Commassie blue staining in 3.42 were also 
detected by Western Blot using anti-2C antibodies, in the same way as described in 
the above section.  
 
Transfer buffer:    
75 ml of 10 x transfer buffer (30.3 g Tris base, 144 g glycine, in1 l distilled water,     
                                              adjust pH with HCl to pH 8.3) 
150 ml methanol 
fill up with H2O to 750 ml 
 
TBST: 
 Dissolve the following in 800 ml of distilled H2O: 8.8 g of NaCl, 0.2 g of KCl, 3 g  
                                                                                         of Tris Base 
 Add 500 µl of Tween 20 
 Adjust the pH to 7.4 
 Add distilled H2O to 1 l 
 
3.44 Mobility shift assay with MBP-2C 
Probe preparation: A DNA fragment containing the T7 promoter, the hammerhead 
ribozyme sequences and the cDNA of the wild-type positive-strand cloverleaf, was 
generated in a  standard PCR reaction using prib(+)Luc-Wt as a template and the 
following primers: forward  5’- GCAGAGGCCGAGGCCGCCTCGGCCTCTGAG 
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CTATT-3’ and reverse 5’-GAACTTGGTTTTGTGCGTCTAAGTAAC-3’. A second DNA 
fragment was generated containing the T7 promoter and the cDNA of the wild-type 
negative-strand cloverleaf using prib(+)LucWt as a template and the following primers: 
forward 5’-TTAATTTAATACGACTCACCTATAGGCCTTCTATTGAACTTGGTTTTG-3’ 
and reverse 5’-TTAAAACAGCTCTGGGGTTGTAC-3’. The PCR fragments were 
purified using the QIAquick PCR purification kit (Qiagen). 12 µl of the PCR product was 
used in a transcription reaction containing 1 x transcription buffer (80 mM HEPES-
KOH, pH 7.5; 24 mM MgCl2; 2 mM spermidine; 40 mM DTT), 5 µl NTP-mix (500 µM 
UTP, 4 mM ATP, GTP, CTP), 25 µCi [α32P]UTP (800 Ci / mmol; Perkin Elmer), and 0.5 
µl T7 RNA polymerase. The reaction was incubated for 2 h at 37°C. 25 µl of 
formamide-loading buffer (90% formamide, 1 x TBE, 0.5% bromphenolblue) was added 
to the reaction. 
Gel-purification of probes: The complete RNA reaction was separated on an 8% 
acrylamide / UREA gel (13.25 ml 30% acrylamide/bis (37.5:1)), 1 x TBE, 21 g UREA, 
add H2O to 50 ml, then add 500 µl of 10% APS and 50 µl TEMED. The gel was run at 
15 W for 40 min. The gel was exposed for 5 seconds to a film, by matching the film and 
the gel, the bands were cut out and soaked over night at 37 °C in 700 µl NaOAc (0.3 
M), 0.1% SDS (pH 7.0). After the overnight elution, the gel pieces were removed, 1 µl 
of yeast tRNA (10 mg/ml), and 1 volume of phenol/chloroform/Isoamylalcohol (25:24:1, 
v/v) was added to precipitate the labeled RNA. After centrifugation at 12,000 g for 3 
min the upper phase was transferred to a new tube and 600 µl of Isopropanol was 
added. The RNA was precipitated over night at -20°C. The RNA was pelleted by 
centrifugation at 12,000 g for 40 min at 4°C, washed once with 70% ethanol, and air-
dried for 5 min. CPM was measured of the RNA pellet in a scintillation counter 
(LS6500, Beckman Coulter, Fullerton, CA). The RNA was resuspended in HMK buffer 
(200 mM HEPES, pH7.9; 600 mM KCl; 100 mM MgCl2) to a concentration of 20,000 
CPM/µl.  
Mobility shift of probes: 
For binding, 20,000 CPM of probe is mixed in 1 x binding buffer (10 x binding buffer: 50 
mM HEPES,pH 8.0; 250 mM KCl; 20 mM MgCl2; 38% glycerol) with 20 mM DTT, 10 µg 
tRNA and 2 mM ATP. The desired amount of MPB-2C protein is added and/or protein 
buffer to a total volume of 15 µl. The binding reactions are incubated for 15 min at 30°C 
and analyzed on a polyacrylamide glycerol gel (20 ml of 30% acrylamide/bis (30:1), 7.5 
ml of 10 x TBE, 7.5 ml glycerol, add H2O to a total volume of 150 ml; then add 1.5 ml 
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10% APS, and 150 µl TEMED). The gel is run with 0.5 x TBE as running buffer for 4 h 
at 120 V constant current at 4°C. The gel was dried and autoradiographed for 
visualization of product using a phosphorimager (Typhoon, 9400, GE Healthcare). 
 
3.45 Structural mapping of tandem cloverleaf probe 
Probe preparation: A DNA fragment containing the T7 promoter, the hammerhead 
ribozyme sequences and the cDNA of the two cloverleaf structures, was generated in 
standard PCR reaction using pdouble-Luc-Wt as a template and the following primers: 
forward  5’- GCAGAGGCCGAGGCCGCCTCGGCCTCTGAGCTATT-3’ and reverse 5’-
GAACTT GGTTTTGTGCGTCTAAGTAAC-3’.  The PCR fragments were purified using 
the QIAquick PCR purification kit (Qiagen). 0.5 µl of the DNA fragments were used in a 
transcription reaction (as described in 3.25) to transcribe a tandem cloverleaf RNA.  
Labeling the probe:  
1.5 µl of RNA transcripts (=> 100 pmol of 5’-ends) were dephosphorylated in a reaction 
containing 1 x dephosphorylation buffer (Roche) and 2 U of alkaline phosphatase 
(Roche) in a total volume of 150 µl. The mixture was incubated for 30 min at 37°C, then 
another 2 U of alkaline phosphatase was added and the incubation was continued for 
30 min.  
50 µl of RNase free water, and 200 µl of phenol/chloroform (v/v = 1:1) was added. The 
mixture was vortexed for 2 seconds and then centrifuged for 3 min at 12,000 g. The 
upper phase was transferred into a new tube and the RNA was precipitated by adding 
500 µl of ethanol and 20 µl of 3M NaOAc (pH 5.2) and vortexing for 2 seconds. The 
RNA was pelleted by centrifugation at 12,000 g for 20 min. The supernatant was 
removed and the pellet washed once with 500 µl of 70% ethanol and then air-dried for 
5 min. The pellet was resuspended in 10.5 µl of RNase free water.  
2.5 µl of 10 x kinase reaction buffer (NEB), 10 µCi of [γ32P]ATP (3000 Ci/mmol, Perkin 
Elmer), and 20 U of T4 Polynucleotide kinase (NEB) were added to the 
dephosphorylated RNA. The reaction was incubated for 1 h at 37°C and quenched by 
adding 25 µl of formamide-loading buffer (90% formamide, 1 x TBE, 0.5% 
bromphenolblue). The probe was gel-purified as described in 3.44.  
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Structural mapping:  
RNase A (1 µg/ml; Ambion, Austin, TX) was diluted in 1 x RNase structure buffer 
(provided with enzyme, Ambion) in the following dilution series: 1:40, 1:80, 1:160, 
1:320 
RNase T1 (1 U/µl; Ambion) and RNase V1 (0.1 U/µl; Ambion) were diluted in 1 x 
RNase structure buffer in the following dilution series: 1:2, 1:4, 1:8, 1:16.  
A reaction mixture in a total volume of 19 µl, containing 1 µl of labeled RNA probe 
(50,000 CPM/µl), 1 x RNA structure buffer and 1 µl of yeast t-RNA (10 mg/ml) was 
heated for 2 min at 94°C and let slowly cool down. 1 µl of enzyme dilution was added 
to a 19 µl reaction mixture, 1 µl H2O was added as a negative-control. The reactions 
were incubated for 10 min at 28°C, and the RNA fragments were extracted by adding 
100 µl of phenol/chloroform (1:1, v/v) and 80 µl H2O. After centrifugation for 3 min at 
12,000 g, the upper phase was transferred to a new tube. The RNA was precipitated 
by adding 250 µl of ethanol, 10 µl of 0.3 M sodium acetate, and 5 µg glycogen and 
incubation over night at -20°C. The RNA was pelleted by centrifugation at 12,000 g for 
20 min, and the pellet was washed once with 70% ethanol. The RNA was resuspended 
in 3 µl loading buffer II (provided with the RNases, Ambion).  
To produce a hydroxyl radical 1 bp ladder (OH-ladder) 1,000,000 CPM of RNA probe 
was mixed with 10 µg of tRNA and dried under vacuum for 15 min (setting “high”). The 
pellet was resuspended in 20 µl 1x alkaline hydrolysis buffer (provided with enzymes, 
Ambion), and heated for 2 min at 94°C. 20 µl of loading buffer II was added, and 5 µl 
was loaded onto the gel. 
The reactions were separated on a 12% sequencing gel (20 ml of 30% acrylamide/bis 
(19:1), 24 g UREA, 5 ml of 10 x TBE, add H2O to a total volume of 50 ml; then add 180 
µl of 10% APS, and 30 µl TEMED) using 1 x TBE as running buffer. The gel was run at 
45 W. The gel was dried and autoradiographed for visualization of product using a 
phosphorimager (Typhoon, 9400, GE Healthcare). 
 
3.46 Expression and purification of coxsackie B3 viral 3Dpol and 
3CDpro6His 
Proteins were expressed by using the pET26-Ub-based prokaryotic expression system 
as reported previously (Gohara et al., 1999), which generates N-terminally linked yeast 
ubiquitin-fusion proteins. Overexpression of protein is performed in the BL21 
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(DE3)pCG1 strain of Escherichia coli. CVB3 3Dpol and 3CDpro-6His were expressed 
essentially in the same manner as the poliovirus proteins described previously (Gohara 
et al., 1999) from the polyethyleneimine precipitation. The protein concentration of 
each collected fraction (0.5 ml) was determined by measuring the  A280 in the presence 
of 6 M guanidine hydrochloride and using the following absorbance coefficients: 3D, 69 
270 M-1cm-1; 3CD, 82 640 M-1cm-1. Samples were aliquoted and stored at -80°C. 
 
3.47 In vitro VPg-uridylylation of coxsackievirus B3 
For short RNA transcripts of wild-type and cre(2C) loop mutants, a PCR product was 
generated, using wild-type or mutant infectious clones as template, with reverse primer 
5’-CAGGCGCAAACATACAGGTTCAA-3’ and forward primer 5’-GGGGGGTAA-
TACGACTCACTATAGGGCGAATGAGCAATTACATACAGTTCAA-3’ containing a T7 
polymerase sequence (italic sequence). For the generation of genomic wild-type and 
mutant RNA transcripts, infectious clone p53CB3/T7 was linearized by using MluI. 
Synthesis of VPgpU was measured by using a reaction mixture (20 µl)  containing 50 
mM HEPES (pH 7.5), 8% (v/v) glycerol, 3.5 mM magnesium acetate, 0.7 µM 3CDpro, 2 
µM 3Dpol,  40 µM  synthetic  CVB3  VPg,  0.75 µCi  (0.277 MBq)   [α32P]UTP    (3000 Ci 
mmol-1) and 25 µM unlabeled UTP. Amount of template for the reaction was 0.5 µg for 
cre(2C) transcript RNA and 2 µg for genomic transcript RNA. Reaction mixtures were 
incubated for 1 h at 34°C and the reaction was quenched  by adding 5 µl  gel-loading 
buffer. The samples were analyzed by Tris/Tricine SDS-PAGE (Bio-Rad) with 13.5% 
acrylamide. The gels were dried and autoradiographed for visualization of product. 
Reaction products were quantified by measuring amount of [32P]UMP incorporated into 
the product by using a phosphorimager (Storm 860; GE Healthcare) and converting it 
into cpm by using a radioactive marker.  
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4. Results 
4.1 The role of the cloverleaf structure in poliovirus replication 
4.11 Cloverleaf mutations and their effect on negative-strand RNA 
synthesis 
The first mutational analysis of the cloverleaf structure was undertaken when a cell-free 
translation replication system was not yet developed. In cell cultures viral RNA 
transcripts carrying cloverleaf mutations were analyzed mainly by their plaque 
phenotype (Andino et al., 1990). Additionally, northern blot analysis of transfected cells 
revealed that some cloverleaf mutations led to a dramatic decrease in the ratio of 
positive- to negative-strands from 30:1 to 1:1. This result indicated a role of the 
cloverleaf structure in positive-strand RNA synthesis. In more recent studies it has 
been demonstrated that the cloverleaf RNA is a key cis-acting element and absolutely 
required for negative-strand RNA synthesis (Barton et al., 2001; Herold & Andino, 
2001).  
To start out, we wanted to take advantage of the now available in vitro system, with 
which we can distinguish between negative- and positive-strand synthesis. With the 
help of this system, we analyzed some of the cloverleaf mutations that were described 
in the original cloverleaf study for their ability to synthesize plus- and minus-strands. 
The cloverleaf RNA forms three important stem-loop structures, with stem a being the 
main stem and basis of the structure. Stem b and stem d have been identified as 
important domains for the formation of the ternary complex with PCBP  (which binds to 
stem-loop b) and 3CDpro (which binds to stem-loop d) (Andino et al., 1990; Andino et 
al., 1993; Gamarnik & Andino, 1997; Parsley et al., 1997). Disruption of either duplex 
structure is lethal for the virus (Andino et al., 1990). Therefore, several poliovirus 
replicons were engineered carrying either a mutation within stem b or stem d of the 
cloverleaf. These poliovirus replicons carry a luciferase reporter gene in place of the 
capsid region which enables us to monitor translation indirectly by measuring luciferase 
activity (Fig. 4.1A). All replicons transcribed from plasmids, contained a hammerhead 
ribozyme 5’ of the poliovirus sequence that cleaves itself off and releases a virus 
transcript with precise 5’ sequences (Herold & Andino, 2000). An overview of the 
mutations that were introduced into the cloverleaf is seen in Fig. 4.1B.  
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Figure 4.1: Schematic of poliovirus replicons with cloverleaf mutations. (A) Schematic representation 
of rib(+)Luc-Wt replicon RNA transcript used throughout this study. The capsid region is replaced by 
luciferase, which is cleaved off by 2Apro during translation of the polyprotein. (B) Schematic representation 
of mutations introduced in either stem b or stem d of the cloverleaf using rib(+)Luc-Wt replicon as the 
parental construct. Mutated sequences are highlighted in red. 
 
The cell-free replication system was used to study the replication phenotype of the new 
engineered constructs (Fig. 4.2A). In this system it is possible to compare the levels of 
negative- and positive-strand RNA synthesis of different viral RNA transcripts by the 
detection of replicative form (RF), a double-stranded intermediate which is synthesized 
during negative-strand RNA synthesis; replicative intermediate (RI), the complex 
synthesized during positive-strand RNA synthesis; and new synthesized single-
stranded RNA (ssRNA). Replication of rib(+)Luc-Wt (see Fig. 4.1A) resulted in the 
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synthesis of RF, RI and new ssRNA (Fig.4.2A, lane 1), as previously shown (Herold & 
Andino, 2000). RF and ssRNA are detected as a sharp band. Each RI complex 
contains one negative-strand, as well as different amounts of unfinished positive-
strands; and thus, RI is seen as a smear. GuHCl was added (lane 2) as a negative 
control for replication since it inhibits replication. rib(-)Luc-Wt (lane 3) contains the 
same Wt replicon sequences as rib(+)Luc-Wt but contains a point mutation in the 
hammerhead ribozyme that renders the ribozyme inactive, which results in additional 
non-viral nucleotides 5’- of the poliovirus sequence (Herold & Andino, 2000). These 
extra sequences result in inhibition of positive-strand RNA synthesis in vitro, and thus, 
only RF is detectable as seen in lane 3 of Fig. 4.2A. This construct was used as a Wt 
replicon control to measure the level of negative-strand RNA synthesis when positive-
strand RNA synthesis is blocked. Five different mutations were introduced into stem b 
and three into stem d of the cloverleaf (Fig. 4.1B). As a result of base-pairing, a similar 
cloverleaf structure is predicted either at the 5’-end of the positive-strand or at the 3’-
end of the negative-strand (Andino et al., 1990). Since initiation of positive-strand 
synthesis occurs at the 3’-end of the negative-strand where the viral primer, VPgpUpU, 
binds, it is possible that the cloverleaf structure in the negative-strand functions as a 
promoter for positive-strand synthesis. To determine whether one or both strands 
require the structure, we used the particular property of G-U base-pairs to selectively 
disrupt the structure in either the positive- or negative-strand. Such G-U pairs can 
replace A-U pairs in one strand, but on the opposite strand the A-C base pairs cannot 
form and the stem structure will be compromised. Thus, by incorporating G-U/A-C 
regions into the stem b or stem d regions of the 5’-cloverleaf, the requirement for 
structure in the two strands for RNA synthesis can be selectively evaluated. First, we 
mutated three consecutive base-pairs in stem b. In StemB-mut(+), the sequence GGG 
was replaced by AAA. This mutation should disrupt the stem in the positive-strand but 
should maintain the structure in the negative-strand. In contrast, the mutation in 
StemB-mut(-) (CCC to UUU) should disrupt the duplex structure in the negative-strand 
but should not alter the structure in the positive-strand. The disruption of the plus-
strand led to a decrease of minus- and plus-strand synthesis in vitro (lane 5); whereas 
the disruption of the minus-strand resulted in the wild-type levels of RNA synthesis 
(lane 6). Consistent with these results, when the stem b sequences were changed but 
the base-pairing on both strands were maintained (StemB-DNC1), no effect on RNA 
synthesis was observed. In StemB-DNC8 and StemB-DNC81, the same sequence 
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changes as in StemB-DNC1 were introduced in addition to one G-U base-pair, such 
that it disrupts the structure in the plus-strand in StemB-DNC8 and the minus-strand in 
StemB-DNC81. This time, the one base-pair disruption on the plus-strand did not have 
any effect on negative- or positive-strand RNA synthesis (lane 7), whereas the 
disruption of the minus-strand led to a slight decrease of RF and ssRNA (lane 8). 
Similar as in stem b, we also used the advantage of G-U base-pairing in stem d of the 
cloverleaf. When the structure of the positive-strand of the stem d duplex structure was 
disrupted in StemD-mut(+) a much bigger decrease in RF and ssRNA was observed 
than with any stem b mutation (lane 9). Maintaining the structure on the plus-strand but 
disrupting it on the minus-strand (StemD-mut(-)), resulted in much higher levels of RNA 
synthesis as in StemD-mut(+), but still showed some decrease in replication in 
comparison to the replicon Wt. The biggest effect on both negative- and positive-strand 
RNA synthesis was observed when four nucleotides were inserted into the loop region 
of stem d (StemD-insert), which essentially resulted in complete inhibition of RNA 
synthesis. These results demonstrate that mutations in the cloverleaf structure can 
have a dramatic effect on RNA synthesis.  
It has been proposed that the cloverleaf is involved in both negative- and positive-
strand RNA synthesis, and the in vitro assay shows the results of RNA synthesis 
accomplished after 2 h of incubation time representing several rounds of replication. 
This makes it difficult to distinguish between effects on minus-strand synthesis which 
then subsequently will affect plus-strand synthesis, or the other way round, effects on 
positive-strand synthesis in the first round of replication will then affect negative-strand 
synthesis in the subsequent round of replication. Therefore, we decided to clone these 
same mutations as just described into ribozyme(-) constructs, which contain the same 
hammerhead mutation as in rib(-)Luc-Wt, and hence, bear non-viral sequences at their 
5’-ends when transcribed. These extra sequences will inhibit plus-strand RNA 
synthesis in vitro, and enable us to evaluate the ability of the mutated cloverleaves to 
synthesize negative-strands in the form of RF. Here, only StemB-DNC1 shows Wt-
levels of RF, now compared to rib(-)Luc-Wt (Fig. 4.2A, lane 15 compare to lane 14). 
StemB-mut(+) shows no RF synthesis (lane 16), whereas the other stem b mutations 
all led to a decrease in RF levels (lane 17-19). No detectable levels of RF were 
observed for any stem d mutations (lane 20-22). The effect on negative-strand RNA 
synthesis was not due to a decrease in translation, since translation levels for all 
constructs as measured as luciferase activity were similar to replicon Wt levels (data 
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not shown). These results clearly confirm the importance of the cloverleaf structure for 
negative-strand RNA synthesis.  
 
 
 
Figure 4.2: Replication of poliovirus replicon RNA transcripts with cloverleaf mutations in a cell-
free translation replication system and in tissue culture cells. (A) RNA replication in translation-
replication extracts. HeLa S10 extract was programmed with 1 µg of RNA transcripts containing either an 
active (ribozyme(+)) or an inactive (ribozyme(-)) hammerhead ribozyme at their 5’-end. After 4 h of 
incubation at 30°C in the presence of 2 mM guanidine hydrochloride, preinitiation complexes were isolated 
by centrifugation at 15,000 x g. Preinitiation complexes were resuspended in labeling mix containing [α-
32P]UTP and incubated for 2 h. Total RNA was prepared and separated on native agarose gels and 
detected by autoradiography. (B) Luciferase expression in replicon RNA-transfected HeLa cells. After 
transfection of the RNA transcripts into HeLa cells, the luciferase activity (relative light units [RLU]) 
corresponding to 2 x 104 cells was measured every hour for 7 h. The cells were either kept in the presence 
(+GuHCl) or absence of 2 mM guanidine hydrochloride.  
 
 
Next, we wanted to evaluate the results seen in the in vitro system by monitoring the 
replication phenotype of the cloverleaf mutants in complete cells. We transfected all the 
ribozyme(+) constructs containing the  cloverleaf mutations into HeLa cells in the 
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presence or in the absence of GuHCl and monitored replication by measuring 
luciferase activity over time (Fig. 4.2B). Monitoring luciferase activity in the presence of 
GuHCl provides a measurement of the translation level of the input-RNA in the 
absence of replication, and permits us to ensure that none of the mutations negatively 
impacts translation directly, since low translation levels would in turn have a negative 
effect on replication. The replication phenotypes of the mutants can be divided into 
three groups. In the first group, both constructs, StemB-mut(+) and StemD-mut(+), in 
which the positive-strand duplex structure is disrupted either in stem b or stem d of the 
cloverleaf, show very little or no replication in vivo. The second group contains StemB-
DNC8, which has one base-pair disruption on the plus-strand of stem b, and StemD-
insert, which has the increased loop in stem d. Both show more than one log-scale 
decrease in replication levels in comparison to rib(+)Luc-Wt. The third group contains 
all other mutants. They all replicate with nearly wild-type levels in HeLa cells. These in 
vivo results verify the requirement of the cloverleaf structure formed on the plus-strand 
for RNA synthesis. In addition, we could confirm a role of the cloverleaf for negative-
strand RNA synthesis using the ribozyme(-) constructs. However, no conclusions can 
be made about the involvement of the cloverleaf in positive-strand RNA synthesis. 
 
4.12 Poliovirus replicons with separate promoters for positive- and 
negative-strand RNA synthesis 
To specifically study the role of the cloverleaf in positive-strand RNA synthesis, we 
needed to develop a system in which we can separate the promoter function of the 
RNA element for minus- and plus-strand synthesis. Since it was shown that the 
cloverleaf can initiate negative-strand RNA synthesis internally, thus does not have to 
be located at the very 5’-end of the genome (Herold & Andino, 2000). We thus 
generated tandem cloverleaf replicons with two wild-type cloverleaves next to each 
other at the 5’-end of the genome. The idea is that the second, internal Wt cloverleaf 
can initiate negative- but not positive-strand RNA synthesis, which enables us to study 
the effect of the cloverleaf mutation in the 5’ cloverleaf on positive-strand RNA 
synthesis. Both cloverleaves were linked by poliovirus sequence 96-112 and a SacI-
site for easier cloning, resulting in Wt-Wt (Fig. 4.3A). Using the Wt-Wt replicon, we then 
engineered three more replicons in which we introduced in each one of the three stem 
d mutations (as described in the previous section) into the upstream, 5’-cloverleaf, 
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resulting in StemD-mut(+)-Wt, StemD-mut(-)-Wt, and StemD-insert respectively (Fig. 
4.3B). We started out with these stem d mutations since they had the most dramatic 
effect on negative-strand RNA synthesis. We then compared replication of these new 
replicons with the replicons with just one cloverleaf, carrying the same cloverleaf 
mutation (Fig. 4.4A). The Wt-Wt replicon showed both negative- and positive-strand 
RNA synthesis but at decreased levels in comparison to rib(+)Luc-Wt (compare lane 3 
with lane 1). Strikingly, all three tandem cloverleaf replicons with stem d mutations 
showed improved replication levels in comparison to their counterpart with the same 
mutation but only one cloverleaf. The decreased levels of RF and ssRNA as seen for 
StemD-mut(-) (lane 4) were completely restored to Wt-levels of rib(+)Luc-Wt (lane 5). 
Both StemD-mut(+) and StemD-insert showed no detectable levels of RF or ssRNA, 
but synthesized both when in the tandem cloverleaf constructs, although to a lower 
level than Wt. The demonstrated defect on the level of negative-strand RNA synthesis 
for these stem d mutations as seen in Fig. 4.2A, could be at least partially restored by 
providing a second cloverleaf internally. 
 
 
Figure 4.3: Schematic of poliovirus replicons with two cloverleaf structures at their 5’-end. (A) 
Schematic of Wt-Wt replicon RNA transcript, containing two wild-type cloverleaf structures at the 5’-end of 
the genome. (B) Schematic representation of mutations introduced in stem d of the 5’-end cloverleaf of the 
Wt-Wt replicon. Mutated sequences are highlighted in red.  
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Figure 4.4: Replication of poliovirus replicon RNA transcripts with either one or two cloverleaves at 
their 5’-end in a cell-free translation replication system and in tissue culture cells. (A) RNA 
replication in translation-replication extracts. HeLa S10 extract was programmed with 1 µg of RNA 
transcripts. After 4 h of incubation at 30°C in the presence of 2 mM guanidine hydrochloride, preinitiation 
complexes were isolated by centrifugation at 15,000 x g. Preinitiation complexes were resuspended in 
labeling mix containing [α-32P]UTP and incubated for 2 h. Total RNA was prepared and separated on 
native agarose gels and detected by autoradiography. (B) Luciferase expression in replicon RNA-
transfected HeLa cells. After transfection of the RNA transcripts into HeLa cells, the luciferase activity 
(relative light units [RLU]) corresponding to 2 x 104 cells was measured every hour for 9 h. The cells were 
either kept in the presence (+ Gu) or absence of 2 mM GuHCl.  
 
Next, we wanted to know if a similar effect can be observed in vivo. We transfected the 
Wt-Wt construct as well as the StemD-insert and the StemD-insert-Wt into HeLa cells 
and monitored luciferase activity over a time course of 8 hours, the typical replication 
cycle of poliovirus (Fig. 4.4B). Wt-Wt replicated nearly with identical levels as observed 
for rib(+)Luc-Wt. StemD-insert reached about 50% of Wt-replication levels; whereas in 
StemD-insert-Wt, this defect in replication was restored to Wt-levels. These findings 
demonstrate that the internal downstream cloverleaf is able to restore a defect in 
negative-strand RNA synthesis caused by a mutation in the upstream cloverleaf. The 
only concern with this tandem cloverleaf construct is, that any additional sequences 
that are not required for replication and are located 5’ of a Wt cloverleaf, will be 
eventually deleted when transfected into cells. This can be observed with rib(-)Luc-Wt 
in Fig. 4.4B. The additional sequences 5’ of the Wt-sequences in this RNA leads to a 
two hour delay in replication and the new synthesized RNA has lost the additional 
sequences as it was demonstrated recently by our lab (Herold & Andino, 2000). 
StemD-insert-Wt does not show the same kind of delay in replication, which suggests 
that the upstream cloverleaf has not been deleted. However, for further studies of such 
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tandem cloverleaf constructs we must avoid this possibility by replacing the internal 
wild-type cloverleaf with a cloverleaf that can only support negative-strand RNA 
synthesis, thus requiring the virus to maintain the 5’-cloverleaf for initiation of positive-
strand RNA synthesis. In addition, the fact that the Wt-Wt construct did not replicate at 
the same level as rib(+)Luc-Wt, indicates that the two cloverleaves of identical 
sequences somehow hinder each other in promoting replication, possibly through 
interaction of complementary sequences between the two cloverleaves. Nonetheless, 
the results so far have been encouraging.  
 
 
 
 
Figure 4.5: Schematic representation of the tandem cloverleaf replicon with separate promoters for 
initiation of negative- and positive-strand RNA synthesis. (A) Model of the tandem cloverleaf 
construct. The replicon RNA transcripts carry two cloverleaf structures at their 5’-end. The downstream G-
C pair cloverleaf can only initiate negative-strand RNA synthesis, whereas the 5’-terminal cloverleaf 
functions as a promoter for positive-strand RNA synthesis. In this context the 5’-end cloverleaf can be 
mutated and analyzed for its ability to support positive-strand RNA synthesis. (B) Schematic 
representation of the double-luc-Wt RNA transcripts, showing the precise sequence of the downstream 
cloverleaf that contains four G-C pairs (highlighted in blue) in stem a instead of the wild-type A-U pairs. 
Nucleotides 96 – 112 (upper case letters) of the poliovirus sequence was inserted as linker in between the 
two cloverleaf structures, as well as a SacI site, which is represented by lower case letters.  
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Using the previous results as a basis, we then designed an improved version of 
replicon RNAs with tandem cloverleaf structures, with the goal of separating the 
promoters for positive- and negative-strand RNA synthesis. Thus, a downstream 
cloverleaf which only supports minus-strand RNA synthesis allows the genetic analysis 
of a 5’-terminal cloverleaf dedicated to promote plus-strand RNA synthesis, as 
demonstrated in Fig. 4.5A. The requirements of the cloverleaf structure for negative-
strand RNA synthesis have been well defined. Previous results have shown that only 
the structure, and not the sequences, of stem a of the cloverleaf are required for 
negative-strand RNA synthesis; but these sequences are important for efficient 
initiation of plus-strand RNA synthesis (Sharma et al., 2005). It was shown that 
additional sequences at the 5’-end of the viral genome lead to a defect in positive- but 
not negative-strand RNA synthesis in vitro (Herold & Andino, 2000).  Therefore, a 
replicon with tandem cloverleaf structures was engineered in the following way: In the 
downstream cloverleaf, the four A-U pairs in stem a were replaced with G-C pairs 
(called G-C pair cloverleaf) resulting in a cloverleaf that can only support negative-
strand RNA synthesis. A wild-type cloverleaf was then inserted 5’ of the G-C pair 
cloverleaf, and both cloverleaves were linked by poliovirus nucleotides 96-112 and a 
SacI-site for easier cloning, resulting in double-luc-Wt (see Fig. 4.5B). The cell-free 
replication system was used to study the replication phenotype of the new engineered 
construct (Fig. 4.6A). A construct containing only a G-C pair cloverleaf was used to 
verify that the downstream cloverleaf in the tandem cloverleaf construct can only 
support negative-strand RNA synthesis (lane 4). The level of translation (measured as 
luciferase-activity, data not shown) and the level of negative-strand RNA synthesis 
were comparable to rib(-)Luc-Wt (lane 3). The double-Luc-Wt RNA, which contains the 
tandem cloverleaf structures, generated the same amount of negative- and positive-
strand RNA synthesis as the rib(+)Luc-Wt RNA with one cloverleaf (compare lane 5 to 
7). We then transfected rib(+)Luc-Wt RNA and double-Luc-Wt RNA into HeLa cells in 
the presence and in the absence of GuHCl to monitor replication by measuring 
luciferase activity over time (Fig 4.6B). Again, the construct with two cloverleaf 
structures showed identical replication kinetics to the RNA with one cloverleaf. Double-
Luc-Wt RNA translated with the same efficiency as rib(+)Luc-Wt RNA. These results 
confirm that the double-Luc-Wt RNA is able to support efficient replication in vitro and 
in vivo, and therefore, provides a suitable system to study the effect of 5’-cloverleaf 
mutations on positive-strand RNA synthesis. All further experiments using tandem 
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cloverleaf constructs will be based on double-luc-Wt containing the G-C pair cloverleaf 
at the downstream position. 
To confirm that both cloverleaves located next to each other in double-Luc-Wt form two 
individual structures, we employed enzymatic mapping using RNA transcripts of the 
two Wt-G-C-pair cloverleaf structures as in double-Luc-Wt that were 5’-labeled with 
[γ32P]ATP as a probe. Fig. 4.7 shows an autoradiograph with the cleavage products of 
the probe by different RNases. The very left lane contains a hydroxyl radical 1bp ladder 
produced from the same probe. As the outline on the left side of the autoradiograph 
demonstrates, the cleavage pattern of the 5’-cloverleaf showed the expected pattern 
for the predicted structure of the cloverleaf. Since the probe was over 200 nucleotides 
long, it was not possible to get the same resolution of the cleavage products of the 3’ 
cloverleaf as for the 5’ one. However, even compressed, the same cleavage pattern by 
the different RNases can be seen for the 3’-cloverleaf as seen for the 5’ cloverleaf. 
Based on this result as well as the studies in vitro and in vivo of double-Luc-Wt, we 
conclude that both cloverleaf structures are able to individually fold into the proper 
structure, and thus, both are able to form the required complexes for RNA synthesis.  
 
 
Figure 4.6: Replication of poliovirus tandem cloverleaf replicons in a cell-free translation 
replication system and in tissue culture cells. (A) RNA replication in translation-replication extracts. 
HeLa S10 extract was programmed with 1 µg of rib(+)Luc-Wt and double-Luc-Wt RNA transcripts. After 4 
h of incubation at 30°C in the presence of 2 mM guanidine hydrochloride, preinitiation complexes were 
isolated by centrifugation at 15,000 x g. Preinitiation complexes were resuspended in labeling mix 
containing [α-32P]UTP and incubated for 2 h. Total RNA was prepared and separated on native agarose 
gels and detected by autoradiography. (B) Luciferase expression in replicon RNA-transfected HeLa cells. 
After transfection of the RNA transcripts into HeLa cells, the luciferase activity (relative light units [RLU]) 
corresponding to 2 x 104 cells was measured every hour for 8 h. The cells were either kept in the presence 
(+ GuHCl) or absence (- GuHCl) of 2 mM guanidine hydrochloride. Each time point represents the mean of 
three independent experiments and SD is indicated.  
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Figure 4.7: Structural mapping of the tandem cloverleaf structures of double-Luc-Wt. The 
autoradiograph of a representative mapping acrylamide gel is shown. The corresponding area within the 
cloverleaf structure is indicated on the left hand side of the autoradiograph. Major ribonuclease cleavages 
are indicted by arrow and the corresponding nucleotide of the cloverleaf RNA starting at the 5’-end. The 
very left lane (OH-ladder) contains a hydroxyl radical 1bp ladder produced from the same probe. The very 
right lane contains probe without any enzyme as a negative-control.  
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4.13 Partial cloverleaf structures at the 5’-end do not support initiation of 
positive-strand RNA synthesis 
It has been shown that the 5’-terminal sequence is required for efficient initiation of 
positive-strand RNA synthesis (Herold & Andino, 2000; Sharma et al., 2005). As the 
cloverleaf structure is at the 5’-end of the poliovirus genome, those sequences are part 
of the stem a duplex structure of the cloverleaf. To test what the minimal structural 
requirements at the 5’-end are to efficiently initiate positive-strand RNA synthesis, we 
engineered tandem cloverleaf constructs in which different parts of the 5’ cloverleaf 
structure were deleted in a way that the 5’-end sequence was left intact. In all cases 
the negative-strand RNA synthesis was ensured by the downstream G-C pair 
cloverleaf (see Fig. 4.8A). The plus9 construct contains only the nine 5’-most-terminal 
nucleotides, plus the SacI site, instead of a second 5’ cloverleaf. In the plus20 RNA, 
the 5’-end sequence is part of stem a, and in the plus27 RNA stem a and stem c have 
been left at the 5’-end. Analyzing these constructs in the cell-free replication system 
revealed that no positive-strand RNA synthesis could be detected for any of them (Fig. 
4.8B). Similar levels of negative-strand synthesis was observed for plus9, plus20 and 
plus27 RNA, which was initiated by the downstream G-C pair cloverleaf. These results 
suggest that more than just the very 5’-terminal sequence and structure is involved in 
initiation of positive-strand RNA synthesis.  
To further address the question of what 5’-end structure is required for initiation of 
positive-strand RNA synthesis, double-Luc-StemA-disr RNA was engineered in which 
the stem a duplex structure of the 5’-end cloverleaf was disrupted but leaving the 5’-
terminal sequences intact (see Fig. 4.8A). This construct shows a big defect in positive-
strand synthesis in the in vitro system. The ratio of positive-strand RNA to RF for 
double-luc-StemA-disr was equal to that for G-C-pair cloverleaf RNA (compare Fig. 
4.8B, lane 1 and 6) and was 20 fold lower than in the Wt control (lane 2). Furthermore, 
when double-Luc-StemA-disr RNA was transfected into HeLa cells no replication could 
be detected as seen in Fig. 4.8C. The same could be observed for plus9 after 
transfection (Fig. 4.8C) as well as for plus20 and plus 27 (data not shown). These 
results establish that not only the 5’-end sequence, but also the 5’-end structure is 
required for efficient positive-strand RNA synthesis. This shows that an intact stem a 
structure is required, but alone is not sufficient, for synthesis of plus-strands.  
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Figure 4.8: Schematic of tandem cloverleaf replicons with partial cloverleaf structures at their 5’-
end and their replication phenotype in vitro and in vivo. (A) Schematic representation of tandem 
cloverleaf replicon RNA transcripts with partial cloverleaf structures at their 5’-end. In addition to the G-C-
pair cloverleaf, plus9 contains the 9 wild-type 5’-terminal nucleotides of poliovirus at its 5’-end. Plus20 
contains stem a and loop sequences of stem-loop c, and  plus27 contains stem a and complete stem c at 
its 5’-end. Sequences in lower case represent a SacI site. StemA-disr. contains two cloverleaf structures, 
downstream the G-C pair cloverleaf and 5’ a cloverleaf with mutations in stem a that disrupt the duplex 
structure but maintains the wild-type 5’-terminal sequences. (B) RNA replication in vitro. HeLa S10 extract 
was programmed with 1 µg of RNA transcripts. After 4 h of incubation at 30°C in the presence of 2 mM 
guanidine hydrochloride, preinitiation complexes were isolated by centrifugation at 15,000 x g. Preinitiation 
complexes were resuspended in labeling mix containing [α-32P]UTP and incubated for 2 h. Total RNA was 
prepared and separated on native agarose gels and detected by autoradiography. (C) Luciferase 
expression in replicon RNA-transfected HeLa cells. After transfection of the RNA transcripts into HeLa 
cells, the luciferase activity (relative light units [RLU]) corresponding to 2 x 104 cells was measured every 
hour for 8 h. The cells were either kept in the presence (+ GuHCl) or absence of 2 mM guanidine 
hydrochloride. 
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4.14 Stem b and stem d mutations and their effect on positive-strand RNA 
synthesis 
4.141 The cloverleaf structure is required in the positive-strand for positive-
strand RNA synthesis. 
With the help of G-U base-pairing as already described in section 4.11, we wanted to 
determine whether the cloverleaf structure was required on the positive- and/or on the 
negative-strand for positive-strand RNA synthesis. We engineered two tandem 
cloverleaf constructs by introducing the StemB-mut(+) and the StemB-mut(-) into the 5’ 
cloverleaf of the tandem cloverleaf construct (see Fig. 4.9). Both mutations lead to a 
great deficiency in positive-strand RNA synthesis in the cell-free replication system; 
although, with StemB-mut(-) resulting in a 3-fold higher ratio of positive-strands to RF 
(Fig. 4.10A, lane 3 + 4). Strikingly, the small difference of both constructs in synthesis 
of positive-strands seen in vitro, resulted in a considerable difference in replication 
when transfected into HeLa cells (Fig. 4.10B). Here, StemB-mut(+) was not able to 
replicate at all; whereas StemB-mut(-), shows wild-type replication kinetics although 
reaching approximately 2-fold less in luciferase-activity at 8 hours post-transfection 
than double-Luc-Wt. These results suggest that the cloverleaf structure in the stem b 
region is absolutely required in the positive-strand for positive-strand RNA synthesis. 
The slight defect seen in replication of StemB-mut(-) could be due to the weaker G-U 
base-pairing in the positive-strands than the G-C base-pairs existing in the Wt- 
sequence or due to slight changes in the structure as a result of the mutations.  
To further confirm the importance of the stem b structure for positive-strand RNA 
synthesis, we generated additional mutations within the stem b region (for overview 
see Fig. 4.9). In StemB-swap, the entire stem b base-pair sequence was swapped so 
that sequences on the top part of the stem were exchanged with the sequences on the 
lower part of the stem. In StemB-shuffle, the consecutive base-pair sequences of stem 
b were shuffled around, resulting in a different order of the original base-pairs but still 
maintaining the same original structure. Both constructs showed a big defect in 
positive-strand synthesis in the cell-free replication system (Fig. 4.10A, lane 5 + 6), but 
were able to replicate with nearly Wt efficiency in HeLa cells (Fig. 4.10B). Again, our 
results suggest that maintaining the stem b structure is important for positive-strand 
synthesis and that changes to the original sequence affect the level of plus-strand RNA 
synthesis.  
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Figure 4.9: Schematic representation of tandem cloverleaf replicons with cloverleaf mutations in 
stem b or stem d of the 5’-terminal cloverleaf. The mutated sequence is highlighted in red. 
 
As a next step, we introduced G-U/A-C pairs into the stem d region of the 5’ cloverleaf 
of the tandem cloverleaf RNA (see Fig. 4.9). In StemD-mut(+), two A-U pairs were 
replaced by A-C pairs, which results in disruption of the stem d duplex structure on the 
positive-strand but not the negative-strand. In contrast, two G-U pairs were introduced 
within the stem d region of StemD-mut(-), which should maintain the duplex structure 
on the positive-strand yet alter the structure on the negative-strand. When tested in the 
cell-free replication system, StemD-mut(+) showed a reduced level of positive-strands 
in comparison to double-Luc-Wt (Fig. 4.10C, lane 2 + 4). Strikingly, StemD-mut(-) 
resulted in an increased level of positive-strand synthesis by over two fold when the 
ratio of positive-strands to RF was calculated and compared to Wt (Fig. 4.10C, lane 2 + 
3). After transfection of these constructs into HeLa cells, wild-type levels of replication 
was observed for StemD-mut(-), whereas, StemD-mut(+) showed a 10-fold decrease in 
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replication when compared to double-Luc-Wt (Fig. 4.10D). These results further 
confirm that compromising the cloverleaf structure in the positive-strand leads to a 
defect in positive-strand RNA synthesis. 
 
Figure 4.10: Replication of tandem cloverleaf replicon RNA transcripts with stem b or stem d 
mutations in the 5’-terminal cloverleaf in a cell-free translation replication system and in tissue 
culture cells. (A)+(C) RNA replication in translation-replication extracts. HeLa S10 extract was 
programmed with 1 µg of RNA transcripts. After 4 h of incubation at 30°C in the presence of 2 mM 
guanidine hydrochloride, preinitiation complexes were isolated by centrifugation at 15,000 x g. Preinitiation 
complexes were resuspended in labeling mix containing [α-32P]UTP and incubated for 2 h. Total RNA was 
prepared and separated on native agarose gels and detected by autoradiography. (B)+(D) Luciferase 
expression in replicon RNA-transfected HeLa cells. After transfection of the RNA transcripts into HeLa 
cells, the luciferase activity (relative light units [RLU]) corresponding to 2 x 104 cells was measured every 
hour for 8 h. The cells were either kept in the presence (+ Gu) or absence of 2 mM guanidine 
hydrochloride.  
 
We further investigated the structural requirement of stem d for positive-strand RNA 
synthesis by introducing more mutations within this region (see Fig. 4.9). When the 
loop region of stem-loop d was increased by insertion of four additional nucleotides, 
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(StemD-insert) no significant changes in replication in either cell extract (Fig. 4.10C, 
lane 5) or in HeLa cells (Fig 4.10D) was observed. However, more drastic changes, 
such as a complete swap of the base-pair sequences (StemD-swap), a complete 
disruption of the duplex structure (StemD-disr) or a complete sequence change within 
the loop region (StemD-loop), all resulted in a big defect on the level of positive-strand 
synthesis in the in vitro system (Fig. 4.10C, lane 6, 7, 9). Strikingly, none of these 
constructs showed any replication in cells (Fig. 4.10D). Therefore, the stem d structure 
appears to be important for the synthesis of positive-strands. These results confirm that  
the cloverleaf structure as it was originally predicted (Andino et al., 1990) plays an 
important role in positive-strand RNA synthesis. 
 
4.142 Binding-sites for PCBP2 and 3CDpro in the cloverleaf are required for 
positive-strand RNA synthesis. 
It was shown that the host factor, PCBP2 (Gamarnik & Andino, 1997; Parsley et al., 
1997), and the viral polymerase precursor, 3CDpro (Andino et al., 1990; Andino et al., 
1993; Silvera et al., 1999), bind to the cloverleaf structure and form a ternary complex 
at the 5’-end of the viral genome, a requirement for negative-strand RNA synthesis 
(Barton et al., 2001; Herold & Andino, 2001). Having defined the structural 
requirements of the cloverleaf RNA for positive-strand synthesis, we examined the 
requirements of intact binding-sites for PCBP2 and 3CDpro within the cloverleaf for 
positive-strand RNA synthesis. A poly(C) stretch within the stem-loop b of the 
cloverleaf has been identified as the binding-site for PCBP2. Using the tandem 
cloverleaf replicon, we introduced a mutation within the 5’ cloverleaf that abolishes 
binding of PCBP2 to the cloverleaf (S1-mutation in (Parsley et al., 1997)), to generate 
StemB-ΔPCBP (Fig. 4.9). This RNA showed a severe defect in positive-strand RNA 
synthesis when tested in the cell-free replication system (Fig. 4.10A, lane 7) and was 
unable to replicate in cells (Fig. 4.10B). This result demonstrates that an intact binding-
site for PCBP2 in the cloverleaf structure is required for positive-strand synthesis. In 
the next step, we engineered StemD-Δ3CD, which has a deletion within the stem d 
region of the 5’ cloverleaf of the tandem cloverleaf RNA (Fig. 4.9). This deletion has 
been previously described as 5’Δd-mutation (Parsley et al., 1997). This mutation was 
shown to disrupt 3CDpro binding to the cloverleaf structure. When cell extract was 
programmed with StemD-Δ3CD, only a very small amount of positive-strand RNA was 
detected (Fig. 4.10C, lane 8). Furthermore, this construct was unable to replicate in 
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vivo (Fig. 4.10D). These findings establish the requirements for intact binding-sites for 
PCBP and 3CDpro within the cloverleaf structure for efficient positive-strand synthesis.  
 
Figure 4.11: VPgpUpU formation in a cell-free translation-replication system. HeLa S10 extract was 
programmed with 1 µg of RNA transcripts. After 4 h of incubation at 30°C in the presence of 2 mM 
guanidine hydrochloride, preinitiation complexes were isolated by centrifugation at 15,000 x g. Preinitiation 
complexes were resuspended in labeling mix containing [α-32P]UTP and incubated for 1 h. Top: 
Replication complexes were isolated by centrifugation at 15,000 x g, resuspended in Tricine-sample buffer, 
separated on a Tris-Tricine gel, and detected by autoradiography. Bottom: VPgpUpU was isolated by 
immunoprecipitation using polyclonal anti-VPg antibodies, separated on a Tris-Tricine gel and detected by 
autoradiography. Translation levels are represented by luciferase activity (relative light units [RLU]) 
measured after the 4 h incubation in the presence of GuHCl. The activity measured for rib(+)Luc-Wt  was 
set to 100%. All other translation levels are expressed as % in relation to rib(+)Luc-Wt. 
 
4.143 Constructs with two cloverleaf structures support cre(2C) mediated VPg-
uridylylation. 
A cis-acting replication element (cre) has been identified within the coding region of the 
picornavirus genome (McKnight & Lemon, 1998; Lobert et al., 1999; Goodfellow et al., 
2000; Gerber et al., 2001a; Mason et al., 2002). For poliovirus, this cre is located within 
the 2C-coding region. This hairpin structure functions as a template for the covalent 
linkage of two UMP nucleotides to the viral primer, VPg, resulting in VPgpUpU (Paul et 
al., 2000; Rieder et al., 2000; Gerber et al., 2001a; Paul et al., 2003). There is evidence 
that cre(2C) mediated VPgpUpU functions as a primer for both negative- and positive-
strand synthesis (van Ooij et al., 2006). However, it is only absolutely required for 
positive-strand RNA synthesis (Goodfellow et al., 2003b; Morasco et al., 2003; Murray 
& Barton, 2003). Since mutations in the cloverleaf negatively affect VPgpUpU 
formation, this structure has been indicated to have a role in VPg-uridylylation (Lyons 
et al., 2001). Most mutants tested in our studies show a severe defect in positive-
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strand synthesis, therefore we wanted to examine if the tandem cloverleaf replicons 
with mutations severely disrupting the structure or protein binding-sites within the 5’-
cloverleaf still support cre(2C) mediated VPg-uridylylation. We programmed HeLa S10 
extract with replicon RNA and stopped the reaction after one hour of replication. Two 
different methods were then used to isolate VPg-pUpU: (i) The replication complexes 
were isolated and separated on a Tris-Tricine gel to be identified. (ii) After the reaction 
was stopped, VPgpUpU was isolated by immuno-precipitation (IP) using polyclonal 
anti-VPg-antibodies and then separated on a gel for detection. rib(+)Luc-Wt was used 
as a positive-control. GuHCl was added as a negative-control, since it is known to 
prevent the formation of VPgpUpU. In addition, a cre-mutant coxsackievirus B3 RNA 
that carries a mutation within the cre(2C) region that prevents VPgpUpU formation (A5 
to C mutation; as decribed later in section 4.2) was used. Using either method, similar 
levels of VPgpUpU synthesis were observed for rib(+)Luc-Wt RNA as well as for 
double-Luc-Wt RNA (Fig. 4.11; lane 1 + 4). VPgpUpU formation was also detected for 
all tandem cloverleaf replicons carrying mutations in the 5’ cloverleaf that either 
disrupted the stem b duplex structure on the positive- or the negative-strand (StemB-
mut(+) and StemB-mut(-)); that disrupted the stem a structure (StemA-disr); or that 
disrupted the binding-sites for PCBP or 3CDpro (StemB-ΔPCBP and StemD-Δ3CD), as 
described before (Fig. 4.11, lane 5-9). These results confirm that the defect in positive-
strand synthesis, when structure or protein binding-sites are disrupted, is not due to a 
lack of VPgpUpU formation. Furthermore, the replication complex formed by the 
downstream cloverleaf to initiate negative-strand synthesis is also able to support the 
cre(2C) mediated formation of VPgpUpU.  
 
4.15 Stem a sequences are required for positive-strand RNA synthesis. 
The stem a duplex structure in the cloverleaf is required for negative-strand RNA 
synthesis (Sharma et al., 2005). Using double-Luc-StemA-disr RNA, we established 
that the stem a structure is also required for positive-strand RNA synthesis. However, 
changes in the base-pair sequences of stem a only affect negative- but not positive-
strand synthesis, as previously demonstrated (Sharma et al., 2005) and shown here 
with the G-C pair cloverleaf RNA. To further investigate the precise sequence 
requirements of stem a in the cloverleaf for positive-strand synthesis, we engineered 
tandem cloverleaf replicons with a series of stem a mutations within the 5’ cloverleaf 
(for overview see Fig. 4.12A). Since disrupting the duplex structure leads to a decrease 
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in the level of positive-strand synthesis, base-pair sequences were replaced by 
different base-pair sequences without disrupting the structure. The 5’ terminal two U’s 
were always kept intact since they are the template for the 3’ terminal two A’s on the 
negative-strand, which is the location where the primer, VPgpUpU, binds. Following the 
first two U’s, there are four consecutive A’s, which all base pair with U on the other side 
of the stem. Those four A-U pairs were replaced in 10 different combinations. All 
mutated tandem cloverleaf RNAs were tested for positive-strand synthesis in the cell-
free replication system (Fig 4.12B) and transfected into HeLa cells to identify their 
replication phenotype in vivo (Fig. 4.12C). The mutants could be separated into three 
groups based on their replication phenotype: 
 Group 1 (highlighted in blue): When the upper two A-U pairs were swapped to U-A 
pairs, or either the first (starting count on the lowest), third or  fourth  A-U pair  replaced 
with G-C pairs  (StemA-mut2, -mut4, -mut6, -mut7, respectively; Fig. 4.12A), a clear 
defect in positive-strand synthesis could be observed in vitro (Fig. 4.12B, lane 4, 6, 8, 
9). However, the levels of positive-strands for those mutants were higher than for any 
other mutants. In addition, they all showed similar replication kinetics and reached the 
same level of luciferase-activity in cells as double-Luc-Wt (Fig. 4.12C). This shows that 
those mutations have no significant effect on replication in vivo.  
Group 2 (highlighted in green) contained StemA-mut1, StemA-mut5, and StemA-mut9 
where either the lower two A-U pairs were swapped into U-A pairs, the second A-U pair 
replaced by G-C, or the upper two A-U pairs were replaced with G-C pairs, respectively 
(Fig. 4.12A). Hardly any positive-strands could be detected for mutants in this group 
when tested in the cell-free replication system (Fig. 4.12B, lane 3, 7, 11). After 
transfection into cells, they all showed significantly decreased replication levels in 
comparison to double-Luc-Wt (Fig. 4.12C). These results establish that the decrease in 
replication seen in cells for those mutants is due to their defect in positive-strand 
synthesis as seen in vitro.  
Group 3 (highlighted in red) contained the mutants with the most severe changes in 
base-pairing. In StemA-mut3 all four A-U pairs were swapped into U-A pairs, in StemA-
mut8 the lower two A-U pairs were replaced by G-C pairs, and in StemA-mut10 all four 
A-U pairs were replaced by two G-C pairs and two C-G pairs (Fig. 4.12A). None of 
these mutants was able to synthesize detectable levels of positive-strands in cell 
extract (Fig. 4.12B, lane 5, 10, 12). Furthermore, no replication could be observed for 
either of them in cells (Fig. 4.12C).  
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Figure 4.12: Schematic of tandem cloverleaf replicons with stem a mutations in their 5’-terminal 
cloverleaf and their replication phenotype in vitro and in vivo. (A) Schematic representation of tandem 
cloverleaf replicon RNA transcripts with stem a mutations in their 5’-terminal cloverleaf. Mutated 
sequences are highlighted in red. (B) RNA replication in vitro. HeLa S10 extract was programmed with 1 
µg of RNA transcripts. After 4 h of incubation at 30°C in the presence of 2 mM guanidine hydrochloride, 
preinitiation complexes were isolated by centrifugation at 15,000 x g. Preinitiation complexes were 
resuspended in labeling mix containing [α-32P]UTP and incubated for 2 h. Total RNA was prepared and 
separated on native agarose gels and detected by autoradiography. (C) Luciferase expression in replicon 
RNA-transfected HeLa cells. After transfection of the RNA transcripts into HeLa cells, the luciferase activity 
(relative light units [RLU]) corresponding to 2 x 104 cells was measured every hour for 8 h. The cells were 
either kept in the presence (+ GuHCl) or absence of 2 mM guanidine hydrochloride.  
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These results establish the importance of the sequences of all four A-U pairs in stem a 
for positive-strand RNA synthesis, since changes in the upper and lower part results in 
a defect in positive-strand RNA synthesis. However, more dramatic changes from A-U 
to G-C pairs can easier be tolerated in the upper two base-pairs than in the lower two, 
showing that the lower two A-U base-pairs are the most important ones for the 
synthesis of positive-strands. 
 
 
 
Figure 4.13: One-step growth curve of rib(+)Xpa and double-Wt viruses. HeLa cells were infected at a 
MOI of 10 Pfu/cell with either rib(+)Xpa or double-Wt viruses. At different time-points post infection (p.i.) 
supernatants were harvested and their virus titers were determined by standard plaque-assays. Each time-
point represents the mean of triplicate samples and SD is indicated.  
 
4.16 The importance of stem a sequences in the full-length virus 
Our study of stem a mutations within the cloverleaf revealed the importance of the 
stem a sequences for positive-strand synthesis. We wanted to further investigate the 
significance of these sequences in the context of the full-length virus. To do so, we 
engineered virus RNA transcripts carrying the same tandem cloverleaf structures as in 
double-Luc-Wt, resulting in double-Wt RNA. This new RNA was transfected into HeLa 
cells and viruses were harvested and titered in standard plaque assays. First, we 
compared virus growth between double-Wt virus and rib(+)Xpa virus, the previously 
described wild-type poliovirus Mahoney strain 1 (Herold & Andino, 2000). A one-step 
growth curve of these two viruses revealed that their growth kinetics are identical (Fig. 
4.13). An RT-PCR on virus sampled at 12 and 24 hours post-infection confirmed that 
the two cloverleaf structures in double-Wt were maintained (data not shown). The 
plaque-phenotypes for both were also similar in that the diameters for the biggest 
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plaques they both produced were the same (Fig. 4.14A). However, double-Wt 
produced a higher quantity of smaller plaques than rib(+)Xpa. These results establish 
that even full-length viruses with tandem cloverleaf structures provide a suitable 
system to study the promoter activity of the cloverleaf for positive-strand RNA 
synthesis.  
 
 
 
 
Figure 4.14: Plaque morphology of tandem cloverleaf viruses with stem a mutations in the 5’-
terminal cloverleaf and sequences of revertant viruses. (A) Plaque morphology of tandem cloverleaf 
viruses with stem a mutations are shown in comparison to rib(+)Xpa (Poliovirus type 1 Mahoney) and 
double-Wt. Monolayers of HeLa cells were infected with the virus produced after transfection of viral in 
vitro RNA transcripts into HeLa cells. The cells were overlaid with DMEM/F12 medium, 1% agar and 
incubated at 37°C for 2 days if not indicated otherwise. Plaques were visualized by staining the 
monolayers with 0.02% crystal violet. Representative wells for the virus produced in the transfections 
containing rib(+)Xpa and each of the indicated tandem cloverleaf virus RNA are shown. (B) Sequences of 
5’-terminal ends of input virus transcript RNA (mutations are highlighted in red) and recovered progeny 
virion RNA (revertant sequences are indicated in blue). The sequences for wild-type poliovirion RNA and 
for the virion RNAs from virus produced after transfection into HeLa cells were determined using a 5’-
RACE procedure as described in Materials & Methods.  
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RNA-dependent-RNA polymerases such as in poliovirus have no proof-reading 
mechanism and, therefore, display a very high error rate when synthesizing new RNA. 
Under pressure, for example when the viral genome carries lethal mutations, revertant 
viruses can emerge. These viruses contain mutations that either compensate for the 
original lethal mutations or the lethal mutations have reverted back to the wild-type 
sequence to make the virus viable. For this reason, we chose four different mutations 
within stem a, StemA-disr, StemA-mut3, StemA-mut8, and StemA-mut10 (see Fig. 
4.12A), that all lead to a complete inhibition of replication in cells and introduced them 
into the 5’ cloverleaf of the tandem cloverleaf virus RNA. We transfected the in vitro 
transcribed virus RNA into HeLa cells and incubated them for three days or until total 
cytopathic effect was reached. Viruses were harvested and tested for their ability to 
form plaques in a standard plaque-assay. No plaques were detected for either StemA-
disr-virus, with a complete disruption of stem a, or StemA-mut3 virus, that had all four 
A-U pairs swapped to U-A pairs within stem a (Fig. 4.14A). However, plaques were 
detected for StemA-mut8-virus and StemA-mut10-virus. StemA-mut8-virus, in which 
the lower two A-U pairs of stem a were replaced by G-C pairs, showed mostly smaller 
plaques after two days incubation than double-Wt; and after three days incubation, the 
plaques reached the same size than double-Wt reached after two days (Fig. 4.14A). 
StemA-mut10, in which the lower two A-U base pairs of stem a were replaced with G-C 
pairs, showed hardly visible plaques after two days incubation, which slightly increased 
in size after three days incubation. Even longer incubation did not result in bigger 
plaque-sizes than what was observed after three days (data not shown). The complete 
genomes of several plaque-purified StemA-mut8-viruses and StemA-mut10-viruses 
were sequenced. No mutations were found for either virus within the coding region or 
anywhere other than the very 5’-end. Using 5’-RACE, the mutated stem a area was 
sequenced and mutations identified. In StemA-mut8, in which two base pairs were 
mutated, the same point mutation was identified in all nine plaque-purified viruses that 
were sequenced. A reversion of the G of the second G-C base pair to A was observed, 
which represents the wild-type sequence, resulting in one mismatch within the stem a 
duplex structure (Fig. 4.14B). For StemA-mut10-virus, the other mutant that generated 
plaques, the population of the original passage 0 virus was used for sequencing of the 
5’-end. Strikingly, it was found that the lower two G-C base-pairs reverted back to wild-
type A-U pairs, a result that requires four individual point mutations to occur (Fig. 
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4.14B). These results strongly support the idea that the sequences of stem a are 
essential determinants for positive-strand RNA synthesis of poliovirus.  
 
Figure 4.15: MBP-2C expression and purification, and mobility shift assay with cloverleaf probes. 
(A) SDS-PAGE gel with fractions eluted during purification of MBP-2C from an amylose column. MBP-2C 
was expressed in E.coli. Crude E. coli extract was purified by binding of MBP to amylose resin, which was 
subsequently, after washing, eluted in the presence of 10 mM maltose. Samples were mixed with protein-
sample buffer, separated on SDS-polyacrylamide gel and stained with Coomassie blue. (B) 
Autoradiograph of Mobility shift assay with either a [α-32P]UTP-labeled positive- or negative-strand 
cloverleaf probe using increasing amounts of MBP-2C protein.  
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4.17 The role of 2CATPase in positive-strand RNA synthesis 
4.171 Binding affinities of MBP-2C to the cloverleaf 
The viral protein 2CATPase is implicated in a variety of functions during viral replication, 
ranging from virus uncoating (Li & Baltimore, 1990) and host cell rearrangement to 
RNA synthesis (Cho et al., 1994) and encapsidation (Vance et al., 1997). The 2CATPase 
protein has ATPase and GTPase activity as well as two NTP-binding domains 
(Rodriguez & Carrasco, 1993, 1995). GuHCl, which inhibits initiation but not elongation 
of negative-strand synthesis (Barton & Flanegan, 1997), targets the 2CATPase protein 
(Pincus & Wimmer, 1986), although the mechanism by which it does so is not clear. 
Banerjee et al. reported that both 2CATPase and its precursor 2BC have binding-affinity 
to the 3’-end of the negative-strand of poliovirus, implicating a role of 2CATPase in 
positive-strand RNA synthesis (Banerjee et al., 1997; Banerjee et al., 2001). This 
interaction was shown to require the sequence of UGUUU in stem a of the minus-
strand cloverleaf in the form of a double-stranded structure. However, the 2CATPase 
polypeptide analyzed in these studies was a renatured product isolated originally from 
an insoluble fraction after expression in E. coli. The studies demonstrating the ATPase 
and GTPase activity of 2CATPase, on the other hand, used a fusion protein of 2CATPase 
with the Maltose-binding-protein (MBP) (Rodriguez & Carrasco, 1993, 1995). In this 
case, the expression of 2CATPase as MBP-2C in E. coli produces a soluble fusion protein 
that does not need denaturing and renaturing for purification steps. We wanted to see if 
such a MBP-2C fusion protein also possesses a specific binding-affinity to the minus-
strand cloverleaf. To this end, poliovirus 2CATPase was expressed in E. coli as a fusion 
polypeptide containing MBP at the amino-terminus. Expression and purification of 
MBP-2C was monitored on a Coomassie-stained SDS-PAGE gel (Fig.4.15A) and 
MBP-2C was purified on an amylose resin. Figure 4.15A shows the crude extract 
before purification (lane 1) and 13 fractions eluted during purification from the amylose 
column. The fractions with the strongest bands (fractions 5 - 8) were combined and 
further concentrated. The protein was then used for mobility shift assays using a 
[32P]UMP-labeled probe of either the positive- or negative-strand cloverleaf. Neither 
probe showed any specific RNA binding affinities with the MBP-2C protein as seen in 
Figure 4.15B. This result indicates that the MBP-2C protein expressed in our study 
does not possess the same binding affinities as the 2CATPase protein isolated from 
insoluble fractions by Banerjee et al. (1997, 2001). 
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Figure 4.16:  Replication of rib(+)Luc-Wt RNA transcripts in translation-replication extracts in the 
presence of guanidine hydrochloride or anti-2C antibodies. (A) Western Blot demonstrating the 
specific recognition of MBP-2C, before or after induction with 0.3 M IPTG, by purified polyclonal anti-2C 
antibodies and pre-immune serum. (B) HeLa S10 extract was programmed with 1 µg of rib(+)Luc-Wt RNA 
transcripts. After 4 h of incubation at 30°C in the presence of 2 mM guanidine hydrochloride (GuHCl), 
preinitiation complexes were isolated by centrifugation at 15,000 x g. Preinitiation complexes were 
resuspended in labeling mix containing [α-32P]UTP and incubated for 90 min. At indicated time-points 
either 2 mM GuHCl, polyclonal anti-2C antibodies, or pre-immune serum was added to the reaction. Total 
RNA was prepared and separated on a native agarose gel and detected by autoradiography. 
 
4.172 A role for 2CATPase in positive-strand RNA synthesis 
Using the cell-free replication system, we wanted to specifically answer the question if 
2CATPase has any role in positive-strand RNA synthesis. We programmed HeLa cell 
extract with rib(+)Luc-Wt RNA and added either GuHCl, polyclonal anti-2C antibodies 
or pre-immune serum (as a control) at different time points during a 90 min replication 
period. The polyclonal anti-2C antibodies and the pre-immune serum used in this 
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experiment were purified on an FPLC using a protein A column. The specificity of the 
antibodies after purification are demonstrated in a Western Blot using crude extract 
from E.coli before and after induction of MBP-2C expression as seen in Figure 4.16A. 
The pre-immune serum did not recognize any protein before or after induction 
(compare lane 1 and 2), whereas anti-2C antibodies recognized a single band of the 
expected size of approximately 80 kDa, only after induction of MBP-2C (compare lane 
3 and 4). As expected, when adding GuHCl up to 30 min into the replication period, 
negative- and positive-strand RNA synthesis was inhibited (Fig. 4.16, lane 3-6). When 
the drug was added after 60 min, no inhibition of either strand synthesis was detected 
(Fig. 4.16, lane 7). The ratio of ssRNA to RF in this sample was the same as when no 
drug was added (Fig. 4.16, lane 1). When anti-2C antibodies were added at time-point 
0 min, severe inhibition of both negative- and positive-strand RNA synthesis was 
observed (Fig. 4.16, lane 8). However, when anti-2C antibodies were added at 5 min or 
at any later time-point, a specific inhibition of positive-strand synthesis could be 
observed. When anti-2C antibodies were added at 5 min, the ratio of ssRNA to RF was 
decreased 12-fold in comparison to when pre-immune serum was added at this time 
(Fig. 4.16, compare lane 9 to 14). This decrease in ratio declined when anti-2C 
antibodies were added at a later time-point but was still 6-fold at 15 min and 3-fold at 
30 min, and 1.5-fold when the antibodies were added at 60 min, in comparison to the 
samples with pre-immune serum (Fig. 4.16, compare lanes 10-12 with 15-17). These 
results show that the viral 2C protein has an important role in initiation of both negative-
strand (as seen when GuHCl was added to the in vitro assay) and positive-strand RNA 
synthesis (as demonstrated when anti-2C antibodies were added). 
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4.2 The role of cre(2C) in RNA synthesis of coxsackievirus B3 
4.21 Identification of the CVB3 cre(2C) 
The genome of coxsackievirus B3 (CVB3) resembles that of poliovirus in organization 
of the UTRs and the coding region (Fig. 4.17a). Based on homology with poliovirus, it 
was suggested that a cre RNA is also located in the 2C coding region of coxsackievirus 
B3 (Goodfellow et al., 2000; Paul et al., 2000; Rieder et al., 2000; Witwer et al., 2001). 
Experimental evidence, however, is lacking. The corresponding region was predicted 
by MFOLD (Zuker, 1999) to form a hairpin structure with a terminal loop region of 14 nt 
(Fig. 4.17b). In order to investigate whether this RNA structure is indeed required for 
CVB3 replication, silent mutations designed to disrupt the stem of cre were introduced 
into a CVB3 replicon in which the capsid region was replaced by a luciferase gene 
(distortion mutant, CRE(2C)-DM, Fig. 4.17c). Transfection of this replicon into 
susceptible BGM cells yielded less luciferase activity (< 1%) than transfection of a wild-
type replicon (Fig. 4.18a). The same translational levels were achieved by the replicon 
wild-type RNA in the presence of guanidine hydrochloride, emphasizing the strong 
defect in RNA replication (Fig. 4.18a).  
In poliovirus and rhinovirus, the cre RNAs within the coding-region are the primary 
templates required for VPg-uridylylation (Paul et al., 2000; Gerber et al., 2001a; Yang 
et al., 2002; Goodfellow et al., 2003a). This prompted us to establish whether the 
CVB3 cre(2C) is also the primary site for VPgpUpU synthesis. Full-length genomic 
RNA transcripts, containing either wild-type cre(2C) or the DM mutant, were used as 
templates together with purified CVB3 3Dpol, 3CDpro, VPg and Mg2+ in an in vitro 
uridylylation assay. Using full-length genomic RNA transcripts, wild-type RNA was able 
to support VPg-uridylylation in the presence of both 3Dpol and 3CDpro, whereas no 
detectable amount of uridylylated VPg was observed upon distortion of the cre(2C) 
structure (Fig. 4.18b). These results suggest that the CVB3 cre(2C) is indeed the 
primary template for VPg-uridylylation. 
 
4.22 Effect of disrupting the CVB3 cre(2C) stem-loop structure on 
negative-strand RNA synthesis 
A cell-free translation replication system (as demonstrated in detail in part 4.1 of this 
thesis) has been used to study the effect of mutations on replication in poliovirus, 
including the effect of gross distortions of the cre structure on negative-strand RNA 
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synthesis (Goodfellow et al., 2003b; Morasco et al., 2003; Murray & Barton, 2003). 
However, this system has never been used to study replication of coxsackievirus. To 
ascertain whether CVB3 transcript RNA is able to function as a template for RNA 
replication in the cell-free system, CVB3 replicon RNA containing different 5’-ends was 
used (Fig. 4.18c). RNA containing the 5’ hammerhead ribozyme (HR) sequence 
(Herold & Andino, 2000), which produces RNA with authentic 5’ termini after 
transcription, efficiently produced both negative-stranded (RF) and positive-stranded 
RNA (ssRNA). Absence of this HR sequence produced CVB3 transcripts that 
contained two non-viral guanosine residues at their 5’-terminus, which only produced 
RF intermediates (Herold & Andino, 2000) and therefore efficiently blocked the 
accumulation of RI and ssRNA during the 2h incubation period (Fig. 4.18c). No bands 
were observed when CBV3 HR transcripts were incubated in the presence of 
guanidine hydrochloride, indicating that the cell-free system only displays viral RNA 
production (Fig. 4.18c).   
It was previously shown that disruption of the cre structure in poliovirus does not 
interfere with the accumulation of negative-strands (Goodfellow et al., 2003b). In order 
to quantify the amount of minus-strands produced by coxsackievirus RNA in HeLa S10 
cell extracts, we used RNA transcripts containing two non-viral guanosine residues at 
their 5’-terminus. Wild-type RNA produced a band corresponding to the RF of RNA 
replication. Accumulation of this band was abolished upon addition of guanidine 
hydrochloride, an observation demonstrating that this band is indeed of viral origin 
(compare WT with WT+GuHCl, Fig. 4.18d). In HeLa S10 cell extracts, CRE(2C)-DM 
RNA also accumulated RF, indicating that negative-strand RNA synthesis in this 
mutant is not inhibited (lane DM, Fig. 4.18d). Quantification indicated that CRE(2C)-DM 
RNA produces comparable amounts of RF to those of wild-type (Fig. 4.18d). In 
contrast to wild-type transcript containing a cis-acting HR-sequence, HeLa S10 cell 
extract programmed with CRE(2C)-DM RNA containing an HR sequence produced 
only the RF intermediates, but no ssRNA accumulation was observed (Fig. 4.18e). 
These results suggest that, under the conditions of the experiments, cre(2C)-mediated 
VPgpUpU is required for the initiation of positive-strand, but not negative-strand, RNA 
synthesis.  
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Figure 4.17. Coxsackievirus CRE(2C) and RNA replicons. (a) Schematic representation of the 
coxsackievirus genome. VPg (3B) is linked covalently to the 5’-end of coxsackieviral RNA. The RNA 
contains a 5’NTR consisting of two functional domains, the cloverleaf and the IRES, followed by a single 
open reading frame encoding a single polyprotein and a 3’NTR with a poly(A). The polyprotein contains a 
structural (P1) and two non-structural (P2, P3) domains, which are processed to the different proteins as 
indicated in the shaded box. The location of the CBV3 CRE(2C) element within the coxsackievirus genome 
is also depicted. (b) A representation of the secondary structure of the CBV3 wild-type CRE(2C) from nt 
4365 to 4425 in the 2C protein-coding region as predicted by MFOLD. The CRE(2C) folds into a hairpin 
structure containing a loop of 14 nt and an imperfect stem. The silent mutations introduced to disrupt the 
CRE(2C) structure are indicated in bold type. (c) Two structural predictions, as proposed by MFOLD, of 
the disrupted CRE(2C) mutant (DM). The introduced silent mutations are indicated in bold type.  
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Figure 4.18. Identification of the CVB3 CRE(2C). (a) Replicons in which the capsid-coding region is 
replaced by a luciferase gene, incubated in the absence or presence (+GuHCl) of guanidine hydrochloride 
or containing the CRE(2C) distortion mutant, CRE(2C)-DM, were transfected into BGM cells. Ten hours 
post-transfection, cell lysates were harvested and assayed for luciferase activity. Each column represents 
the mean of five independent experiments and SD is indicated.  (b) Uridylylation of VPg in vitro by using 
genomic CVB3 RNA transcripts containing wild-type (WT) or CRE(2C)-DM as template. Where indicated, 
3CDpro was omitted from the reaction mixtures. The in vitro uridylylation products were separated on a 
Tris/Tricine SDS-PAGE gel and visualized by using autoradiography. (c) In vitro replication assay using 
wild-type CVB3 RNA containing a 5’ hammerhead ribozyme sequence incubated in the absence (HR) or in 
the presence (+GuHCl) of guanidine hydrochloride and a ribozyme-negative construct, that after RNA 
transcription using T7 RNA polymerase, gives rise to transcript RNA containing two non-viral guanosine 
residues at the 5’ terminus (GG). (d) In vitro replication assay using RNA derived from ribozyme-negative 
constructs containing wild-type or CRE(2C)-DM. The mutants are indicated above the autoradiography 
and RF accumulation was quantified by measuring [32P]UMP incorporation by using a phorphorimager. All 
values were normalized to wild-type RNA. (e) In vitro replication assay using wild-type (WT) or CRE(2C)-
DM HR transcript RNA. As a control, wild-type CVB3 RNA incubated in the presence of guanidine 
hydrochloride is shown (WT+GuHCl).  
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4.23 Effect of cre(2C) point mutations on replication efficiency 
A functional analysis was undertaken to determine whether the consensus sequence 
for the apical loop postulated by Yang et al. (2002) (R1NNNAAR2NNNNNNR3 motif; R, 
A/G; N, any nucleotide) for the loop of rhinovirus and enterovirus cre’s, is also 
applicable to the CVB3 cre(2C). Subsequently, every nucleotide involved in this 
consensus sequence was substituted for almost all other nucleotide possibilities and, 
additionally, the coxsackie B-specific A5AAUG9 loop sequence was substituted for the 
consensus AAACA sequence (consensus mutant CM) to ascertain the relevance of the 
CVB3-specific U8G9 residues (Fig. 4.19b) (Rieder et al., 2000). Since the cre is located 
within the coding region, point-mutational analysis of the cre(2C) at its original location 
faces complications due to amino acid changes in the 2C region. However, the cre 
function has been described to be position-independent (Goodfellow et al., 2000; Yin et 
al., 2003), which enabled us to engineer an HR-CRE(Art) construct containing the 
cre(2C) distortion mutant at the original 2C position and a second, artificial cre at the 
junction of the P2 region and the luciferase gene, which replaces the capsid-coding 
region (Fig. 4.19a). Also, a cis-acting hammerhead ribozyme sequence was introduced 
in order to generate RNA transcripts with authentic 5’-ends (Herold & Andino, 2000). 
This construct enabled a mutational analysis of the CVB3 cre(2C) for its function in 
RNA replication, without altering the amino acid sequence of the CVB3 2C protein. In 
vitro transcribed RNA was transfected into BGM cells, and at 10 h post-infection 
luciferase activity was measured as described previously (van Kuppeveld et al., 1995). 
Substituting the coxsackievirus-specific AAAUG sequence for the consensus AAACA 
motif showed wild-type-like luciferase activity (lane CM, Fig. 4.19b). Alterations 
affecting the adenosine triplet showed that A7 can only be replaced by another purine, 
whilst for A5 and A6, no substitutions were permitted (Fig. 4.19b). Substituting A5 for a 
uridine residue, which results in the introduction of a stop codon (UAA), is included as 
a negative control for further studies described below. In this assay, however, no 
conclusions can be drawn for this mutation with respect to virus replication. Purine 
residues at the extreme ends of the cre(2C) loop sequence were proposed by Yang et 
al. (2002) to be required for rhinovirus and enterovirus replication. Substitutions 
regarding G1 were in accordance with this consensus, as only a transition to an 
adenosine conferred the ability to replicate. Interestingly, residue A14 can be 
substituted by both a guanosine and a uridine, although the uridine substitution 
displayed reduced replication efficiency compared with the guanosine substitution. This 
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difference in replication efficiency, when comparing A14U with the A14G transition, might 
be explained by alternative folding of the loop as a result of non-canonical base-pair 
formation (MFOLD prediction), as opposed to changes in the primary cre sequence 
(data not shown).  
In summary, the structure of the CVB3 cre(2C) loop resembles previously examined 
picornavirus cre elements and is in accordance with the consensus sequence 
proposed by Yang et al. (2002), with the exception of nucleotide A14, which can be 
substituted by a guanosine or a uridine residue.  
 
4.24 Effect of cre(2C) point mutations on VPg-uridylylation efficiency 
The capacity of CVB3 cre(2C) mutants to support VPg uridylylation was tested by 
using short mutant cre(2C) transcripts RNAs, representing only the cre(2C). 
Uridylylation efficiencies were quantified as described in Materials and Methods. 
Consistent with the results obtained by using genomic RNA transcripts, a short 
transcripts containing only the cre(2C) distortion mutant (Fig. 4.17c) was unable to 
support uridylylation above detectable levels (lane DM, Fig. 4.19c). Substituting the 
AAAUG9 sequence for the AAACA9 consensus motif showed only a slight decrease in 
uridylylation efficiency compared with wild-type (lane CM, Fig. 4.19c). In general, 
mutants that were able to support RNA replication (Fig. 4.19b) also showed efficient 
VPg-uridylylation (G1A, A7G, U8C/A, A14G/U and CM, Fig. 4.19c). Interestingly, lower 
levels of uridylylation did not always correlate with reduced levels of RNA replication, 
as shown for mutants U8C and U8A (compare Fig. 4.19b with Fig. 4.19c). The reason 
for this might be that the uridylylated products are made in large excess over what is 
used for RNA synthesis (Murray & Barton, 2003). No VPgpUpU synthesis above 
background levels, however, could be detected for G1C, A7C/U or A14C substitutions or 
for any of the A5 or A6 mutants (Fig. 4.19c), which were also defective for RNA 
replication (Fig. 4.19b). Therefore, it can be concluded that uridylylation of VPg is 
essential for viral RNA replication. 
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Figure 4.19. RNA replication and uridylylation efficiency of CVB3 CRE(2C) point mutants. HR-
CRE(Art) was generated to assess replication capabilities of CRE(2C) mutants. The P1 region was 
substituted for the firefly luciferase gene. Wild-type or mutant CREs were introduced between the 
luciferase gene and the 2A junction by using a cloning cassette. Simultaneously, an additional 3CDpro 
cleavage site was introduced to ensure release and activity of the luciferase polypeptide from the 
polyprotein. The CRE(2C) at its original 2C position was disrupted by using silent mutations as depicted in 
Fig. 4.17(c). Additionally, a hammerhead ribozyme (HR) sequence was inserted downstream of the 
promoter sequence to generate RNA transcripts containing authentic 5’ ends. (b) Luciferase activity of the 
HR-CRE(Art) RNA transcripts described above, transfected into BGM cells. Each column represents the 
mean of five independent experiments and SD is indicated. A luciferase replicon that solely contained the 
cre(2C)-DM was used as a negative control (DM); mutant CM represents the substitution of the CVB3 
AAAUG sequence for the picornaviral consensus sequence AAACA. The sequence above the graph 
represents the loop region of CRE(2C) and the arrows indicate the nucleotides that have been substituted. 
The adenosine characters in bold type could not be substituted for any other nucleotide. (c) Determination 
of uridylylation efficiency, using short RNA transcripts of wild-type and mutant CRE(2C) as templates. The 
amounts of [α-32]UMP incorporated into the VPgpU and VPgpU(pU) products were quantified by using a 
phosphorimager. An autoradiograph of the reactions is shown above.  
 
4. Results 98 
 
 
 
 
 
 
 
 
Figure 4.20. Effect of CRE(2C) mutations on RNA-strand synthesis. (a) GG-CRE(Art) transcripts RNA 
synthesized with T7 RNA polymerase from plasmids lacking a 5’-terminal hammerhead ribozyme. These 
transcripts carry a non-viral pppGG dinucleotide at their 5’ terminus. (b) Pre-initiation complexes were 
incubated with transcript RNA derived from ribozyme-deletion constructs containing a translocated 
CRE(2C) (see Fig. 4.20(a)). The tested mutants are indicated above the autoradiograph and both the 28S 
rRNA band and the RF accumulation were quantified by measuring [32P]UMP incorporation using a 
phosphorimager. All values were corrected for RNA loading as described in Materials and Methods and 
normalized to wild-type RNA. (c) In vitro replication assay using GG-CRE(Art) transcript RNA containing 
either a wild-type, the CRE(2C)-DM or CRE(2C)-DM-A5G mutant in the mutation cassette. The mutants 
are indicated above the autoradiograph and RF accumulation was quantified by measuring [32P]UMP 
incorporation using a phosphorimager. All values were normalized to wild-type RNA.  
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4.25 Effect of cre(2C) point mutations on negative-strand RNA synthesis 
To ascertain the effect of cre(2C) point mutations on RF synthesis, we used a construct 
from which RNA transcripts containing two non-viral guanosine residues at their 5’end, 
termed GG-CRE(Art), are derived (Fig. 4.20a), allowing us to specifically evaluate and 
quantify the effect of cre(2C) mutations on RF synthesis. A very good correlation was 
observed between the [32P]UMP labeling of the 28S rRNA band and the ethidium 
bromide staining of the gel, which allowed us to quantify RF accumulation irrespective 
of loading by determining the ratio between the 28S rRNA band (Herold & Andino, 
2000) and synthesized viral RF.  
As a completely distorted cre(2C) structure produced RF levels similar to wild-type, and 
therefore was not or could not be used as a negative control (Fig. 4.18d) (Morasco et 
al., 2003; Murray & Barton, 2003), it was rather unexpected that the majority of the 
cre(2C) substitutions regarding the enterovirus consensus sequence did not 
accumulate wild-type-like RF levels. Mutants positive for both luciferase activity (Fig. 
4.19b) and VPg uridylylation (Fig. 4.19c) accumulated, albeit with different efficiencies, 
the highest levels of RF synthesis (G1A, A7G, U8C/A, and A14G/U, Fig. 4.20b). Only the 
U8 mutants, a residue not belonging to the consensus sequence, showed wild-type RF 
production (U8C/A, Fig. 4.20b). In general, a good correlation was observed between 
the luciferase activity and the efficiency of RF synthesis using these mutants (compare 
Fig. 4.19b with Fig. 4.20b). VPgpUpU-defective point mutations accumulated RF 
synthesis only to approximately 20% of that of wild-type CVB3 RNA (G1C, A5C, 
A6G/C/U, A7C and A14C, Fig. 4.20b), whereas the VPgpUpU-defective A5G mutant was 
unable to support RF synthesis above detectable levels (Fig. 4.20b). The fact that point 
mutations reduced in VPgpUpU formation were affected in RF accumulation already 
suggests that cre(2C)-derived VPgpUpU is also utilized to initiate negative-strand RNA 
synthesis. Because inhibiting RF synthesis by introducing a stop codon (A5U, Fig. 
4.20b) displayed results similar to those for the A5G transition, it was concluded that 
this latter mutant was defective for negative-strand RNA synthesis. This, again in 
contrast to previous reports, implies the necessity for the cre(2C) not only in positive-
strand, but also in negative-strand RNA synthesis. Additionally, GG-CRE(Art) transcript 
RNA, containing a completely distorted cre(2C) with an additional A5G mutation, still 
produced wild-type RF levels, concluding that the dominant-negative effect of the A5G 
transition is only functional in the context of a wild-type cre(2C) structure (Fig. 4.20c).  
4. Results 100 
In summary, all cre(2C) point mutations affecting the enteroviral cre consensus 
sequence, so excluding U8A/C, showed a marked decrease in their capacity to support 
negative-strand RNA synthesis. Therefore, it can be concluded that these results 
ascribe an important role to the coxsackievirus cre(2C) in the initiation of both positive- 
and negative-strand RNA synthesis. However, this requires a new model that can 
explain the apparently contradictory results about he role of cre(2C) in negative-strand 
RNA synthesis. 
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5. Discussion 
5.1 The multi-functional role of the cloverleaf in poliovirus 
replication 
A functional ribonucleoprotein complex forms around the cloverleaf structure at the 5’-
end of the poliovirus genome. The RNA structure is a cis-acting replication element 
that participates in the assembly of the complex that catalyzes the initiation of both 
negative- and positive-strand RNA synthesis. The interaction of this complex with the 
3’-end of the viral genome leads to initiation of negative-strand RNA synthesis. In this 
case, the cloverleaf structure at the 5’-end acts as a promoter for negative-strand RNA 
synthesis which is initiated at the opposite end of the genome. Our study demonstrates 
that the cloverleaf structure in the positive-strand is also required for positive-strand 
RNA synthesis. Here, the same RNA element at the 5’-end of the genome functions as 
a promoter for positive-strand RNA synthesis, which is initiated at the 3’-end of the 
opposite (negative) strand. We provide evidence that the same ternary complex formed 
around the cloverleaf structure displays a bi-functional role in two subsequent and 
differently regulated steps in viral replication.  
 
5.11 The role of the cloverleaf in negative-strand RNA synthesis 
Using the ribozyme(-) constructs with cloverleaf mutations clearly shows their effect on 
negative-strand RNA synthesis. For both stem b and stem d disrupting the positive-
strand duplex structure completely abolished the formation of RF. Except for the 
mutation in StemB-DNC1, in which proper base-pairing is maintained on both strands; 
all other mutations affected the synthesis of negative-strands to different degrees. 
Mutations on stem d resulted in a much bigger defect in negative-strand RNA synthesis 
than most mutations in stem b. One possibility is that all the mutations in stem d that 
we analyzed might affect binding of 3CDpro to this part of the cloverleaf structure, since 
the exact binding-site of the 3CDpro protein is not known. The binding-site of PCBP2 to 
the cloverleaf, on the other hand,  is narrowed down to a poly(C) stretch within the loop 
of stem-loop b and protein-binding might only be strongly affected by mutations 
completely disrupting the duplex structure of stem b (such as StemB-mut(+)). The 
effect of cloverleaf mutations on negative-strand RNA synthesis is well in accordance 
with previous studies that showed that either a complete deletion of the cloverleaf 
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(Lyons et al., 2001) or the same mutation as in StemD-insert (Barton et al., 2001) 
abolishes negative-strand RNA synthesis. However, the in vitro assay with the 
ribozyme(+) constructs containing cloverleaf mutations effectively illustrates the 
problem in analyzing a multi-functional role of a cis-acting replication factor in 
subsequent steps of replication. The defect in negative-strand RNA synthesis, clearly 
revealed by the study with the ribozyme(-) constructs, is more difficult to identify with 
the ribozyme(+) replicons. The replicons undergo several rounds of replication within a 
2 hour incubation period, and since one minus-strand can be used to synthesize 
several plus-strands, which then undergo new minus- and plus-strand synthesis, this 
will eventually result in negative- and positive-strand RNA synthesis as seen for 
StemB-mut(+). If the same mutation affects minus- and plus-strand RNA synthesis in a 
similar way, then all replication products such as RF and ssRNA will be synthesized on 
a lower level than wild-type, but it would be impossible to make any conclusions as to 
which step in replication is affected. In the original study of the cloverleaf, the StemD-
insert mutant (referred to as  DNC11 in (Andino et al., 1990)) not only showed a 
reduction in the ratio of plus- to minus-strand synthesis, but also a dramatic decrease 
in the synthesis of negative-strands in comparison to wild-type. This result indicates a 
role of the cloverleaf in both negative- and positive-strand RNA synthesis.   
The replication phenotypes of the cloverleaf mutations after transfection into HeLa cells 
correlate for the most part with the data obtained in vitro. They confirm the importance 
of the cloverleaf structure in the positive-strand for efficient replication. They are also in 
good agreement with the changes in plaque-phenotypes of these mutants as analyzed 
in Andino et al. (1990).  
In summary, our data demonstrate that the cloverleaf structure in the positive-strand is 
an important cis-acting replication element which is required for negative-strand RNA 
synthesis.  
 
5.12 A novel system to analyze the role of the cloverleaf in positive-strand 
RNA synthesis 
The findings that the cloverleaf structure functions as a promoter for both positive- and 
negative-strand RNA synthesis is in agreement with the original implications of such a 
role for the cloverleaf. As mentioned in the previous section, several point mutations 
within the cloverleaf RNA reduce both positive- and negative-strand RNA synthesis, 
5. Discussion 104 
with positive-strand synthesis being more affected, resulting in a 5- to 10-fold decrease 
in the ratio of plus- to minus-strands (Andino et al., 1990). These results implied that 
mutations within the cloverleaf abrogated positive-strand RNA synthesis and/or stability 
(Andino et al., 1990). We developed a novel approach to analyze this dual role of the 
same RNA element in viral replication by engineering poliovirus replicons carrying 
tandem cloverleaf structures at their 5’-end. Using the cell-free replication system we  
showed that the downstream G-C pair cloverleaf in the tandem cloverleaf construct 
could not only provide negative-strand RNA synthesis, but also VPgpUpU formation, 
both of which are preconditions for positive-strand RNA synthesis to occur (Goodfellow 
et al., 2003b; Morasco et al., 2003; Murray & Barton, 2003). This set-up enabled us to 
examine the direct impact of mutations in the 5’-end structure and sequence on 
positive-strand RNA synthesis.  
One concern we had about placing two cloverleaf structures right next to each other 
was the risk of interaction between the two identical sequences. There are many 
interactions between cloverleaf sequences, which result from the stem structures found 
in the RNA. Having two cloverleaf sequences next to each other could result in 
interactions between regions of one cloverleaf with the other. Such interactions could 
interfere with the original role of the cloverleaf in forming a ternary complex with 
proteins and hence, with the role of the cloverleaf in promoting RNA synthesis. This 
was reflected in the first tandem cloverleaf construct that was engineered and 
contained two wild-type cloverleaves at its 5’-end. Its replication phenotype in cells was 
nearly identical to a wild-type replicon with one cloverleaf; however, it showed some 
defect in synthesis of both RF and ssRNA in the cell-free replication system. This 
defect was not observed when the tandem replicon contained a StemD-mut(-) mutation 
in its 5’-terminal cloverleaf. This result supports the idea that two cloverleaves next to 
each other with less identical sequences might decrease the possibility of interactions 
between the two RNA structures. In addition, in replicons that carry a wild-type 
cloverleaf at its downstream position and a mutated cloverleaf upstream, the mutated 
cloverleaf will most likely be deleted after transfection into cells, releasing a replicon 
with all wild-type sequences. This phenomenon can be observed for rib(-)Luc-Wt that 
contains additional non-viral sequences at its 5’-end that get deleted after transfection 
into cells (Herold & Andino, 2000), which leads to a two hour delay in viral replication 
as seen in Figure 4.4B. Based on these findings, we were able to engineer a new 
tandem cloverleaf replicon that contains a G-C pair cloverleaf at its downstream 
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position. In this construct, the identical sequences between the two cloverleaves are 
reduced and the 5’-terminal cloverleaf cannot be deleted since it can only support 
negative-strand RNA synthesis, as we demonstrated. The new tandem cloverleaf 
construct double-Luc-Wt was able to replicate identically to rib(+)Luc-Wt in vitro and in 
vivo. Structural mapping further confirmed that the two cloverleaf structures in double-
Luc-Wt indeed form two separate but identical structures.  
 
5.13 The structural and functional requirements of the cloverleaf for 
positive-strand RNA synthesis 
5.131 The 5’-end sequence and structure 
Recent studies identified the importance of the accurate 5’-end sequences for efficient 
positive-strand RNA synthesis (Herold & Andino, 2000; Sharma et al., 2005). Our lab 
showed that additional non-viral sequences at the 5’-end of the viral genome leads to a 
defect in positive-strand RNA synthesis in the cell-free replication system, as well as to 
a delay in replication in cells (Herold & Andino, 2000). Such additional sequences are 
eventually deleted after transfection into cells. These results indicate the importance of 
the 3’-terminal sequences of the negative-strands and suggest that the viral primer for 
positive-strand RNA synthesis, VPgpUpU, recognizes the 3’-terminal AA only when 
they are available as terminal sequences. For this reason, we left the two 5’-terminal 
UU in all tandem cloverleaf constructs intact to not interfere with positive-strand RNA 
synthesis. Another study identified the 5’-terminal 9 nucleotides of the positive-strand 
to be important for efficient initiation of positive-strand RNA synthesis, again indicating 
that these sequences are important on the level of the negative-strand (Sharma et al., 
2005). In this study, the authors proposed that there is no structural requirement at the 
5’-end of the plus-strand or the 3’-end of the negative-strand to initiate positive-strand 
RNA synthesis (Sharma et al., 2005). However, the results with the plus9, plus20, and 
plus27 replicons clearly imply that a promoter element on the very 5’-end of the 
positive- or the 3’-end of the negative-strand is required to initiate positive-strand RNA 
synthesis. Even when the terminal 9 nucleotides as part of a wild-type stem a duplex 
structure (plus20) is present, there was no initiation of plus-strand RNA synthesis. The 
most surprising result was the inability of the plus9 replicon to replicate at all in vivo 
and to synthesize positive-strands in vitro. Here, the cloverleaf structure on the 
positive-strand is only 15 nt away from the 5’-terminus, in addition to the wild-type 9 
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terminal nucleotides being present on the 3’-end of the negative-strand, and still no 
positive-strand synthesis could be observed. These findings demonstrate that the 
terminal structure itself (at the 5’-end of the plus-strand or/and at the 3’-end of the 
minus-strand) is as important as the precise sequences for initiation of positive-strand 
RNA synthesis. It also highlights that the cloverleaf structure can only function as a 
promoter for positive-strand RNA synthesis when it is located at the very end of the 
genome. This is contrary to the cloverleaf function as a promoter for negative-strand 
RNA synthesis, for which the cloverleaf can be located hundreds of nucleotides away 
from the 5’-end of the genome as demonstrated by the G-C pair cloverleaf in the 
tandem cloverleaf replicon.  
 
5.132 The cloverleaf on the positive-strand 
The results with the tandem cloverleaf constructs with stem b and stem d mutations 
demonstrate the requirements of the cloverleaf structure in the positive-strand for the 
synthesis of plus-strands. However, comparing the results in the cell-free replication 
system and in vivo revealed some differences between these two systems. Small 
differences on the level of positive-strand RNA synthesis such as between StemB- 
mut(-) and StemB-mut(+) resulted in a big difference in their replication phenotype in 
cells. This was in agreement with several other stem b mutants that were able to 
synthesize only a small amount of positive-strands in vitro but replicated with nearly 
wild-type level in cells. However, the overall ratio of plus-strand to minus-strand 
synthesis in vitro correlated with the replication level in vivo: a higher ratio in vitro 
resulted in better replication in vivo and the other way around. Keeping in mind that the 
cell-free replication system is a more artificial system and replication in cells mimics 
more closely the events of real host – virus interaction, we always used the in vivo data 
to evaluate the significance of a defect in positive-strand RNA synthesis seen in the in 
vitro system. Based on this guideline, we conclude that the stem b sequences are not 
crucial; but an intact stem b duplex structure on the positive-strand is required for 
efficient positive-strand RNA synthesis. The ratios of positive-strands to RF in vitro for 
the stem d mutants also correlate to the replication level of these mutants in vivo. 
However, a lower level of positive-strand RNA synthesis was observed in vitro for all 
stem d mutants which were not able to replicate in cells. The same was sometimes 
observed for the G-C pair cloverleaf construct alone as well as rib(-)Luc-Wt (data not 
shown). In vitro, it might be possible that the primer VPgpUpU binds to the 3’-terminal 
5. Discussion 107 
AA in a less regulated manner and initiates rather inefficiently positive-strand RNA 
synthesis. This phenomenon might not occur in cells, and therefore, no replication 
would be observed. This difference might be due to the location in which replication 
occurs in both systems. After viral infection of cells, a complete rearrangement of cell 
organelles can be observed and membranous vesicles are formed to which the 
replication complexes are attached (Bienz et al., 1983; Bienz et al., 1992; Troxler et al., 
1992; Egger et al., 1996). In cell extract as used in our study, the cell organelles are 
disrupted by homogenizing and the replication complexes are most likely attached to 
membrane particles rather than defined membranous vesicles. This may enable the 
synthesis of some positive-strands in a less regulated manner. The StemD-mut(+) 
mutation did not have such a dramatic effect on positive-strand RNA synthesis and 
replication in cells as the StemB-mut(+) had. The reason might be that the stem b 
mutant contained three base-pair changes whereas the stem d mutant only contained 
two. The effect of two changes in stem d might not disrupt the structure as much as the 
changes in the stem b mutant. However, when four base-pairs were disrupted in stem 
d, as in StemD-disr, no replication was observed in cells. We conclude that the entire 
cloverleaf structure, including an intact stem b and d, is required for positive-strand 
RNA synthesis. Interestingly, for StemD-mut(-) the ratio of plus-strands to minus-
strands in the cell-free replication system was increased by over two-fold in 
comparison to wild-type.  
The defects observed in vitro in positive-strand RNA synthesis and in cells in 
replication were not due to problems with RNA stability since no decrease in translation 
was observed in any of the systems. It is possible that a disrupted stem d duplex 
structure in the cloverleaf on the negative-strand helped the negative-strand to unfold 
properly for the polymerase to move along and synthesize a new plus-strand. The level 
of luciferase activity as an indirect measure for translation was approximately the same 
for all the mutants in comparison to wild-type (data not shown) at the end of the 
translation period in the cell-free replication system. After transfection into cells we 
monitored luciferase activity also in the presence of GuHCl for all mutants, which 
provides the translation levels of just the input RNA (data not shown). If RNA stability 
was affected we would expect a decrease in translation of the RNA. Though, all 
mutants reached similar levels of translation as the wild-type RNA. Thus, we exclude 
RNA stability issues as an explanation for the decrease in positive-strand RNA 
synthesis.  
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5.133 PCBP2 and 3CDpro binding sites 
The cloverleaf RNA forms a ternary complex together with the cellular PCBP2 and the 
viral 3CDpro (Andino et al., 1990; Andino et al., 1993; Parsley et al., 1997). As shown in 
a previous study, this complex can interact with the 3’-end of the viral genome through 
a RNA-protein-protein-RNA bridge and initiates negative-strand RNA synthesis (Herold 
& Andino, 2001). Our results show that functioning PCBP2- and 3CDpro-binding sites in 
the cloverleaf structure are required for efficient positive-strand RNA synthesis in vitro 
and in vivo. We conclude that the same ternary complex used for initiation for negative-
strand RNA synthesis also plays a role in positive-strand RNA synthesis. However, the 
mechanism used by this complex to support plus-strand synthesis has to be different 
from the one used in the synthesis of minus-strands, since positive-strand RNA 
synthesis is initiated at the 3’-end of the negative-strand. PCBP2 interacts with PABP, 
which binds to the poly(A) tail for negative-strand synthesis. However, this would not 
be helpful for initiation of positive-strand RNA synthesis. One can imagine that after 
unwinding of the RF intermediate, PCBP2 binds to the cloverleaf on the plus-strand  to 
stabilize the complex formation and to keep the plus-strand separated from the minus-
strand, which helps with binding of the primer and the polymerase to the minus-strand. 
3CDpro might partly play the same role, helping to stabilize the complex formation, but 
might have additional roles. 3CDpro could provide the viral polymerase 3Dpol for 
initiation of positive-strand RNA synthesis by cleavage of 3CDpro. This way, the ternary 
complex around the cloverleaf could guide the polymerase to the exact location to 
synthesize plus-strands. The requirement of 3CDpro in positive-strand RNA synthesis 
could also be a way to eventually down regulate replication and support encapsidation 
of viral RNA into new virions. The level of 3CDpro as a protein precursor goes down 
over time during replication since it gets cleaved into 3Cpro and 3Dpol. With less 3CDpro 
available, encapsidation might be favored. Since clear encapsidation signals in 
poliovirus are missing (reviewed in 1.44), it seems that several steps in the life cycle 
might contribute to this event. The down regulation of 3CDpro might be one of the 
factors that eventually contribute to the encapsidation event. 
 
5.134 The significance of stem a 
Our results using the StemA-disr construct show that the duplex structure of stem a in 
the cloverleaf is required for positive-strand RNA synthesis. In the original analysis of 
the cloverleaf, a disrupted stem a (referred to as DNC91) has proven to be lethal for 
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the virus (Andino et al., 1990). A previous study identified the importance of an intact 
stem a structure for negative-strand RNA synthesis (Sharma et al., 2005). The 
disruption of two base-pairs on stem a showed no effect on positive-strand RNA 
synthesis (Sharma et al., 2005). However, we provide evidence that disruption of four 
base-pairs in stem a leads to a severe defect in positive-strand RNA synthesis and 
completely abrogates replication in cells. We conclude that stem a is required for both 
negative- and positive-strand RNA synthesis. Furthermore, we demonstrate that the 
entire stem a sequence is involved in plus-strand synthesis. Our findings are consistent 
with the results of a previous study in which the same mutations (StemA-mut1, -mut2, 
and –mut3) were studied in vitro and led to a similar decrease in positive-strand RNA 
synthesis (Sharma et al., 2005). The importance of the stem a sequences for positive-
strand RNA synthesis was further demonstrated by our studies using full-length virus. 
The reversion found in the StemA-mut8-virus highlights the importance of position A4 in 
poliovirus. It appears that a one base-pair disruption can be tolerated in this context. 
Strikingly, the four point mutations found in the viruses isolated from StemA-mut10 
restored two of the wild-type base-pairs in stem a. Based on our results we cannot 
identify if the stem a duplex structure is required on the positive- or on the negative-
strand to support the cloverleaf formation for positive-strand RNA synthesis. However, 
a recent study identified that hnRNP C1/C2 proteins (heterogeneous nuclear 
ribonucleoprotein C1/C2) have binding-affinities to the 3’-end of the negative-strand of 
poliovirus (Sokolowski & Schwartz, 2001; Brunner et al., 2005). Depleting HeLa cell 
extract of these proteins resulted in a decrease in RNA synthesis, a defect that can be 
restored when recombinant hnRNP C1 was added. The hnRNP C proteins bind to (U)n 
motifs that contain 3 consecutive Us (Sokolowski & Schwartz, 2001). Accordingly, the 
3’-terminal sequence of the poliovirus negative-strand, 3’-AAUUUUGU-5’, could be a 
candidate sequence for binding hnRNP C. This could give a possible explanation why 
we found one point mutation (from G4 back to A4) in the StemA-mut8 virus, which 
restores a previous 3’-C4U5U6 stretch in the negative-strand to a 3’-U4U5U6 stretch, thus 
providing a target sequence for hnRNP C to bind. This however, does not explain the 
requirement of the stem a duplex structure for initiation of positive-strand RNA 
synthesis. One could think, that an intact stem a structure might help the cloverleaf to 
form properly on the positive-strand, and thus, for the proteins to bind the structure and 
form the required ternary complex. The requirement of the intact sequences at the very 
end might be an additional requirement to the duplex structure of stem a and these 
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requirements might display two different roles in positive-strand RNA synthesis.   
 
5.14 The role of 2CATPase in RNA synthesis 
Much has been speculated about possible roles of viral proteins in positive-strand RNA 
synthesis. Viral non-structural proteins and their precursors have several overlapping 
functions at different steps throughout the viral life cycle. This makes it difficult to 
dissect those different roles by genetic analysis since one mutation often affects 
several functions. The viral 2CATPase protein has been proposed to be involved in 
negative- and positive-strand RNA synthesis (Banerjee et al., 1997; Barton & 
Flanegan, 1997; Banerjee et al., 2001). Our results suggest that there might be at least 
two different functions for 2CATPase during RNA replication. A guanidine-hydrochloride 
sensitive function was indicated to be required for initiation but not elongation of 
negative-strand RNA synthesis (Barton & Flanegan, 1997). Our results using guanidine 
are in agreement with those findings. In our study GuHCl either inhibited negative-
strand RNA synthesis, and consequently, also positive-strand RNA synthesis, or 
neither when added at a later time point. After addition of anti-2C antibodies we 
observed a different inhibition pattern. When added at time 0 of replication, we 
observed inhibition of negative-strand synthesis but when added at 5 minutes or later, 
we only saw inhibition of positive-strand synthesis. The question is, whether the 
2CATPase function inhibited by the antibodies at time-point 0 is the same as the 
guanidine-sensitive function, since in both cases negative-strand RNA synthesis is 
affected. We can think of two possible explanations. One, a different function of 
2CATPase required for negative-strand RNA synthesis is inhibited by anti-2C antibodies 
than by GuHCl. 2CATPase can have multiple roles during negative-strand RNA synthesis. 
The one targeted by the antibodies might only be required at the very first moment of 
replication initiation. 5 minutes after initiation this function is no longer required. Or two, 
for antibodies to inhibit the function of a protein they have to interact with this protein. 
The 2CATPase protein might not be easy accessible for the antibodies once replication is 
initiated in the replication complexes, whereas guanidine is still able to reach its protein 
target and inhibit the 2CATPase function in negative-strand RNA synthesis. In this case, it 
is possible that they both inhibit the same function in negative-strand RNA synthesis.  
Based on binding-affinity of 2CATPase and its precursor 2BC to the 3’-end of the 
negative-strand, a role for 2CATPase in positive-strand RNA synthesis has been 
proposed (Banerjee et al., 1997; Banerjee et al., 2001). This interaction was shown to 
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require the sequence UGUUU in stem a of the minus-strand cloverleaf in the form of a 
double-stranded structure. Such a requirement for interaction of 2CATPase to stem a of 
the minus-strand cloverleaf could explain the requirement of an intact stem a for 
positive-strand RNA synthesis. However, the 2CATPase polypeptide analyzed in these 
studies was a renatured product isolated originally from inclusion bodies after 
expression in E. coli. The studies demonstrating the ATPase and GTPase activity of 
2CATPase used a fusion protein of 2CATPase with the Maltose-binding-protein (Rodriguez & 
Carrasco, 1993, 1995). The expression of 2C as MBP-2C in E. coli produces a soluble 
fusion protein that does not need denaturing and renaturing for purification steps. With 
such a fusion protein we were not able to demonstrate specific binding-affinities of 
2CATPase to either the positive- or negative-strand cloverleaf RNA. This is in agreement 
with Pfister & Wimmer (unpublished results in Paul, 2002) who also failed to observe 
specific interaction of MBP-2C to the minus-strand cloverleaf. Furthermore, they could 
not detect any ATPase activity in a 2CATPase protein that was renatured after purification 
from an insoluble fraction in E.coli. This suggests that the binding properties of 2CATPase 
as observed by Banerjee et al. (1997, 2001) might not reflect the binding properties of 
the 2CATPase protein when expressed during viral infection. However, in our study we 
provide the first functional evidence that 2CATPase has an important role in positive-
strand RNA synthesis. Because of its nucleoside triphosphate binding domain it has 
been speculated that 2CATPase may function as a helicase with possible involvement in 
the strand separation during replication (Dmitrieva et al., 1991; Teterina et al., 1992). 
For such an activity, 2CATPase would not require any specific interaction with either 
cloverleaf structure since it would act on the level of the double-stranded intermediate 
(RF). However, such a function for 2CATPase during positive-strand RNA synthesis still 
needs to be shown.  
 
5.15 A model for initiation of positive-strand RNA synthesis in poliovirus 
replication 
Based on data presented in this study, we propose the following model for initiation of 
positive-strand RNA synthesis in poliovirus (see Figure 5.1): Negative-strand RNA 
synthesis results in a double-stranded intermediate, the RF. The end of it, which 
contains the 5’-end of the plus-strand and the 3’-end of the negative-strand, is 
recognized by a helicase, possibly the 2CATPase protein (Fig. 5.1A). Upon unwinding of 
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the strands, the cloverleaf structure forms on the positive-strand. PCBP2 and 3CDpro 
bind to the cloverleaf structure and form a ternary complex (Fig. 5.1B). This will 
stabilize the complex and also help to keep the 3’-end single-stranded and available for 
the primer to bind. The primer, VPgpUpU, is recruited (maybe with help of the ternary 
complex) and binds to the 3’-terminal AA of the minus-strand. Binding of the primer will 
bring in the polymerase 3Dpol. It is possible that the ternary complex on the plus-strand 
once again helps recruiting the polymerase for this step, or might provide it directly 
through cleavage of 3CDpro. Once positive-strand RNA synthesis is initiated and the 
polymerase moves along the minus-strand template to synthesize a new plus-strand, 
this new plus-strand will replace the old positive-strand which eventually will be 
completely detached from the minus-strand. The new 5’-end of the positive-strand and 
the 3’-end of the negative-strand will be double-stranded again until it gets unwound, 
possibly by the 2CATPase protein (Fig. 5.1C). Unwinding the end will result in forming the 
ternary complex around the cloverleaf of the positive-strand and initiate in return 
positive-strand RNA synthesis on the negative-strand (Fig. 5.1D). The newly 
synthesized positive-strand will replace the old one when the polymerase moves along 
the minus-strand. This way, the latest synthesized positive-strand will always provide 
the promoter for the initiation of a new plus-strand. New initiation of plus-strand 
synthesis can occur when still several polymerases are moving along the minus-strand 
template, each replacing the positive-strand synthesized right before them. This 
mechanism will not only result in the observed asymmetry in replication, in which more 
positive- than negative-strands are generated, but also in the replicative intermediate 
(RI) observed during positive-strand RNA synthesis that is partially single- and partially 
double-stranded (Wimmer et al., 1993; Agol et al., 1999). It will also ensure that 
initiation of positive-strand RNA synthesis stays highly regulated within the replication 
complexes. 
The question is, whether this model applies only to poliovirus, or to all enterovirus and 
rhinovirus, of which most of them have a cloverleaf structure at the 5’-end of their 
genome. This mechanism might be even a common strategy for positive-strand RNA 
viruses to initiate positive-strand RNA synthesis. Most positive-strand RNA viruses 
have large 5’ UTRs which contain often several cis-acting replication elements. It is 
possible that some of those RNA elements have dual functions in replication and 
promote both negative- and positive-strand RNA synthesis. Some viruses might 
actually have separate promoters for negative-strand RNA synthesis but both in the 
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5’UTR and both might functioning on the positive-strand. For example, bovine 
enteroviruses have two cloverleaf-like structures at the 5’-end of their genome. 
Deletion of either one of them results in non-viable viruses (Zell et al., 1999). However, 
after exchange of the region spanning both cloverleaves with the CVB3 cloverleaf, a 
viable chimera was generated (Zell et al., 1999). Therefore, the two cloverleaf 
structures in bovine enteroviruses can display the same role as the one cloverleaf in 
CVB3, suggesting that one cloverleaf might function as a promoter for negative- and 
the other as a promoter for positive-strand RNA synthesis.  
 
 
 
 
 
Figure 5.1: A model for initiation of positive-strand RNA synthesis during poliovirus replication. (A) 
The double-stranded intermediate (RF), after negative-strand RNA synthesis is completed, is unwound by 
a helicase, possibly 2C. (B) Upon unwinding, the cloverleaf structure in the positive-strand folds into its 
secondary structure and recruits PCBP and 3CDpro to form a ternary complex. This complex promotes 
initiation of positive-strand RNA synthesis at the 3’-end of the negative-strand. The primer VPgpUpU binds 
to the terminal sequences of the negative-strand and the polymerase moves along the minus-strand 
template to synthesize a new plus-strand, this way replacing the old plus-strand in front of it. (C) The new 
plus-strand displays a double-stranded intermediate at its 5’-end with the minus-strand that needs to be 
unwound. This could be done by the same helicase as in step 1, possibly 2C. (D) Once the ends are 
unwound, the ternary complex around the cloverleaf on the positive-strand forms and promotes in return 
initiation of plus-strand RNA synthesis on the negative-strand. When the polymerase moves along the 
minus-strand template, it replaces the old plus-strand in front of it.  
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5.2 The multi-functional role of cre(2C) in Coxsackievirus B3 
RNA replication 
5.21 The coxsackievirus B3 cre(2C) 
Our study describes the presence of a cre within the CVB3 2C coding region, named 
cre(2C), that functions as a template for VPg-uridylylation in vitro. We have shown that 
the cre(2C) is required for the initiation of both negative- and positive-strand RNA 
synthesis. The cre(2C) is predicted to fold into an imperfect stem with a large loop 
region of 14 nt, containing a coxsackie B cluster-specific 5’-AAAUG-3’ sequence. 
Substituting this sequence for the consensus sequence found in all cres described thus 
far, 5’-AAACA-3’ (Paul et al., 2000; Yang et al., 2002) , did not affect VPg-uridylylation 
efficiency of RNA replication significantly. Characterization of the CVB3 cre(2C) loop 
showed that the proposed entero- and rhinoviral consensus sequence 
(R1NNNAAR2NNNNNNR3), extrapolated from sequence-alignment studies and 
extensive mutational analysis of the rhinovirus 14 cre(VP1) loop region (Yang et al., 
2002; Yin et al., 2003), is also applicable to the CVB3 cre(2C) loop sequence; 
mutations that interfered with this consensus sequence affected CVB3 VPg-
uridylylation and RNA replication to a similar extent.  
 
5.22 A role of cre(2C) in both negative- and positive-strand RNA synthesis 
Consistent with previous reports, a mutant in which the cre(2C) structure was 
completely disrupted still supported efficient negative-strand RNA synthesis in a cell-
free replication system (Goodfellow et al., 2003b; Morasco et al., 2003; Murray & 
Barton, 2003). This suggested that, under the conditions of the experiment, cre-
mediated VPg-uridylylation is required for positive-strand, but dispensable for negative-
strand, RNA synthesis. However, we also found a direct correlation between cre(2C) 
point mutants producing lower, but detectable, amounts of VPgpU(pU) and reduced RF 
levels, affected to a similar extent. These latter results suggest that cre(2C)-derived 
VPgpU(pU) is also involved in the initiation of negative-strand RNA synthesis. In 
correlation, cre(2C) point mutants unable to support VPg-uridylylation to a detectable 
level also showed a severe defect in RF accumulation. In addition, the A5G transition 
that affects the first templating adenosine residue was found to completely abolish RF 
synthesis completely. 
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5.23 Is cre(2C) mediated VPgpUpU required for negative-strand RNA 
synthesis?  
How can we explain such apparently contradictory results? A recent study reported, by 
using poliovirus cre(2C) mutants, that a dominant-negative effect is observed on wild-
type poliovirus replication using cre(2C) point mutants, but not when the cre(2C) has 
been disrupted completely (Crowder & Kirkegaard, 2005). This suggests that RNA 
containing a complete cre(2C) distortion mutant, as opposed to point mutants, utilizes 
an alternative mode of RNA replication that is so distinct form wild-type poliovirus 
replication that it does not interfere. As RF synthesis, in the absence of detectable 
levels of VPgpU(pU), was observed in the cell-free replication system using RNA 
containing a completely distorted cre(2C) structure, it was suggested previously that 
this alternative mode of replication might involve the 3’-poly(A) tail. This homopolymeric 
stretch might serve as the alternative template for the covalent linkage of uracil 
residues to VPg (Goodfellow et al., 2003b; Morasco et al., 2003; Murray & Barton, 
2003), which was based on the findings that negative-strand RNA synthesis is VPg-
dependent (Nomoto et al., 1977a; Nomoto et al., 1977b) and that poly(A) templates 
supported VPg-uridylylation in vitro (Paul et al., 1998).  
A wild-type cre(2C) structure sequesters replication proteins (Yin et al., 2003) and the 
formation of such protein-RNA interactions is most probably affected upon distortion of 
the cre(2C) structure. Absence of this RNP complex in a genome containing a 
completely distorted cre(2C) structure might favor the 3’-poly(A) tail as the alternative 
template for the covalent linkage of UMP to VPg in vitro. The ability to detect free 
VPgpU(pU) within purified replication complexes might imply that VPg is elongated 
immediately into complementary negative RNA strands (Murray & Barton, 2003). A 
number of cre mutants unable to accumulate detectable levels of uridylylated VPg still 
retained the ability to induce RF synthesis (e.g. G1C, A6C/G/U, A7U/C and A14C). 
Therefore, it can be speculated that these mutants also utilize the proposed alternative, 
3’-poly(A) tail-dependent mechanism, to induce negative-strand RNA synthesis. 
However, whereas the cre(2C) distortion mutant showed wild-type levels of RF 
synthesis at the measured time-point, RF accumulation was reduced  severely in 
cre(2C) mutations affecting the enterovirus consensus sequence.  Also, in contrast to 
the cre(2C) distortion mutant, the G1C, A6C/G/U and A7U/C substitutions all maintained 
a wild-type cre(2C) conformation, which we propose enabled them to sequester the 
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proteins required for VPg-uridylylation. As shown previously for poliovirus, A6 
substitutions still produced VPg(pU), albeit with reduced efficiency, which might 
support this speculation (Paul et al., 2003). Although the A14C mutation is predicted by 
MFOLD to adopt an alternative conformation due to a GC base pair formation between 
the  G1 and C14 residue, this mutant was found in poliovirus not to be reduced in protein 
binding (Yin et al., 2003) and might therefore still be able to produce VPgpU(pU). 
Additionally, Nayak et al. showed that A6 and A7 mutations displayed higher 
uridylylation activities in the context of full-length RNA compared with short hairpin 
RNAs, concluding that the template used in the uridylylation reaction determines both 
the specificity and efficiency of the assay (Nayak et al., 2005). In summary, we 
speculate that the cre-dependent uridylylation mechanism prior to negative-strand RNA 
synthesis is strongly favored when the cre structure is intact.  
By using purified components (cre(2C), VPg, 3Dpol and 3CDpro), poliovirus VPg-
nucleotidylylation has been found not to be stringently dependent upon an AAACA 
motif in the cre loop if one of the NTPs other than UTP was present. For example, 
VPgpG is formed by CAACA and GTP, as the first nucleotide, in this case a C residue, 
functions as a template (Gerber et al., 2001a; Paul et al., 2003). Similarly, an A5C 
transversion or an A5G transition in the CVB3 A5AAUG motif yielded VPgpG and 
VPgpC, respectively, in the CVB3 cre(2C) nucleotidylylation reaction (unpublished 
results). Nucleotidylylation is aborted at the stage of VPgpG or VPgpC because of the 
‘slideback’ mechanism to A6 (Gerber et al., 2001a; Paul et al., 2003). If dual cre(2C) 
CVB3 transcripts carry a 59-terminal pppG group (Fig. 4.20a), only the A5C 
transversion mutant produced some RF, albeit in greatly reduced yield (Fig. 4.20b). 
The rationale for employing the pppGG transcript was to reduce positive-strand RNA 
synthesis in the cell-free replication system, thereby shifting the complex to synthesize, 
if possible, predominantly negative-strand RNA (Herold & Andino, 2000). Virological 
characterization of both the CVB3 A5C and A5G mutants using a single cre(2C) 
construct showed that the A5G mutation was quasi-infectious and reverted to a wild-
type cre sequence, whereas, in contrast to previous reports (Morasco et al., 2003; Yin 
et al., 2003) the A5C mutant proved to be a lethal mutation, probably caused by a 
dysfunctional 2C protein (unpublished results). On the basis of these data, we suggest 
that initiation of negative-strand RNA synthesis in CVB3 requires the A5 residue, but 
that, at least in assays performed using cell-free extract, this requirement is leaky (see 
below). 
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The stringency of sequence requirement does not appear to apply to the AA6AUG 
residue, as all mutations in A6 still produce RF, albeit also at reduced yield (Fig. 4.20b). 
This corresponds to data from poliovirus, which have revealed that mutations in the 
corresponding adenosine residue (AAACA) yielded quasi-infectious phenotypes (Paul 
et al., 2003). These phenotypes were also found for the analogous point mutants in 
CVB3 cre(2C) (unpublished data). Perhaps VPgpU formed on ANACA cre(2C) mutants 
of the poliovirus or ANAUG cre(2C) mutants of CVB3 can still function as primer for 
negative-strand RNA synthesis on the 39 poly(A) template.  
RNA replication of human enterovirus genomes proceeds on membranes in RNP 
complexes of which the structures have not yet been entirely deciphered. Available 
evidence suggests that the 59-terminal cloverleaf and the 39-terminal poly(A) tail 
induce the formation of a circular RNP complex via protein–protein interaction (Barton 
et al., 2001; Herold & Andino, 2001). Moreover, it has been suggested that the 
cloverleaf structure is also involved in VPg uridylylation (Lyons et al., 2001). Thus, all 
three elements, the cloverleaf, the cre and the 39 poly(A) tail, may interact for initiation 
of genome replication to occur. Elimination of the cre by destroying its stem–loop 
structure may allow the system to bypass the cre requirement for negative-strand RNA 
synthesis and, by a default mechanism, make use of the genetically encoded 39 
poly(A) tail as template for uridylylation in a cell-free in vitro system (Paul et al., 1998; 
Goodfellow et al., 2003b; Morasco et al., 2003; Murray & Barton, 2003). As viral 
negative-strand RNA was found to be absent in cells transfected with the complete 
cre(2C) disruption mutant (Goodfellow et al., 2000), it is sensible to conclude that 
utilization of the 39 poly(A) tail for uridylylation can only be seen in the in vitro  
translation/replication system. In stark contrast, if the replication proteins are presented 
with a cre element which A5 has been mutated to a G residue, the aberrant 
nucleotidylylation product VPgpC might operate as a dominant-negative element. The 
nucleotidylylation complex, however, is not “frozen” on the mutated cre(2C) itself, as 
the addition of a second wild-type cre restored the ability to initiate RNA replication (Yin 
et al., 2003). An alternative mechanism could be envisaged in which the replicase 
complex containing VPgpC is positioned on the 39 poly(A) tail and thereby might block 
the initiation of negative-strand RNA synthesis. We speculate that the A5C transition 
mutant, accumulating a VPgpG nucleotidylylation product, may form a less-stable RNP 
complex on the 39 poly(A) tail, allowing a severely reduced yield of complementary 
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RNA strands via the alternative 39 poly(A) tail-dependent mechanism, although further 
investigation is required to elucidate the exact mechanism. 
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5.3 General conclusions 
What are the advantages for the virus in having several multi-functional cis-acting 
replication elements? Picornaviruses have very small genomes and to cover all 
required functions for the various steps in the viral life cycle, the genomes must be 
used very efficiently. This might require for the virus to have overlapping functions of 
the same element. However, in the need to organize its genome very resourcefully, the 
result of this might actually provide the virus with an advantage that ensures efficient 
RNA synthesis.   
Replication of positive-strand RNA viruses occurs in replication complexes attached to 
membranous vesicles. The advantage of a promoter for positive-strand RNA synthesis 
to be located in the positive-strand is that all required trans-acting factors for replication 
are recruited early to the replication complex. In poliovirus, the cloverleaf structure will 
recruit all necessary components for the ternary complex formation to the replication 
complex before negative-strand RNA synthesis is initiated. By using the same ternary 
complex also as a promoter for positive-strand RNA synthesis, the virus ensures that 
the required trans-acting factors for positive-strand RNA synthesis are already in the 
right location. The same is true for the viral 2CATPase protein. Since it has a role in both 
negative- and positive-strand RNA synthesis, replication can only be initiated when 
2CATPase is present in the replication complex, therefore, it will be available for both 
steps. Finally, our results that cre(2C)-derived VPgpUpU is used as a primer for both 
negative- and positive-strand RNA synthesis in coxsackievirus B3 is in total agreement 
with this idea. As demonstrated in the VPg-uridylylation experiment with the tandem 
cloverleaf constructs, VPgpUpU is accumulated in the replication complexes during 
RNA synthesis, thus, available for both steps in replication. This strategy will ensure 
efficient positive-strand RNA synthesis, and subsequently efficient virus progeny.  
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